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SUMMARY
Experiments have been conducted with Boran ( Bos 
indicus) c a tt le  to determine the factors that influence the 
duration of isometamidium (Samorin) prophylaxis against 
experimental challenge with metacyclic forms of Trypanosoma 
conoolense and Trypanosoma vivax.
The duration of a single isometamidium prophylactic 
treatment against T.conoolense ILNat 3.1 and T.conoolense 
IL 2642 was examined in 24 Boran steers with regard to ( i )  
the dose of drug, ( i i )  the level of metacyclic challenge, 
and ( i i i )  the influence of infection at the time of 
treatment with an unrelated serodeme. The c a tt le  were 
repeatedly challenged at monthly intervals between 2 and 7 
months following treatment, e ither by 5 infected Glossina 
morsitans central is or by intradermal inoculation of 5x103 
or 5xl05 in v i t r o -derived metacyclic trypanosomes. A dose 
of 1 mg kg-1 body weight afforded complete protection for 4 
months and 0.5mg kg-1 for 3 months against the two 
T.conoolense serodemes examined, irrespective of the method 
or weight of challenge. In another group of c a t t le ,  which 
had an established infection at the time of treatment, the 
duration of chemoprophylaxis against an unrelated serodeme 
was the same as the other groups which had no previous 
experience of trypanosome infection. Antibodies to 
metacyclics did not appear in any of the c a tt le  as long as 
the chemoprophylaxis was e ffec t ive . An exception to this  
was the group challenged with 5xl05 in v i t r o -derived 
metacyclic parasites, in which low antibody t i t r e s  were
detected. In a ll  cases these proved to be non-protective. 
I t  was therefore concluded that under the experimental 
conditions employed, ( i )  there was a d irect relationship  
betwen drug dosage and the duration'of chemoprophylaxis,
( i i )  the weight of metacyclic challenge did not a ffect the 
duration of chemoprophylaxis, and ( i i i )  when used to tre a t  
an existing in fection, isometamidium exerted the same 
degree of chemoprophylactic a c t iv ity .
In experiments with T.vivax. twenty Boran steers were 
infected with T.vivax transmitted by G.m.central i s : f ive  
with a T.vivax clone from Zaria, Nigeria (IL  2968), f ive  
with a T.vivax clone from K i l i f i ,  Kenya (IL  2969), f ive  
with a T.vivax population from Galana, Kenya (IL  2982) and 
f iv e  with a T.vivax population from Likoni, Kenya (IL  
2986). Eleven days a fte r  infection a ll  20 animals were 
treated with 0.5mg kg-1 isometamidium chloride. All steers 
except one infected with the Zaria T.vivax were completely 
cured. When twenty d if fe ren t Boran steers were 
administered a single prophylactic dose of 0.5mg kg-1 
isometamidium chloride and subjected to monthly 
tsetse-transmitted challenge with the same T.vivax  
populations, complete protection was afforded for two 
months against challenge with the Zaria T .v ivax . for one 
month against the Likoni T.vivax and for less than one 
month against the K i l i f i  and Galana T .v ivax . The findings 
indicated that the level of se n s it iv ity  of a T.vivax  
population to the prophylactic a c t iv ity  of isometamidium 
cannot be concluded from s en s it iv ity  studies based on the
therapeutic action of the drug.
In a s im ilar manner to studies with T.congolense. 
acquisition of immunity to homologous T.vivax challenge did 
not appear to occur whilst animals were protected by 
isometamidium and did not contribute to the apparent 
prophylactic period.
Using a T.congolense in v itro  culture system, a 
q u a lita t ive  technique was developed to detect trypanocidal 
a c t iv ity  in sera from drug-administered c a tt le :
Trypanocidal a c t iv ity ,  as detected by inh ib ition  of 
in fe c t iv i ty  and in v itro  growth of T.congolense ILNat 3 .1 ,  
was detected in sera, collected from c a tt le  as long as 5 
months a fte r  administration of lmg kg-1 isometamidium 
chloride; a c t iv ity  that correlated with susceptib ility  of 
c a tt le  to challenge with T.congolense ILNat 3 .1 .
The same technique was used to confirm the high level 
of resistance expressed by the K i l i f i  T.vivax to the 
prophylactic a c t iv ity  of isometamidium. Trypanocidal 
a c t iv i ty ,  against T.congolense ILNat 3 .1 , was detected in 
serum taken from ca tt le  1 and 2 months a fte r  administration 
of 0.5mg kg-1 isometamidium chloride, at a time when the 
c a ttle  were susceptible to challenge with the K i l i f i  
T.vivax .
Similar studies were conducted with a T.vivax in v itro  
culture system: Freshly isolated bloodstream forms of
T.vivax IL 2968 (Zaria) expressed a s im ilar level of 
s e n s it iv ity  as T.congolense ILNat 3.1 bloodstream forms to 
trypanocidal a c t iv ity  in sera from drug-treated c a t t le .
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Freshly isolated murine bloodstream forms were found to be 
better suited to the detection of trypanocidal a c t iv ity  in 
sera from drug-treated ca tt le  than freshly isolated bovine 
bloodstream forms.
I t  was concluded from in v itro  tests using 
T.congolense ILNat 3.1 and T.vivax IL 2968 that there was 
in general a positive correlation between the expression of 
trypanocidal a c t iv ity  of serum in v itro  and the 
susceptib ility  of ca tt le  to challenge with the same 
trypanosome populations. However, the r e l ia b i l i t y  of the 
in v itro  test was diminished by the observation that sera 
from untreated c a tt le  occasionally possessed trypanocidal 
a c t iv i ty .  The reason for this la t t e r  observation is , at 
present, unknown.
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Despite 65-70% of the world's livestock population 
residing within the developing countries, th is  only 
provides 30% of the world's meat output (FAO, 1975). Since 
the estimated production of animal protein from livestock  
farming per 1,000 hectares in 1975 was 542kg in Africa,  
4,113kg in Latin America and 38,083kg in Europe (FAO,
1975), African livestock farming appears to produce less 
animal protein than livestock farming in any other 
continent. I t  seems l ik e ly  that th is  situation may 
deteriorate further since A frica 's  human population 
increased by twice the rate of food production between 1980 
and 1985, and w ill  probably increase from an estimated 470 
m illion  in 1985 to 877 m illion in 2000 (Anon, 1984). An 
increase in the continent's food production is thus 
urgently required.
Probably the most s ign ificant factor l im it ing  
extension of the c a tt le  producing areas of Africa is the 
tsetse f ly ,  the vector of trypanosomiasis (FAO, 1961; ILCA, 
1985). The disease is c yc lica lly  transmitted by tsetse 
which belong to the genus Glossina (Mulligan, 1970). As 
early as 1857, David Livingstone had indicated the great 
importance of the disease in African c a tt le  and linked its  
presence with the tsetse f ly  d is tr ib u tio n . Tsetse-born 
trypanosomiasis renders approximately 10,000,000km2 of 
prime African land unsuitable for c a tt le  production 
(Swynnerton, 1936; FAO, 1961; FA0/WH0/0IE, 1982) and tsetse  
infested areas encompass 37% of the continent, including 38 
countries. I f  i t  were not for the tsetse, 7,000,000km2 of
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th is land would otherwise be suitable for livestock or 
mixed agriculture and would support an extra 140 m illion  
c a tt le  and at least the equivalent number of sheep and 
goats (FA0/WH0/0IE, 1982). In so doing, i t  would generate 
an additional yearly income of US$750 m illion at 1980 
prices (F ine lle , 1980).
Of the 147 m illion ca tt le  liv in g  within the 38 
countries in which tsetse occur, approximately 30% are 
exposed to infection (FAO/WHO/OIE, 1982; Murray and Gray, 
1984). In 1960 the potential capital value lost through 
permanent infestations was estimated to be US$5,000,000,000 
(FAO, 1982). The most severely affected countries are 
those in West and Central A frica. Thus, although 26% of 
A frica 's  human population l iv e  in 18 countries in the land 
mass from Senegal to Zaire, the same area contains only 9% 
of A frica 's  c a t t le ,  sheep and goats (ILCA, 1979). In this  
region the average livestock biomass per capita is 26kg, 
contrasting to 136 kg for the remainder of Africa south of 
the Sahara, and 79 kg for the continent as a whole (ILCA,
1979). I f  one could remove trypanosomiasis from th is  
region, the average c a tt le  carrying capacity would increase 
from the current 3.4 ca tt le  knr2 to a potential of 20 knr2. 
In addition, the small ruminant population would increase 
approximately f ive  fold (FAO, 1974).
In Southern and Eastern Africa the situation in many 
areas is no better, with up to 70% of the land infested by 
tsetse (e .g . ,  Tanzania (FAO, 1974)).
Tsetse, by v irtue of trypanosomiasis transmission,
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exclude c a tt le  from considerable areas. Where c a tt le  are 
kept in association with tsetse, severe losses occur in 
livestock production; poor growth, weight loss, lowered 
milk y ie ld , reduced traction capability , i n f e r t i l i t y  and 
abortion (FA0/WH0/0IE, 1963; McDowell, 1977). The annual 
meat production loss due to trypanosomiasis has been 
estimated to be US$5 b i l l io n  (FA0/WH0/0IE, 1963).
During the 1890's the rinderpest panzootics removed 
tsetse food sources and thus produced a large scale 
regression in tsetse-infested areas. However, most areas 
from where they disappeared have subsequently been 
reinfested (MacLennan, 1980). Since the 1950's, widespread 
t e r r i to r ia l  expansions of tsetse infestation in savanna 
areas has occurred. Since 1952, Glossina morsitans has 
re-occupied at least 25,900km2 of central and northern 
Nigeria. Since 1950, G.morsitans in central Cameroon has 
re-occupied 20,860km2 (MacLennan, 1980) and in south west 
Zambia, G.morsitans has re-occupied 11,700km2 since 1953 
(MacLennan, 1975). Similar advances are also known to be 
occurring in South-East Angola (FAO, 1979; MacLennan,
1980).
Because of the expansion of tsetse-infested areas, 
increasing pressure is being exerted on tsetse-free  
pastures, resulting in pasture degradation, decreased 
output and increased production costs. To meet the needs 
of the increasing African population, and to a l le v ia te  the 
pressure on the tsetse-free regions, the African farmer 
w il l  have to u t i l is e  the tsetse-infested regions (ILCA,
"  5  ■
1985).
BOVINE TRYPANOSOMIASIS - THE DISEASE SYNDROME
As early as 1857 a disease syndrome associated with 
the b ite  of the tsetse f ly  was described by Livingstone. A 
few days a fte r  being b itten , c a tt le  were observed to 
develop an oculonasal discharge, submandibular, and 
occassional ventral abdominal, swelling and progressive 
emaciation.
In the ensuing years three d is t in c t species of 
trypanosomes belonging to d if fe re n t sub-genera, and la te r  
shown to be pathogenic for domestic ruminants (Fiennes, 
1950; Mulligan, 1970), were id en tif ied : Trypanosoma brucei 
brucei (subgenus Trvpanozoonl (Plimmer and Bradford, 1899), 
T.(Nannomonasl congolense (Broden, 1904), T .(Duttonella)  
viyax (Ziemann, 1905). All three trypanosome species are 
found throughout the tsetse-infested areas with mixed 
infections being common in the f ie ld  (Stephen, 1970).
The two most commonly used techniques for 
id en tif ic a t io n  of the three species in the f ie ld  are e ither  
morphological differences on stained fixed blood smears or 
characteristic  m o til ity  behaviour when observed in a fresh 
blood f ilm  (see table 1).
Because of the occurrence of mixed infections and also 
the wide variation in species virulence, c learly  defined 
c lin ic a l syndromes are by no means the usual. However, 
studies on f ie ld  and experimental infections have indicated 
three main types of disease syndrome in c a tt le  (Morrison,
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Murray and Akol, 1985):
1) ANAEMIA AND EMACIATION /  POOR GROWTH
The most common c lin ica l syndrome associated with 
bovine trypanosomiasis is that of progressive anaemia, the 
"cardinal c lin ica l sign" (Hornby, 1921; Murray, 1974), 
associated with a persistent fluctuating parasitaemia 
(Morrison et a l . .  1981; Murray, 1979). All three 
pathogenic trypanosome species may produce this syndrome.
The outcome of the disease depends on a number of 
factors; the level of challenge, species of trypanosome 
(Hornby, 1952), breed of ca tt le  (Morrison et a l . ,  1981), 
the species of tsetse f ly  (Harley and Wilson, 1968), the 
absence or presence of intercurrent helminth infection  
(G r i f f in ,  Allonby and Preston, 1981; Specht, 1982) and 
probably the level of nu tr ition  (Morrison et a l . .  1981). 
Generally, the pack red cell volume per cent (PCV) 
undergoes a progressive decrease to approximately 20% over 
the f i r s t  4-6 weeks of in fection. In some animals the PCV 
continues to decline until death occurs, in others i t  is 
maintained at th is  low level for a variable period of time. 
In some of these animals death eventually occurs, however 
in others, a fte r  the disappearance of parasitaemia, the PCV 
rises and the animal recovers (Morrison et a l . .  1981).
2) ACUTE T .V I V A X  SYNDROME
An acute haemorrhagic syndrome in which death occurs 2 
to 4 weeks a fte r  infection has been described in East 
Africa and is associated with certain isolates of T.vivax
- 8 -
(Hudson, 1944; Mwongela, Kovatch and Fazil ,  1981). A 
hyperacute syndrome associated with T.vivax infection was 
f i r s t  recorded in 1923 in Dar es Salaam, Tanganyika.
Cattle in good body condition died a fte r  a b r ie f  il lness  
(Anon, 1923). ' Cornell (1936) reported sim ilar acute 
T.vivax infections in Mbulu d is t r ic t ,  Tanganyika. In 
Kenya, acute T.vivax haemorrhagic syndromes have been 
described in which death occurred a fte r  a short i l lness  
(Hudson, 1944; Lewis, 1949; Anon, 1966; Mwongela et_al_., 
1981; Wellde, Chumo, Adoyo, Kovatch, Mwongela and Opiyo,
1983). An outbreak of acute T.vivax infections has also 
been described in Ethiopia (Roeder, Scott and Pegram,
1984).
The syndrome is characterised by pronounced pyrexia, 
persistent high levels of parasitaemia and, in the 
haemorrhagic form, blood-stained diarrhoea (Hudson, 1944; 
Lewis, 1949; Anon, 1966; Mwongela et a l . .  1981; Wellde et 
a l . ,  1983). Gross pathological changes described for the 
haemorrhagic form include diffuse petechial or ecchymotic 
haemorrhages on a ll  visceral surfaces, and haemorrhage 
into the alimentary trac t  (Hudson, 1944; Anon, 1966; 
Mwongela et a l . .  1981).
3) MENINGOENCEPHALITIS
Early studies on human African trypanosomiasis 
("sleeping sickness") described a meningoencephalitic stage 
(Thomas and Breinl, 1905; Mott, 1906) associated with 
infections by both T.brucei rhodesiense and T.brucei
- 9 -
gambiense. This, so called stage I I  form of the disease, 
is conventionally defined by the presence of trypanosomes 
in the central nervous system (CNS) as assessed by lumbar 
puncture (WHO, 1979). Compared to infections with 
T.congolense and T.vivax in c a t t le ,  T.brucei is considered 
to be the least pathogenic, based on the severity of 
anaemia produced and the level of parasitaemia (Fiennes, 
1970; K illick-Kendrick, 1971). However, c lin ic a l  
abnormalities of the central nervous system are observed 
when c a tt le  are infected with certain serodemes of T.brucei 
(Losos and Ikede, 1972; Morrison, Murray, Whitelaw and 
Sayer, 1983). Affected animals showed a gradual loss of 
body condition over 2-6 weeks prior to death. Signs of CNS 
involvement were always observed: depression, unsteady 
g a it ,  head pressing and in some, c irc l in g . One to three 
days before death the animals became recumbent and 
exhibited opisthotonus and paddling of the limbs. In those 
c a tt le  that developed CNS disease the pathological changes 
were very sim ilar to those described for fa ta l cases of 
human trypanosomiasis (Mott, 1907; Manuelidis, Robertson, 
Amberson, Polak and Haymaker, 1965; Morrison et a l . .  1983). 
In both cases an extensive in f i l t r a t e ,  composed of 
lymphocytes, plasma cells  and macrophages, occurred in the 
meninges and perivascularly in the Virchow-Robin spaces. A 
bovine CNS syndrome has been described in two situations;  
f i r s t l y  as a primary infection with certain serodemes of 
T.brucei and, secondly, varying periods a f te r  c a tt le  
infected with T.brucei were treated with the trypanocidal
- 10 -
drug Berenil (diminazene aceturate, Hoechst, Frankfurt, W. 
Germany) (Morrison et_a]_., 1981). A sim ilar disease 
syndrome has been described in ca tt le  experimentally 
infected with T.b.rhodesiense (Wellde, Kovatch, Hockmeyer, 
Owiti, Masaba and Arap Siongok, 1980). I t  therefore has to 
be questioned as to whether some putative populations of 
T.b.brucei are in re a l i ty  T.b.rhodesiense. Morrison et a l . 
(1983) described one cow, which developed CNS disease. A 
population of trypanosomes was found which was resistant to 
lys is  by human serum in the blood incubation in fe c t iv i ty  
te s t ,  despite the fact that the population (GUTat 3.1) used 
to in fect the animal was sensitive to human serum. The 
authors suggested that a clear d istinction between the two 
subspecies T.brucei brucei and T.b.rhodesiense. did not 
ex is t, but instead that each serodeme can elaborate 
variants that are, or are not, in fective for man.
PATHOGENESIS
THE CHANCRE - The local skin reaction
Subsequent to the successful b ite  of an infected 
tsetse f ly  a local skin reaction of variable in tensity  
develops several days a fte r  challenge in susceptible 
domestic animals and man. This occurs in association with 
the establishment of metacyclic trypanosomes (Emery, Akol, 
Murray, Morrison and Moloo, 1980a). Since the lesion in 
domestic livestock is analogous to that considered 
pathognomonic of primary syphilis in man i t  has been termed 
the "chancre" (Stargardt, 1914). Localised skin swellings
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associated with the b ite  of tsetse have been described both 
in man (Manson, 1903; Ringenbach, 1913) and ca tt le  
(Livingstone, 1857). However, i t  was not until Kleine 
(1909) demonstrated that the tsetse f ly  was the vector of 
trypanosomiasis that the development of a chancre was 
realised to be the f i r s t  sign of infection.
That the skin reaction represents a response towards 
the trypanosome was shown by the fa i lu re  of bites from 
uninfected tsetse f l ie s  to e l i c i t  any such reaction (Emery 
and Moloo, 1980; Akol and Murray, 1982). Immediate 
hypersensitivity reactions associated with the bites of 
uninfected tsetse have been described in goats (Nash,
1970), c a tt le  (Akol and Murray, 1983) and humans (Lester 
and Lloyd, 1928; Gordon and Crewe, 1948) though these were 
assumed to be hypersensitivity reactions to tsetse saliva  
since they only occurred in animals previously b itten . A 
sim ilar immediate wheal and f la re  reaction, occurring 2-3 
minutes post tsetse-feed, also occurred in c a tt le  receiving 
several bites from infected tsetse. The response developed 
independently of any subsequent chancre reaction (Akol and 
Murray, 1983). This is in contrast to the chancre which 
begins as a nodular lesion 5-10 days a fte r  an infected bite  
(Luckins and Gray, 1978; Emery and Moloo, 1980).
Chancres have been reported to occur in a ll  domestic 
ruminants following tsetse-transmitted infection with the 
three pathogenic trypanosome species.
In c a t t le ,  chancres have been described following 
experimental infection with T.congolense (Roberts, Gray and
- 12 -
Gray, 1969; Bolton, 1970; Luckins and Gray, 1978; Gray and 
Luckins, 1979, 1980a,b; Murray, Barry, Morrison, Williams, 
Hirumi and Rovis, 1980; Emery et a l . ,  1980a; Akol and 
Murray, 1981, 1982, 1983), T.vivax (Emery et a l . ,  1980a; 
Akol and Murray, 1981, 1983) and T.b.brucei (Emery et a l . ,  
1980a; Akol and Murray, 1981, 1983).
In goats, chancres have occurred following 
experimental infection with T.congolense (Emery and Moloo,
1981); T.vivax (Emery and Moloo, 1981) and T.b.brucei 
(Emery and Moloo, 1980; Barry and Emery, 1984).
In sheep, chancres have also been experimentally 
produced following f ly  infection with T.congolense 
(Uilenberg, M aillo t and Giret, 1973; Gray and Luckins,
1979, 1980a,b).
In addition to tsetse inoculation of metacyclic 
trypanosomes, intradermal syringe inoculation has also been 
shown to e l i c i t  chancre development (Bolton, 1970; Luckins, 
Rae and Gray, 1981; Akol and Murray, 1982).
The development of a chancre is not indicative of 
subsequent systemic infection since chemoprophylactic 
studies in rabbits have shown that chancres can occur 
without the subsequent development of parasitaemia (Silayo,
1984).
Trypanosomes may be found in f lu id  aspirated from the 
skin lesions several days before detection in the 
peripheral blood (W ille t  and Gordon, 1957; Seed and Gam, 
1967; Bolton, 1970; Luckins and Gray, 1978; Emery et a l . .  
1980a). Thus the chancre appears to i n i t i a l l y  r e s tr ic t
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systemic migration of the trypanosomes. The a b i l i ty  of the 
skin to re s tr ic t  the immediate spread of trypanosomes has 
been suggested to be associated with a physiological 
response of the skin and also with the skin thickness 
(Emery and Moloo, 1980) since chancres are not a feature of 
the thin-skinned smaller laboratory animals; namely mouse, 
ra t and guinea pig (W ille t  and Gordon, 1957; Emery and 
Moloo, 1980). In these animals, trypanosomes appear to be 
deposited subcutaneously and rapidly enter the bloodstream 
(W il le t and Gordon, 1957).
In domestic livestock, a fte r  p ro life ra tio n  at the 
level of the skin, trypanosomes reach the systemic 
circulation via the lymph stream (Emery, Barry and Moloo, 
1980b; Barry and Emery, 1984).
The development and degree of skin reaction can vary 
greatly . In tr in s ic  differences occur between serodemes of 
T.congolense. with some regularly inducing reactions and 
others consistently fa i l in g  to do so (Gray and Luckins, 
1980a). The degree of skin reaction is also dependent on 
the number of trypanosomes inoculated (W ille t  and Gordon, 
1957; : Emery et a l . .  1980a; Emery
and Moloo, 1981; Luckins et a l . .  1981). Similar 
conclusions can be drawn from studies on the lesion 
e lic i te d  by each trypanosome species. Based on daily  
examination of saliva, Otieno and Darji (1979) suggested 
that tsetse extrude fewer T.vivax metacyclics than 
T.congolense metacyclics, whilst tsetse infected with 
T.brucei extrude much greater numbers of metacyclic
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trypanosomes than f l ie s  infected with T.congolense (Moloo, 
S.K., unpublished data). In a comparison of the skin 
reactions e l ic i te d  in goats by metacyclic forms of T .v ivax , 
T.congolense and T.brucei. that induced by T.vivax was the 
least dramatic and the chancre produced by T.brucei 
appeared 3-4 days e a r l ie r  than with the other two species 
(Emery and Moloo, 1980, 1981).
H isto logically  the skin at the s ite  of the tsetse b ite  
undergoes marked changes in c e l lu la r i ty  and structure. 
Generally, between approximately day 8 and 15 there is 
progressive disorganisation and degeneration of dermal 
collagen, during which a large c e llu la r  in f i l t r a t e  occurs. 
Between day 14 and 21 the inflammation subsides. The 
trypanosomes appeared most numerous in reactions up to 
approximately day 12 but were s t i l l  detected in low numbers 
until at least day 30 in calves (Gray and Luckins, 1979, 
1980b).
In goats, the c e llu la r  in f i l t r a t e  e l ic i te d  by T.brucei 
was characterised i n i t i a l l y  by a pronounced in flux  of 
polymorphonuclear leucocytes (PMN) which were replaced by 
plasma cells  and macrophages during regression of the 
lesion (Emery and Moloo, 1980). That produced by 
T.congolense was approximately s im ilar. In contrast, the 
c e llu la r  in f i l t r a t e  in response to T.vivax was composed 
mainly of lymphocytes and macrophages with a minimal PMN 
contribution (Emery and Moloo, 1981). The involvement of 
PMN appeared to paralle l the level of inflammation and 
tissue oedema. Gray and Luckins (1979, 1980b) demonstrated
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that the c e llu la r  in f i l t r a t e  associated with T.congolense 
infection in c a tt le  consisted principa lly  of lymphocytes 
and macrophages. Akol and Murray (1982) described a 
sim ilar constructed experiment in which the in i t i a l  intense 
inflammatory reaction contained numerous PMN which were 
la te r  replaced by lymphocytes and plasma ce lls .
Differences in virulence or antigenicity  of the d if fe ren t  
trypanosome stocks used in the two reports, as well as the 
timing of the skin biopsy, may account for the differences 
in c e llu la r  in f i l t r a t e  described (Akol and Murray, 1982). 
The in i t i a l  c e llu la r  in f i l t r a t e  is probably a response to 
chemotactic factors (Cook, 1980) as well as other factors 
generated by parasites that increase vascular permeability 
(Tizard and Holmes, 1977). Subsequent c e llu la r  in f i l t r a te s  
probably occur in association with an immune response to 
surface antigens of the parasite, although the exact nature 
of th is  response is as yet unknown.
ANAEMIA
The development of anaemia is a characteristic  
occurrence in c a tt le  infected with both T.congolense 
(Hornby, 1921, 1929, 1952; French and Hornby, 1935;
Fiennes, 1950, 1954) and T.vivax (Johnson, 1941; Hudson, 
1944; Hornby, 1952; Stephen, 1965a; Godfrey, Leach, Roberts 
and Killick-Kendrick, 1968; Fiennes, 1970) so much so that  
i t  has been termed the "cardinal sign" and "major 
disease-promoting factor" of bovine African trypanosomiasis 
(Hornby, 1921; Murray, 1974).
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Murray (1979) divided the disease into three stages 
according to the absence or presence of trypanosomes and on 
c lin ic a l and pathological findings:
During the f i r s t  stage, which may last anything from 3 
to 12 weeks (Murray, 1979) the onset and severity of 
anaemia correlates with the level and duration of 
parasitaemia (Jennings, Murray, Murray and Urquhart, 1974; 
Holmes and Mamo, 1975; Holmes and Jennings, 1976; Dargie, 
Murray, Murray and McIntyre, 1979b). Numerous reports have 
described the anaemia during this stage as haemolytic 
(Fiennes, 1954; Naylor, 1971; Woodruff, Z ieg ler, Hathaway 
and Gwata, 1973; Jennings et a l . .  1974; Murray M., Murray, 
Jennings, Fisher and Urquhart, 1974; Mamo and Holmes, 1975; 
Holmes and Jennings, 1976; V a l l i ,  Forsberg and McSherry, 
1978a; V a ll i  and M il ls ,  1980) and being intravascular in 
origin (Fiennes, 1954; Esievo, Saror and Adegoke, 1984); 
although extravascular haemolysis has been described 
(Naylor, 1971).
The haemolytic nature of the anaemia appears to be 
multi fac to ria l in orig in (Murray, 1979) and depends on the 
presence of trypanosomes. The production of a haemolysin 
by trypanosomes was postulated by Fiennes (1950). Studies 
in v itro  with T.brucei have lead to the characterisation  
and purif ica tion  of a haemolytic pronase-sensitive factor  
(Chi, Webb, Lambert and Miescher, 1975, 1976). In 
addition, free fa tty-ac ids and phospholipase A, exhibiting  
haemolytic a c t iv i ty ,  have been shown to be released by 
T.congolense undergoing autolysis (Tizard and Holmes, 1976;
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Tizard, Holmes and Nielsen, 1978a,b). Work conducted with 
T.brucei-infected rats indicated that haemolytic factors 
were also operative in v i t r o , although the a c t iv ity  was 
generated by dying trypanosomes (Murray, 1979). F ina lly ,  
workers have postulated that at high levels of parasitaemia 
in T.vivax infections of c a tt le ,  trypanosomes produce 
neuraminidase which cleaves erythrocyte surface s ia l ic  
acid, predisposing the cells  to physiological damage and 
phagocytosis by the mononuclear phagocytic system (Esievo, 
Saror, Ilemobade and Hall away, 1982).
A state of pyrexia often occurs during trypanosome 
infections. Since red blood ce lls  exposed to temperatures 
a few degrees above normal have a shortened h a lf  l i f e  in  
vivo, associated with increased osmotic f r a g i l i t y  (Karle,
1969), pyrexia may contribute towards red cell damage and 
destruction (Murray, 1979).
An association between parasite destruction and 
haemolysis has been reported (Fiennes, 1970; Kobayashi, 
Tizard and Woo, 1976). A phenomenon observed in many 
immune-complex diseases is that preformed 
antigen-antibody-complement complexes may be adsorbed onto 
erythrocytes (Worledge, 1973). In trypanosomiasis, the 
occurrence of glomerulonephritis (Lambert and Houba, 1974), 
high immunoconglutinin levels (Ingram and Soltys, 1960) and 
rheumatoid factors (Klein, Mattern and Meuwissen, 1971) 
indicate that immune complexes are produced. Woo and 
Kobayashi (1975) have shown that trypanosome antigens can 
be adsorbed onto the surface of rabbit red blood cells
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which, in the presence of homologous antibody and 
complement are lysed. In T.congolense-infected calves, 
trypanosome specific IgG and IgM have been eluted from the 
surface of red blood cells  (Kobayashi et a l . .  1976). 
Antigen-anti body complexes adherent to red blood ce lls  have 
also been described in c a tt le  infected with T.vivax but not 
with T.congolense (Maxie, Losos and Tabel, 1976).
In stage 1 of the anaemia, splenomegaly is a 
consistent finding (Murray, 1979) and is due to a 
combination of lymphoid hyperplasia and erythrophagocytosis 
(MacKenzie and Cruickshank, 1973; Jennings et a l . .  1974; 
Murray M. et a l . .  1974).
The exact mechanism in it ia t in g  red blood cell removal 
from the c irculation is unclear, though there is much 
evidence for the operation of immune mechanisms 
predisposing cells  to phagocytosis (Zoutendyk and Gear, 
1951; Ingram and Soltys, 1960; Woodruff, 1973; Woo and 
Kobayashi, 1975; Kobayashi et a l . .  1976; Maxie et a l . ,
1976).
Haemodilution also appears to play a s ign ificant part 
in the aetiology of the anaemia in c a tt le  infected with 
e ither T.congolense or T.vivax (Fiennes, 1954; Clarkson, 
1968; Naylor, 1971; Holmes and Mamo, 1975; V a ll i  et al ♦, 
1978a) although subsequent work with both T.congolense and 
T.brucei in N'Dama and Zebu ca ttle  has shed doubt on this  
finding (Dargie, Murray, Murray, Grimshaw and McIntyre, 
1979a; Dargie et a l . .  1979b).
During stage 1 of the anaemia in rabbits and c a t t le ,
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erythropoiesis is e ither unaffected or increased (Boreham 
and Goodwin, 1966; Holmes and Mamo, 1975; Holmes and 
Jennings, 1976; Dargie et a l . ,  1979b).
With both T.vivax and T.congolense infections in 
c a ttle  a macrocytic normochromic anaemia occurs. However, 
as the disease progresses to stage 2 and 3 the anaemia 
becomes normocytic normochromic (Fiennes, 1950, 1954; 
Naylor, 1971; Maxie et a l . .  1976; V a ll i  et a l . .  1978a).
Mamo and Holmes (1975) descibed the anaemia as being 
normocytic normochromic in stages 1. In many animals death 
occurs at this stage. However, in some animals a further  
two stages are observed:
Stage 2 of the anaemia is characterised by 
in term ittent low level parasitaemia and by a persistent low 
level anaemia. Haemolysis continues, and is associated 
with sustained hyperactivity of the mononuclear phagocytic 
system (Murray, 1979). Despite this fac t, splenomegaly is 
no longer prominent and the level of haemosiderin 
deposition throughout the body is increased.
Stage 3 is characterised by the absence of 
trypanosomes both in the blood and tissues and animals may 
either remain anaemic or recover.
Cattle may die in stage 2 or stage 3 of the disease 
(Murray, 1979).
PYREXIA
In T.congolense infections, persistent low level 
pyrexia has been described in acute infections,
-  2 0  -
in term ittent low level pyrexia in subacute disease and 
occasional pyrexia in chronic disease (Fiennes, 1970; 
Hornby, 1952; V a l l i ,  Forsberg and Robinson, 1978b). In 
contrast, T.vivax infections in ca tt le  are commonly 
characterised by pyrexia (Hudson, 1944; H i l l  and Esuruoso, 
1976; Van den Ingh, Zwart, Van Miert and Schotman, 1976; 
Esuruoso, 1977; Maxie, Losos and Tabel, 1979; Obi and 
Anosa, 1980; Mwonoela et a l . .  1981). Furthermore, Maxie et 
a l.  (1979) showed that throughout the entire  infection  
there was a s ign ificant positive correlation between the 
daily  level of parasitaemia and the temperature elevation  
in a group of ca tt le  infected with T.vivax but not in a 
group of c a tt le  infected with T.congolense.
During infections with both T.vivax and T.congolense 
periods of pyrexia have been associated with periods of 
parasitaemia (Hudson, 1944; Fiennes, 1950, 1970; Van den 
Ingh et a l . .  1976), while normal temperatures occurred 
during periods of aparasitaemia. The highest temperatures 
observed in bovine trypanosomiasis (104+°F) have been 
described in association with the severest c lin ic a l  
syndrome; haemorrhagic T.vivax (Hudson, 1944).
Reports on the pathogenesis of pyrexia in 
trypanosomiasis are lacking. Presumably, in response to 
contact with trypanosome antigens, endogenous pyrogen is 
released from phagocytic ce lls  resulting in the 
hypothalamic thermoregulatory set point being elevated 
(Kluger, 1981).
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HAEMORRHAGIC T . V I V A X
Since haemorrhagic T.vivax often presents as a 
hyperactil/e syndrome, with animals dying as l i t t l e  as 14 
days post infection (Hudson, 1944), dead animals are often 
found in good bodily condition. The main pathological 
findings are generalised petechial and ecchymotic 
haemorrhages on mucosae and serosae. Often, frank 
in testina l haemorrhages also occur (Hudson, 1944; Morrison 
et a l . .  1981; Mwongela et a l . .  1981; Wellde et a l . ,  1983).
The development of severe thrombocytopaenia has been 
the major factor implicated in the development of the 
haemorrhages (Van den Ingh et a l . ,  1976; Wellde et a l . ,
1983). Prolonged bleeding and prothrombin times, increased 
levels of fibrinogin (Wellde et a l . .  1983) and the presence 
of f ib r in  degradation products (Van den Ingh et a l . ,  1976; 
Wellde et a l . .  1983) indicate that disseminated 
intravascular coagulation may be responsible for the 
thrombocytopaenia.
IMMUNOLOGICAL MECHANISMS ASSOCIATED WITH 
BOVINE-TRYPANQSQMIASIS
ANTIGENIC VARIATION
The entire  trypanosome plasma membrane of the body and 
flagellum is covered in a surface coat, 12-15nm thick  
(Vickerman, 1969; Vickerman and Luckins, 1969). When 
bloodstream forms of T.brucei are ingested by the tsetse  
f ly  the coat is shed. Only, when the trypanosome has
-  2 2  -
transformed through to the metacyclic stage, in the 
salivary gland, is the coat reacquired (Barry and 
Vickerman, 1979). The major constituent of the surface 
coat, isolated from T.brucei. is a glycoprotein (molecular 
weight approximately 65,000, as determined by sodium 
dodecyl sulphate gel electrophoresis) (Cross, 1975). 
Immunisation of mice with purified surface glycoprotein 
conferred protection against challenge with a small number 
of homologous, but not heterologous, trypanosomes.
The iden tity  of any bloodstream or metacyclic 
trypanosome is based on the antigen expressed on i ts  
surface; the "variable antigen type" or VAT. Thus, an mVAT 
denotes the antigenic type expressed by a particu lar  
metacyclic trypanosome and bVAT the antigenic type 
expressed by a particu lar bloodstream trypanosome. A VAT 
reperto ire consists of a ll  the VATs that can po ten tia lly  be 
expressed by a cloned trypanosome, and a serodeme refers to 
a clonally  derived population expressing a certain VAT 
reperto ire, as determined serologically (W.H.O., 1978).
The number of serologically d if fe ren t variant specific  
surface antigens (VSSAs) that can be expressed in a 
population derived from one trypanosome is unknown. 
Serological studies with T.b.eouiperdum have shown there to 
be at least 101 (Capbern, Giroud, Baltz and Mattern, 1977). 
Until very recently variant specific antibody was thought 
to be responsible for inducing antigenic variation  
(Vickerman, 1978). However, in v i t r o , in the absence o f  
any immune response mechanisms, antigenic variation s t i l l
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occurred (Doyle, Hirumi, Hirumi, Lupton and Cross, 1980) 
and thus "nailed this particu lar theory in its  coffin"  
(Vickerman, Barry, Hajduk and Tetley, 1980).
Regardless of the T.congolense or T.brucei bVAT 
ingested by the f ly  the mVAT reperto ire, consisting of 
several d if fe re n t VATs (LeRay, Barry and Vickerman, 1978; 
Nantulya, Musoke, Moloo and Ngaira, 1983), is constant for  
a given serodeme (Jenni, 1977a,b; Vickerman et a l . .  1980; 
Esser, Schoenbechler, Gingrich and Diggs, 1981).
The mVAT repertoire appears to be more lim ited than 
the bVAT repertoire (Nantulya et a l . ,  1983). Thus, Crowe, 
Barry, Luckins, Ross and Vickerman (1983) described the 
mVAT repertoire of a T.congolense stock as consisting of 12 
d iffe re n t VATs.
Subsequent to an infected f ly  b iting an animal, the 
VATs of the extruded T.brucei metacyclic trypanosomes 
continue to be expressed in the bloodstream trypanosome 
population present during the f i r s t  parasitaemic wave 
(Barry, Hajduk, Vickerman and LeRay, 1979; Hajduk and 
Vickerman, 1981; Esser et a l . ,  1981; Barry and Emery,
1984). I t  appears that a ll  mVATs of T.brucei and 
T.congolense are expressed as bVATs (Nantulya, Musoke, 
Rurangirwa and Moloo, 1984). These findings explain the 
finding of Gray (1965); a fte r  cyclic transmission by tsetse  
there were certain VAT(s) that appeared in the f i r s t  
parasitaemic wave, termed the basic antigen(s), 
characteristic  for each trypanosome lin e .
Thus, a combination of spontaneous antigenic variation
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and immune selection appear to be responsible for the 
parasitaemia cycling observed in animals (Esser, 
Schoenbechler and Gingrich, 1982).
F ina lly , although a VAT may have been expressed i t  
does not prevent i ts  re-expression (Nantulya, Musoke,
Barbet and Roelants, 1979; Nantulva et a l . ,  1984). This 
fact may explain the self-cure phenomenon (Nantulya et a l . ,
1984).
IMMUNOLOGICAL CHANGES DURING TRYPANOSOMIASIS
Work in mice has shown much evidence that antibody is 
the most important effector mechanism in immunity to 
trypanosomiasis. Immunity to homologous variant was 
passively transferred via serum from an immunised mouse 
(Campbell and P h ill ip s , 1976). The transfer of splenic 
ce lls  from an immunised mouse also conferred immunity 
(Luckins, 1972a; Campbell and P h ill ip s , 1976) and of this  
cell population, a B-cell rich fraction rather than a 
T-cell rich fraction was shown to confer the immunity 
(Campbell and P h ill ip s , 1976). B-cell defic ien t mice, to 
which anti-u-serum was administered from b irth , could not 
be immunised with irradiated trypanosomes and were highly 
susceptible to infection (Campbell, Esser and Weinbaum,
1977). In contrast, congenitally athymic mice could be 
read ily  immunised with irradiated trypanosomes (Campbell, 
Esser and P h ill ip s , 1978). Parasite VAT-specific antibody 
responses appear to be responsible for elimination of 
trypanosomes (Murray and Urquhart, 1977). For example, in
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c a tt le  infected with T.congolense. weekly collection of 
trypanosomes and serum showed that trypanosome populations 
were only neutralised in serum collected one or more weeks 
a fte r  collection of the trypanosome population (Wilson and 
Cunningham, 1972). In addition, a close correlation has 
been demonstrated between the degree of protection and the 
neutralising antibody t i t r e  (Morrison, Black, Paris, Hinson 
and Wells, 1982a; Wells, Emery, Hinson, Morrison and 
Murray, 1982).
Hypergammaglobulinaemia is a consistent finding in 
bovine trypanosomiasis, and soon a fte r  infection is largely  
due to elevated IgM levels (Luckins, 1972b,c, 1976;
Clarkson and Penhale, 1973; Clarkson, Penhale, Edwards and 
F a rre l l ,  1975; Kobayashi and Tizard, 1976; Nielsen, 
Sheppard, Holmes and Tizard, 1978a). In fac t, elevated IgM 
levels have been said to possibly be indicative of 
trypanosome infection (Luckins, 1972c). Only s ligh t  
alterations occurred in IgGi and IgG2 levels during 
infection (Luckins, 1976; Nielsen et a l . .  1978a) although 
elevated IgG levels have been described (Luckins, 1972c). 
Since the rates of catabolism of IgGi, IgG2 and IgM 
increased 9 fo ld , 13 fold and 5 fo ld , respectively, there 
was a large increase in production of a l l  three antibody 
isotypes. Trypanosome neutralising antibody a c t iv ity  in 
the f i r s t  part of the infection occurred in these 
fractions, especially IgM (Luckins, 1976; Musoke, Nantulya, 
Barbet, Kironde and McGuire, 1981). However, from the 
second parasitaemic peak onwards the IgG fraction exhibited
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the principle neutralising a c t iv ity  (Seed, 1972; Musoke et 
a l . ,  1981).
In laboratory animals IgM appears to be the important 
isotype in controlling parasitaemia and conferring 
protection (Campbell et a l . .  1978) and there is evidence 
for the same in c a tt le  (Luckins, 1976). Small animal 
studies have shown that some of the immunoglobulin is not 
directed towards trypanosome antigen and consists of 
heterophile antibodies, in addition to rheumatoid factors  
and a range of autoantibodies. Workers have suggested that 
th is  is associated with polyclonal B-cell activation  
(Houba, Brown, and Allison, 1969; Hudson, Byner, Freeman 
and Terry, 1976; Corsini, Clayton, Askonas and Ogilvie, 
1977; Morrison, Roelants, Mayor-Withey and Murray, 1978), 
thereby resulting in exhaustion of B-lymphocyte potentia l,  
as observed in chronic infections. However, th is  may not 
occur in c a tt le  since absorption with VATs isolated during 
the entire  infection showed a ll  the IgM and IgGi produced 
during the f i r s t  3 weeks of infection to be VAT specific  
(Musoke et a l . ,  1981).
Immunoglobulin changes in ca tt le  accompany a 
hypocomplementaemia (Nielsen, Sheppard, Holmes and Tizard, 
1978b; Kobayashi and Tizard, 1976) which may be associated 
with trypanosomes producing complement activating  
substances or with increased complement catabolism. The 
presence of complement binding antigen-antibody complexes 
along with increased levels of immunoconglutinin, in 
laboratory animal infections, indicates widespread
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u t i l is a t io n  and f ixation  of complement (Murray, P., 
Jennings, Murray and Urquhart, 1974).
Goodwin (1970) and Goodwin, Green, Guy and Voller
(1972) reported on the immunodepressive e ffec t of 
trypanosomiasis; they demonstrated depression of humoral 
responses to non-trypanosomal antigens during trypanosome 
infections of small animals. Altered macrophage a c t iv ity  
(Grosskinsky and Askonas, 1981) and generation of 
suppressor T-ce lls  (Eardley and Jayawardena, 1977) have 
both been described in small animal infections, and, in 
addition to a decreased ha lf  l i f e  of serum immunoglobulins 
(Nielsen et a l . .  1978a), may act together or separately to 
bring about immunodepression.
Suppression of antibody responses in infected ca ttle  
to several v ira l and bacterial vaccines have been examined; 
polyvalent c lo s tr id ia l  vaccine (Holmes, Mammo, Thomson, 
Knight, Lucken, Murray, Murray, Jennings and Urquhart,
1974) Vibrio foetus antigen (Mackenzie, Boyt, Emslie,
Lander and Swanepoel, 1975), foot and mouth disease vaccine 
(Scott, Pegram, Holmes, Pay, Knight, Jennings and Urquhart, 
197.7), lo up in g -il l  vaccine (Whitelaw, Scott, Reid, Holmes, 
Jennings and Urquhart, 1979) and Brucella abortus vaccine 
(Rurangirwa, Musoke, Nantulya and Tabel, 1983). Humoral 
immune responses to these vaccines appeared to be 
suppressed.
Simultaneous administration of a trypanocide on the 
day of vaccination produced a large improvement in the 
immune response to the lo up ing -il l  vaccine (Whitelaw et
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al., 1979).
In contrast to the above findings, infections with 
T.congolense or T.vivax did not s ig n if ican tly  depress the 
neutralising antibody response to l iv e  rinderpest vaccine 
when vaccination was carried out 8 or 25 days a fte r  
infection (Rurangirwa, Mushi, Tabel, Tizard and Losos, 
1980).
IMMUNITY ASSOCIATED WITH CYCLICAL INFECTION
Cattle infected by tsetse harbouring a cloned 
derivative of T.congolense. and treated with diminazene 
aceturate 3-4 weeks following in fection, were immune when 
challenged with tsetse infected with homologous clones 3-5 
weeks la te r .  Skin reactions at the s ite  of tsetse bites, 
and development of parasitaemia did not occur. However, i f  
the second challenge was conducted with a heterologous 
clone, c a tt le  developed chancres and became parasitaemic 
(Emery et a l . .  1980a; Akol and Murray, 1983). Similar  
findings have been made in goats fed on by 
T.brucei-infected tsetse (Emery et a l . .  1980a). The 
protective immunity appeared to be effected e ither at the 
level of the skin or the drainage lymph node since a skin 
reaction, indicative of trypanosome p ro life ra t io n , did not 
occur (Emery et a l . .  1980a; Akol and Murray, 1983).
Immunity to cyclical challenge also occurred with 
uncloned stocks provided the same stock was used for  
rechallenge and that i t  only consisted of one serodeme 
(Akol and Murray, 1983).
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The situation following tsetse-transmitted T.vivax  
infection appears to be very d if fe ren t to that described 
for T.congolense and T.brucei. Even when animals were 
repeatedly f ly  infected with the same serodeme and treated  
3 to 4 weeks a fte r  each infection they continued to be 
susceptible both to homologous and heterologous challenge 
(De Gee, 1980). Possibly T .vivax. a fte r  cyclical 
transformation, does not revert to a constant mVAT 
reperto ire . Secondly, since very few metacyclics are 
extruded at each feed, not a ll  the mVATs may be inoculated. 
Thirdly, rapid antigenic variation of the metacyclic 
population may occur so that there is in su ff ic ien t  
expansion of certain mVATs to stimulate protective antibody 
responses.
STRATEGIES FOR THE'cQNTROL OF TRYPANOSOMIASIS
In the absence of a vaccine for bovine 
trypanosomiasis, practical control measures include 
eradication and control of tsetse populations, the 
exploitation of trypanotolerant c a tt le  and the 
administration of antitrypanosomal drugs to c a tt le  
(Morrison et a l . ,  1981).
TSETSE CONTROL
Strategies for the control of tsetse can broadly be 
put under two major headings; chemical and non-chemical.
Chemical control consists of the application of
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insecticides, e ither from the ground or from the a i r .  Only 
three compounds have been used in large-scale f ie ld  
programmes: dichlorodiphenyltrichloroethane (DDT), d ie ldrin  
and endosulfan.
DDT was the f i r s t  of the synthetic insecticides to be 
widely used. Because of its  residual e ffect i t  is usually 
used on a single administration basis since deposits can 
remain lethal for tsetse up to one year a fte r  application  
(Baldry, 1963).
D ieldrin is also a residual insecticide. T r ia ls  have 
shown the compound to be more e ffec tive  than DDT (Burnett, 
Robinson and LeRoux, 1957) in that there was a better  
persistence of lethal deposits compared to DDT, especially  
in high ra in fa l l  areas.
Endosulfan is less persistent than DDT and d ie ld r in .  
Because of i ts  good so lu b il i ty  in spray solvents i t  is 
especially suited to administration from a irc ra f t  (Hocking, 
Lee, Beesley and Matechi, 1966).
The use of insecticides in tsetse control programmes 
can produce environmental pollution and unwanted ecological 
effects (Koeman, Rijksen, Smies, Na'Isa and MacLennan, 
1971). Of the three insecticides described, repeated 
aerial application of endosulfan appears to have less 
general adverse ecological impact (Gray, 1983). However, 
new highly active biodegradable insecticides are being 
developed which would decrease this problem (FAO, 1981).
The application of insecticides is not suited to a ll  
ecological zones. Areas of high ra in fa l l  and dense
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vegetation tend to l im it  the fe a s ib i l i ty  and efficacy of 
insecticidal application (Jordan, 1974).
A variety  of non-chemical methods have also been used 
to reduce tsetse in certain areas:
The clearance of vegetation and encouragement of human 
settlement and agricultural development, to create an 
adverse environment for tsetse, are long practiced 
successful techniques. In addition, workers have advocated 
the destruction of game to decrease the f ly  food source and 
thus the size of the natural infection reservoir (Jordan,
1974).
A wide variety  of tsetse traps have been designed and 
used for ecological studies. In recent years, tsetse traps 
have been re-examined to see i f  th e ir  catching effic iency  
could be improved, so tha t, in some circumstances, they 
might be used to control tsetse populations. Workers have 
demonstrated that the effic iency of traps could be greatly  
improved i f  a source of natural host odour (Vale, 1974; 
Hargrove and Vale, 1979) or a mixture of carbon dioxide and 
acetone (a simulated host odour) (Vale, 1980) was 
associated with the trap. l-0cten-3-ol has been id en tif ied  
as a potent olfactory stimulant for some Glossina spp. and 
in the f ie ld  has been shown to be a ttrac tive  by i t s e l f  and 
also to enhance the attractiveness of carbon dioxide and 
acetone (Bursell, 1984; H all,  Beevor, Cork, Nesbitt and 
Vale, 1984). Possibly, these developments may play a role  
in future tsetse control programmes.
A s te r i le  insect technique has also been investigated.
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A small-scale t r ia l  was conducted with G.m.morsitans in 
Rhodesia. After releases, on an island in lake Kariba, of 
puparia which had been dipped in 5% tepa, 98% control was 
obtained in 9 months (Dame and Schmidt, 1970). Failure to 
achieve G.m.morsitans eradication with the same technique 
in other areas has been attributed to inadequate isolation  
barriers and the resultant immigration of f l ie s  
(Williamson, Dame, Gates, Cobb, Bakuli and Warner, 1983).
TRYPANOTOLERANCE
The trypanotolerance t r a i t  was f i r s t  described at the 
beginning of the twentieth century when certain indigenous 
taurine c a tt le  breeds of West Africa were observed to 
survive and be productive in tsetse-infested areas (P ierre,  
1906); in particu lar the N'Dama and West African shorthorn. 
Only these two breeds survive in large numbers, without the 
aid of trypanocides, in areas where s ign ificant tsetse r isk  
exists (ILCA, 1979). In addition to these two breeds of 
c a tt le ,  many species of wild Bovidae have also been shown 
to exhibit innate resistance to trypanosomiasis (Murray, 
Morrison and Whitelaw, 1982).
N'Dama and West African shorthorn breeds constitute  
approximately 5% of the tota l c a tt le  population in the 38 
countries where tsetse occur (ILCA, 1979; FA0/WH0/0IE, 
1982). In addition, i t  is estimated that without any 
additional control measures an area of about 2 m illion  
square kilometers exists in West and Central Africa that is 
suitable for trypanotolerant c a tt le  (FAO, 1976). Their
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fa i lu re  to be exploited has been because of the breeds' 
small size and assumed low productivity. However, in areas 
of low or n il tsetse challenge, th e ir  productivity has been 
shown to be much higher than was o r ig in a lly  believed (ILCA, 
1979).
The trypanotolerance t r a i t  is not absolute since 
productivity appears to decrease as the level of challenge 
increases. Thus, N'Dama may exhibit stunting, wasting, 
abortion and even death, associated with trypanosomiasis 
(ILCA, 1979). That trypanotolerance is innate (genetically  
based) and not solely associated with acquired resistance 
to local trypanosome populations has been demonstrated 
(Murray et a l . .  1982). Using animals with no previous 
exposure to trypanosomiasis, N'Dama were s ig n if ican tly  more 
resistant to trypanosomiasis than Zebu and imported exotic 
breeds in terms of productivity and survival. The 
prevalence, leve l, duration of parasitaemia and severity of 
anaemia were s ig n if ican tly  less in trypanotolerant c a t t le .  
Because of the superior control of parasitaemia in these 
c a tt le ,  trypanotolerance was often attributed to 
differences in immune responsiveness. However, l i t t l e  data 
exists to support this theory. Murray et a l . (1982) showed 
no s ign ificant difference in antibody levels in N'Dama and 
Zebu following challenge with T.brucei bloodstream forms. 
Desowitz (1959) found that N'Dama, previously infected with 
trypanosomes, eliminated a subsequent infection more 
rapidly than Zebu with a s im ilar history. Using a 
respiratory inhib ition  test Desowitz demonstrated greater
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a c t iv ity  in the N'Dama sera as compared to Zebu sera, and 
therefore suggested that the N'Dama's trypanotolerance lay  
in th e ir  a b i l i ty  to mount a superior secondary immune 
response. However, the antigenic composition of the 
trypanosome population used was unknown. Roberts and Gray
(1973) showed l i t t l e  difference in susceptib ility  to 
primary challenge between the two breeds. However, 
following a second challenge the superior resistance of the 
N'Dama became apparent.
Using erythrokinetic studies, the superior resistance 
of N'Dama has been shown to be associated with th e ir  
capacity to control parasitaemia rather than an a b i l i t y  to 
mount a more e f f ic ie n t  erythropoietic response (Dargie et 
a l . , 1979a,b). The exact mechanism(s) underlying 
parasitaemia control in the bovine await further  
investigation.
Other factors that may play a role in trypanotolerance 
are the N'Dama's a b i l i ty  to forage, capacity for water 
conservation and heat tolerance, and skin physiology 
(Murray et a l . ,  1980).
F ina lly , in addition to exhibiting trypanotolerance, 
N'Dama also appear to be more resistant to t ic k  borne 
diseases; heartwater, anaplasmosis and babesiosis (Epstein, 
1971). They also appear to be more resistant to 
streptothricosis (Stewart, 1937; Coleman, 1967).
CHEMOTHERAPY (GENERAL)
The demonstration by Plimmer and Thomson (1908) that
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administration of ta r ta r  emetic (potassium antimony! 
ta r t ra te )  to mice infected with T.brucei or T.evansi 
effected a cure, led to the f i r s t  application of 
chemotherapy to bovine trypanosomiasis. In Tanganyika, 
Rhodesia and Zululand, regular intravenous application to 
c a tt le  in the f ie ld  demonstrated the drugs efficacy (Anon, 
1923; Bevan, 1928).
Subsequent trypanocides belong to the chemical classes 
of acid naphthylamines, diamidines, quinaldines and 
phenanthridines.
No new trypanocide for domestic livestock has been 
marketed for over 25 years, primarily because of the 
prohibitive costs in developing a new drug (Hutner, 1977; 
Goodwin, 1978) and also the re la t iv e ly  small trypanocide 
market (Leach and Roberts, 1981). The large outlay ($20-30 
m illion ) required to make a new trypanocide commercially 
available (Williamson, 1980) may deter pharmaceutical 
companies unless they are encouraged f in an c ia lly  by funds 
from non-commerical sources (Murray and Gray, 1984). There 
is certa in ly  a need to develop drugs, even though they be 
uneconomic. The co-operation of universities with industry 
under the supervision of an independent "sponsor" may 
provide an answer (Ormerod, 1976).
In addition to the lack of new trypanocides, the 
£
effectivenAss of the currently used trypanocides has been 
threatened due to the development of drug resistance. For 
further deterioration of the situation to be prevented, 
greater expenditure on testing and surveillance for drug
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resistance is required (Leach and Roberts, 1981). However, 
because of lo g is tica l and financial problems associated 
with c iv i l  insurrection, drug costs, lack of funds to 
implement control programmes, the lack of an infrastructure  
required for drug administration, scarcities of fue l,  
vehicles and diagnostic services, e rra t ic  supply of drugs, 
syringes and needles, and the lack of well trained  
permanent s ta f f ,  extreme lim itations are imposed on the 
application of trypanocides in the f ie ld  (Holmes and Scott, 
1982; Murray and Gray, 1984). Because of these problems 
there is an increasing gap between treatment demand and the 
treatments actually administered (MacLennan, 1980).
Chemoprophylaxis and chemotherapy can be e ffec tive  and 
economically ju s t i f ie d  i f  managed in an e f f ic ie n t  manner 
(Blaser, Jibo and McIntyre, 1977; Leach and Roberts, 1981). 
The economic c re d ib i l i ty  of using trypanocides as opposed 
to tsetse control under certain conditions has been 
described (Jahnke, 1974). Unless the incidence of 
trypanosomiasis and stock carrying capacity are both high, 
the protection of c a tt le  with trypanocides is preferable in 
an area where tsetse control costs are high (F in e lle ,
1976).
In areas where the tsetse population has been 
eliminated, chemotherapy, in i ts  broadest sense, has a part 
to play in removing parasites from domestic livestock and 
decreasing mechanical transmission by other arthropod 
species (Gray, 1983).
Current veterinary chemotherapy uses f ive  compounds to
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combat trypanosomiasis; namely, suramin, quinapyramine 
dimethyl sulphate +/■ chloride, diminazene aceturate, 
ethidium chloride/bromide and isometamidium chloride.
CHEMOTHERAPY
Data regarding the generic name, compound class, trade 
name, dosage, route of administration, spectrum of a c t iv ity  
and the species of animal on which the drug is used, for  
the f ive  veterinary trypanocides is shown in table 2.
SURAMIN
Suramin was introduced in 1920 and is the oldest of 
the widely used trypanocides in animals. I t  is: 
hexa-sodium 3 , 3 ' -ureylene-bis [8-(3-benzam ido-p-toluido)-l, 
3,5-naphthalene sulphonate]; (C5iH34N6Na6023S6, molecular 
weight 1429).
Suramin is extremely anionic and binds readily  to 
plasma proteins (Dewey and Wormall, 1945). This property 
may account for the drug's prophylactic a c t iv ity .
Suramin has been shown to be ineffective  against 
T.conoolense and T.vivax infections of c a tt le  (Ruche!,
1975), but does show some therapeutic a c t iv ity  towards 
T.simiae infections of pigs (Stephen, 1966b).
Suramin is efficaceous against infections with 
trypanosomes of the subgenus Trypanozoon. in horses,donkeys 
and camels (Leach, 1961; Leach and Roberts, 1981). I t  has 
been successfully used at lOmg kg-1 as a curative for surra 
in ponies, and at this dosage confers 30 days prophylaxis
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(G ill  and Malhotra, 1971). Because of the lower to x ic ity  
for horses as compared to quinapyramine, suramin is 
p art icu la r ly  useful for the treatment of equine 
trypanosomiasis (Leach and Roberts, 1981). Inspite of 
th is ,  i ts  use has largely been replaced by that of 
quinapyramine.
Repeated administration of suramin to c a tt le  may 
produce resistance to the drug, which can be treated with 
quinapyramine (G i l l ,  1971). The development of suramin 
resistance does not result in cross-resistance to other 
trypanocides (G i l l ,  1971).
Williamson and Desowitz (1956) showed tha t, unlike 
other trypanocides, suramin was acidic and could therefore 
be combined with basic substances, e .g . ,  diminazene 
aceturate, the phenanthridines and quinapyramine 
dimethyl sulphate, to form re la t iv e ly  insoluble complexes. 
The complexes with suramin were termed suraminates.
Compared to th e ir  constituents the complexes exhibited 
decreased to x ic ity ,  and increased prophylactic a c t iv ity  
(Williamson, 1957; G ill and Malhotra, 1963, 1971). The 
reduction in to x ic ity  when given as a suraminate was most 
marked with quinapyramine dimethyl sulphate and least with 
ethidium bromide (Desowitz, 1957).
Both ethidium bromide-suraminate and, to a lesser 
extent, quinapyramine dimethylsulphate-suraminate produced 
marked prophylaxis against fly -transm itted T.conqolense and 
T.vivax when administered subcutaneously to c a t t le .
Greater than 7 months prophylaxis was conferred with the
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ethidium complex (Williamson and Desowitz, 1956). However, 
ethidium bromide-suraminate when given subcutaneously at 
5mg kg-1 produced severe swellings (Stephen, 1958).
The quinapyramine dimethylsulphate-suraminate 
(Williamson, 1957) was very effective  as a prophylactic 
against tsetse-transmitted T.simiae infections in pigs in 
West Africa (Stephen and Gray, 1960; Gray, 1961).
The complex is recommended as a prophylactic at 40mg 
kg-1 and at this dosage w il l  protect growing pigs for 3 
months and adult pigs for 6 months (Gray, 1961; Stephen, 
1966b).
The same complex has been used to protect horses 
against T.evansi (G ill  and Malhotra, 1971). T r ia ls  on 
quinapyramine dimethylsulphate-suraminate in c a tt le  were 
stopped because of the formulation's high.cost (Williamson,
1970).
MODE OF ACTION
Suramin enters trypanosomes complexed with serum 
protein via endocytosis (Fairlamb and Bowman, 1977, 1980). 
Several trypanosomal enzymes of T.b.brucei appear to be 
very sensitive to inhib ition  by suramin; glycerol-phosphate 
oxidase and NAD-1 inked glycerol-3-phosphate dehydrogenase 
(Fairlamb and Bowman, 1977; Fairlamb, 1981). Suramin may 
also in terfere  with ribosomal and lysosomal function of 
trypanosomes (Williamson and Macadam, 1965; Hart and Young,
1975).
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QUINAPYRAMINE DIMETHYLSULPHATE/CHLORIDE
Quinapyramine was f i r s t  described by Curd and Davey 
(1949, 1950) and is 4-amino-6(2-amino-6-methylpyramid- 
4-ylami no)-2 -methylquinoline-l,l'di-metho(methylsulphate); 
(C19H28N6O6S2 , molecular weight 532.6). The drug has a 
broad spectrum of a c t iv ity ,  being active against T.evansi, 
T.eouinum. T.eouiperdum. T.b.brucei (Curd and Davey, 1950; 
Leach, 1961), T.conoolense and T.vivax (Davey, 1950). I t  
appears to be most active against T.conoolense (Davey, 
1957).
Two salts of quinapyramine are used as trypanocides; 
the chloride and the dimethyl sulphate.
Subsequent to the work of Davey (1950) the recommended 
dosage of quinapyramine dimethyl sulphate was 5mg kg-1 
(Davey, 1957). At this dosage i t  was shown to be a good 
therapeutic in the f ie ld ,  throughout Africa (Davey, 1957; 
Aspinall, Ford, Steel, Steele and Swan, 1960).
Following subcutaneous administration of quinapyramine 
chloride the drug remained localised in the subcutaneous 
tissue (Spinks, 1950). Although su ff ic ien t quantities were 
released into the c irculation to exert a trypanocidal 
e ffe c t ,  with regard to prophylaxis (Curd and Davey, 1949), 
the level was too low to be e ffective  as a therapeutic 
(Curd and Davey, 1950). Thus, for prophylactic purposes, 
quinapyramine was o r ig in a lly  used as a mixture containing 
three parts by weight quinapyramine dimethyl sulphate to 
four parts by weight quinapyramine chloride (Davey, 1957). 
Since 1958, a revised cheaper formulation has been used,
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containing dimethyl sulphate and chloride in a ra tio  of 
3:2 w/w. The new formulation was equally as e ffec tive ;  
7.4mg kg-1 protected Zebu ca tt le  in an area of medium 
tsetse challenge in Tanganyika for an average of 144 days 
(Robson, 1962), and for 3 months in an area of medium 
tsetse challenge in Kenya (Whiteside, 1962b).
Systemic to x ic ity  associated with curare-like  
properties sometimes occurred in ca tt le  treated with 5mg 
kg- 1 quinapyramine dimethyl sulphate (Unsworth and Chandler, 
1952; Davey, 1957). Unfortunately, the manufacturers (May 
and Baker Ltd.) recommended that 5mg kg-1 be used to trea t  
T.vivax infections in c a tt le .
Toxicity in equidae may be prevented by dividing the 
dose in two and injecting the second ha lf  5-6 hours a fte r  
the f i r s t  (Leach and Roberts, 1981).
MODE OF ACTION
When administered to cultures of C rith id ia  oncopelti, 
quinapyramine inhibited RNA synthesis at concentrations 
that did not affect DNA synthesis (Newton, 1964). The drug 
also caused aggregation of isolated ribosomes.
Interference with polyamine function is an additional 
suggested mode of action (Bacchi, 1981).
DIMINAZENE ACETURATE
Diminazene aceturate, the derivation of which has been 
described by Jensch (1955, 1958), consists of two
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amidinophenyl moieties joined by a triazene bridge: p, 
p'-diamidino diazoaminobenzenediaceturate tetrahydrate: 
N-l,3-diamidino-phenyltriazene diaceturate tetrahydrate; 
(C22H29N9O6 . 4 H2O, molecular weight 587.6).
Fussganger and Bauer (1958) reported t r ia ls  conducted 
with the drug across Africa. A dosage of 3.5mg kg-1 was 
suff ic ie n t to cure infections with T.vivax and 
T.conqolense. whilst 5mg kg-1 was required for infections  
with T .brucei. The drug appeared to be ineffective  against 
T.simiae.
Use of diminazene aceturate in camels is 
contra-indicated since the therapeutic dosage required for  
T.evansi infections (7mg kg-1) can produce severe side- 
effects and even death (Leach, 1961). The only other 
species where systemic to x ic ity  is a problem is the dog. 
Extensive haemorrhagic malacia of the CNS has occurred 
following administration of 15mg kg- 1 (Losos and Crockett,
1969).
Excretion of diminazene aceturate from the body 
appears to occur rapidly (Bauer, 1958; Fairclough, 1962), 
thereby lessening the r isk  of resistance development (Leach 
and Roberts, 1981). Because of the lack of widespread 
resistance occurring, diminazene has replaced ethidium and 
quinapyramine as the curative trypanocide of choice.
A small number of workers have reported on the period 
of prophylaxis conferred by the drug. Fairclough (1963b) 
described prophylaxis lasting up to 24 hours following drug 
administration, whilst trypanocidal a c t iv ity  (demonstrated
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by inh ib ition  of in fe c t iv i ty  a fte r  incubation in ca tt le  
sera) against T.brucei was detected in sera collected for  
up to 3 weeks from c a tt le  following administration of 7mg 
kg- 1 (Van Hoeve and Cunningham, 1964a,b). However, Wellde 
and Chumo (1983), also using a dosage of 7mg kg-1, 
described complete protection lasting 6 days against 
T.conoolense challenge. One ha lf  of the animals described 
were protected for 12  days following drug-administrati on.
Because of the short period of prophylaxis following 
drug-administration, diminazene aceturate has been used to 
measure the "severity of challenge" in an area. The 
technique has been termed the "Berenil Index" and the index 
refers to the average time required between diminazene 
aceturate treatments to eliminate infections in animals 
under constant challenge ( i . e . ,  the treatments per head per 
annum) (Boyt, Lovemore, Pilson and Smith, 1962). Whiteside 
(1962b) rated the incidence as "very high", "high",
"medium" or "low" when the number of diminazene treatments 
required per head per annum were, respectively, 12, 6.5 , 3 
or 1 .
MODE OF ACTION
Diamidines appear to be actively  transported into 
trypanosomes against a concentration gradient (Damper and 
Patton, 1976a,b). Diamidine sensitive populations appeared 
to accumulate drug more rapidly and were therefore more 
rapidly affected (Damper and Patton, 1976a,b).
The trypanocidal e ffect is thought to be due to the
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drug's interaction with DNA. The amidine moieties of the 
drug probably associate with the DNA phosphate groups, via  
sa lt  bands, thereby inserting into the minor groove of the 
DNA helix , adjacent to an adenine-thymine base-pair (Festy, 
Sturm and Daune, 1975). Diamidines may therefore in terfe re  
with DNA function (Dalbow and H i l l ,  1976).
PHENANTHRIDINES
One of the f i r s t  compounds of the phenanthridine 
series to be described was phenidium chloride (Browning, 
Morgan, Robb and Walls, 1938). Therapeutic studies were 
conducted in c a tt le  but because of poor cure rates 
(approximately 70%) and severe local side effects at the 
s ite  of administration (Hornby, Evans and Wilde, 1943), 
there were obvious reservations as to i ts  usage.
Dimidium bromide was subsequently synthesised and 
appeared to be a promising drug a fte r  t r ia ls  in Uganda on 
c a tt le  infected with T.conoolense (B ell,  1945), using a 
dosage of lmg kg-1. When 2mg kg- 1 was used in f ie ld  
t r i a ls ,  local reactions occurred in most animals and nearly 
a ll  exhibited signs of photosensitisation (Randall and 
Beveridge, 1946). Subsequently, the standard dosage became 
lmg kg-1, administered intramuscularly (Davey, 1957).
HQMIDIUM
Homidium was derived from dimidium by substituting the 
methyl group of the quaternary nitrogen with an ethyl group 
and is 2,7-diamino-9-phenyl-10-ethylphenanthridinium
bromide anhydrate; (C2iH2oBrN3 ; molecular weight 394.3) 
(Watkins and Woolfe, 1952). The compound was f i r s t  
produced as the bromide salt (Ethidium). Homidium chloride 
(Novidium) is equally as active and, unlike the bromide, is 
soluble in cold water (Wragg, 1955).
Work conducted in Uganda using ethidium indicated 
T.vivax to be more sensitive to the drug than T.conoolense 
(Mwambu, 1965).
Subsequent to drug administration only lim ited  
prophylactic a c t iv ity  has been described; complete 
prophylaxis lasted less than 2 weeks a fte r  administration 
of lmg kg-1 (Leach, Karib, Ford and Wilmshurst, 1955).
Using an ethidium group-treatment regime, in an 
endemic area of Uganda, Mwambu (1971) demonstrated the 
resultant increase in productivity associated with a 
decreased incidence of infection.
ISOMETAMIDIUM CHLORIDE
Combination of the diazotised p-aminobenzamide moiety 
of diminazene with homidium chloride produced two isomers, 
both with trypanocidal a c t iv ity ,  the combination of which 
was termed metamidium (M&B 4404) (Wragg, Washbourn, Brown 
and H i l l ,  1958). Metamidium was shown to be active in 
c a ttle  against f ie ld  strains of trypanosomes from East 
Africa (Fairclough, 1958). The drug was reasonably well 
tolerated when administered subcutaneously (Smith and 
Brown, 1960). Metamidium, as noted above, consisted of two 
isomers, one red and one purple (Wragg et a l . .  1958). The
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structure of the highly soluble red isomer was described by 
Berg (1960); 7-(m-amidinophenyldiazo-amino)-2-amino-10- 
e th y l-9 -phenyl-phenanthridinium chloride hydrochloride; 
(C28H25C1 N7HC1 ; molecular weight 531.5). The red isomer 
(M&B 4180A) was termed isometamidium chloride and was 
marketed in 1961 under the trade name Samorin.
May and Baker Ltd. recommend that, for T.conoolense 
and T.vivax infections of c a t t le ,  a therapeutic dosage of 
0.25-0.50mg kg-1 be used, whilst as a prophylactic,
0.5-1.0mg kg-1. Even when administered intramuscularly 
isometamidium chloride produced severe local reactions and 
extensive fibrosis  (Boyt, 1971). These lesions have been 
described both in c a tt le  and camels (Slack and Nineham, 
1968; Toure, 1973; Wilson, LeRoux, Paris, Davidson and 
Gray, 1975b; Balis and Richard, 1977). May and Baker Ltd. 
thus advise that the drug be administered deep 
intramuscularly, in the middle th ird  of the neck. Volumes 
greater than 15ml should not be injected into one s ite ,  but 
divided (F in e lle , 1973b). Intramuscular administration of 
isometamidium chloride at 4mg kg-1 resulted in systemic 
toxic e ffects; staggering, recumbency and occasionally 
death (Robson, 1962).
In an attempt to decrease the to x ic ity  associated with 
isometamidium administration, workers have complexed i t  
with dextran sulphate (m.w.500,000) in a 1 : 1  w/w manner 
(James, 1978; Aliu and Sannusi, 1979; Otaru and Sannusi, 
1979; Aliu and Chineme, 1980). Formation of the complex 
increased the therapeutic index for rodents at least
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four-fo ld  (Otaru and Sannusi, 1979; Aliu and Chineme,
1980). In c a t t le ,  subcutaneous administration of a 2% w/v 
solution, even at 2 mg kg-1, produced a granuloma but no 
severe reaction (Aliu and Sannusi, 1979; Otaru and Sannusi, 
1979). F ina lly , the period of prophylaxis in rodents was 
greatly  extended (James, 1978). This has yet to be 
demonstrated in c a t t le .
Isometamidium is especially useful because of i ts  
efficacy on trypanosomes resistant to other commonly used 
trypanocides (F in e lle , 1973a), and is the drug of choice 
for T.conoolense infections of dogs (A liu , 1981). T.brucei 
infections in dogs respond well to isometamidium (Toure,
1970) though quinapyramine is the drug of choice for f i r s t -  
stage infections (A liu , 1981).
T.evansi infections have been successfully treated in 
camels at lmg kg- 1 (Petrovski, 1974) and in donkeys and 
dogs at 2mg kg-1 (Chand and Singh, 1970).
MODE OF ACTION OF PHENANTHRIDINES
Of the phenanthridine series, most work has been 
conducted with ethidium. Ethidium irrevers ib ly  inhibited  
C rith id ia  oncopelti m ultip lication (Newton, 1964) but was 
not toxic to a non-dividing population (Newton, 1957).
Rapid inhib ition  of C.oncooelti DNA synthesis occurred 
without RNA or protein synthesis being affected (Newton, 
1957). Ethidium probably prevents DNA replication by 
in terca lating between adjacent nucleotide base pairs, 
distorting the double helix  structure and thereby
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preventing DNA polymerases from functioning (Newton, 1974).
The phenanthridines may also in terfe re  with polyamine 
function. I f  polyamines are administered along with 
isometamidium, in v i t r o , the trypanocidal a c t iv ity  of 
isometamidium is abolished (Bacchi, 1981).
CHEMOPROPHYLAXIS
Chemoprophylaxis can be highly e ffective  provided that 
a s t r ic t  treatment regime is used (WHO, 1979; Connor,
1984).
The f i r s t  widely used chemoprophylactic was 
quinapyramine. When used in ca tt le  in contact with tsetse, 
the interval between c a tt le  treatments could not be 
extended beyond 2 months (Fiennes, 1953). Resistance to 
quinapyramine eventually appeared (Robson and Wilde, 1954) 
and became widespread (Cockbill, 1967) with drug- 
administrati on being required every 2-3 weeks.
Pyrithidium bromide (Prothidium) (2-amino-7-(2-amino- 
6-methylpyramid-4-ylamino)-9-p-aminophenylphenanthridine- 
10,l'-dimethobromide) was introduced by Watkins and Woolfe 
(1956) as a prophylactic against bovine trypanosomiasis.
Studies both in East and West Africa showed that 
intramuscular administration of 2mg kg-1 pyrithidium  
bromide would protect c a tt le  for anything from 4-8 months 
(Marshall, 1958; Ly tt le , 1960; F inelle  and Lacotte, 1965) 
and that i t  was superior to quinapyramine as a prophylactic 
(Smith and Brown, 1960). Pyrithidium was used in Nigeria 
but was abandoned because of the high incidence of
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hepatotoxicity and the resultant high m ortality  (Stephen, 
1962b). Because of the to x ic ity  problems and the advent of 
a superior prophylactic, metamidium (Smith and Brown,
1960), usage of the drug declined. Pyrithidium was 
eventually withdrawn from the market in the la te  1970s.
Both metamidium and isometamidium chloride were shown 
to be highly e ffective  prophylactic drugs when given at a 
dosage of 0.5mg kg-1 (Fairclough, 1963a). Since 1967, 
isometamidium has been the sole prophylactic used in areas 
of high tsetse challenge (Williamson, 1976), and of the 
three trypanocides commonly used today in c a tt le  (homidium 
chloride, diminazene aceturate and isometamidium 
chloride), is the only one that can be considered a 
prophylactic (Connor, 1984). A 4 month programme may be 
used, where, every 4 months, a ll animals are administered 
isometamidium (F in e lle , 1973b). I f  trypanosomes appear 
before the next prophylactic in jection is due, the curative  
diminazene aceturate is given (F in e lle , 1973b).
Improvement in the economic return associated with 
using isometamidium prophylaxis, as opposed to other 
control programmes, has been described in Nigerian trek  
c a tt le  (Na'Isa, 1969), ranch c a tt le  in Kenya (Wilson et 
a l . ,  1975b; Wilson, Njogu, Gatuta, Mgutu, Alushula and 
Dolan, 1981), ranch ca tt le  in Tanzania (B1 aser et_al_.,
1977), ranch c a tt le  in Mali (Logan, Goodwin, Tembely and 
Craig, 1984) and work oxen in Ethiopia (Bourn and Scott,
1978).
Reports on the period of prophylaxis conferred to
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c a t t le ,  following administration of isometamidium, vary 
widely, as shown below:
Dose Duration of Author
fmokg-1) prophylaxis
0.5 14 weeks (x) Fairclough, 1963a
ii 24 weeks ( 1 0 %) Wiesenhutter, Turner and 
Kristensen, 1968
1 . 0 2 weeks (c) Pinder and Authie, 1984
i i 4 weeks (c) Lewis and Thomson, 1974
i i 8  weeks (c) Kirkby, 1964
i i 9 weeks (c) Lwembandisa, 1970
i i 14 weeks (c) Omwero-Wafula and Mayende, 
1979
i i 30 weeks ( 1 0 %) Wiesenhutter et a l . .  1968
2 . 0 12 weeks (C) Kirkby, 1964
i i 36 weeks (X) Robson, 1962
4.0 50 weeks (X) Robson, 1962
D efin it ions of "duration of prophylaxis" vary between 
authors. Some define i t  as the average duration of 
prophylaxis within a group of c a t t le  (x ) ;  others as the 
time taken for 1 0 % of a group to become infected ( 1 0 %); and 
others as the complete period of prophylaxis, i . e . ,  the 
period un ti l  the f i r s t  animal in a group becomes infected
(c ) .  The la s t  d e f in it io n  gives an indication of the 
minimum period of prophylaxis to be expected w ith in  a group 
of animals and thus the frequency of drug-administration  
required to prevent trypanosome patency w ith in  the group;
- 52 -
thereby maximising productivity. However, even this las t  
defin it io n  does not give an en tire ly  accurate figure for  
the period of complete prophylaxis since the stated period 
consists of both the true prophylactic period and the false  
prophylactic period (E rco li, 1978). During the true 
prophylactic period the animal is refractory to challenge, 
whilst during the false prophylactic period animals are not 
completely refractory and e ither infections are developing 
but non-patent or the time to onset of parasitaemia is 
extended, thereby giving a false indication of the 
prophylactic cover.
apparent period of prophylaxis. There are a number of 
reasons that may account for the variation:
F irs t ly ,  working with quinapyramine chloride/sulphate, 
an almost lin ear relationship was demonstrated between the 
vector density, or trypanosomiasis r isk , and the drug 
dosage-frequency required (Whiteside, 1955, 1962a,b).
Other workers came to the same conclusion, stating that the 
prophylactic period depended on the virulence of the 
trypanosomes and the number of in fective  tsetse bites  
received per unit time (MacOwan, 1955; Ly tt le , 1960).
Secondly, work in mice with T.b.brucei has shown that 
in animals apparently cured of infections, relapses may 
occur from drug privileged sites (Jennings, Whitelaw and 
Urquhart, 1977a,b; Jennings, Whitelaw, Holmes, Chizyuka and 
Urquhart, 1979), i . e . ,  trypanosomes may re-emerge from 
tissues or organs, such as the brain, which are
there is obviously a wide range in the
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inaccessible to most trypanocides.
Thirdly, acquisition of immunity following the usage 
of trypanocidal drugs has been suggested to contribute 
towards the prophylactic period (Bevan, 1928, 1936;
Fiennes, 1953; Soltys, 1955; Wilson et a l . .  1975b; Wilson, 
Paris, Luckins, Dar and Gray, 1976; Bourn and Scott, 1978). 
As well as the acquisition of immunity following treatment 
of an in fection, antigenic priming may occur in animals 
under chemoprophylactic cover. I f  there were a lim ited  
number of serodemes in a given area then, theo re tica lly ,  
there could be an immune contribution to the apparent 
prophylactic period.
F ina lly , d if fe r in g  levels of drug s e n s it iv ity  between 
trypanosome populations may play a role in determining the 
duration of prophylaxis.
DRUG RESISTANCE
Resistance in parasitic  nematodes is defined as a 
greater frequency of individuals within a population able 
to to lera te  doses of a compound than in a normal population 
of the same species (Prichard, H all, Kelly, Martin and 
Donald, 1980). In schistosomiasis chemotherapy, workers 
have indicated that resistance should be distinguished from 
tolerance (Coles, Bruce, K inoti, Muthahi, Dias and Katz, 
1986). I f  a s ign ificant change in response occurs in an 
area following widespread therapy then resistance is said 
to have occurred. However, unless data is available to 
confirm that resistance has occurred then isolates that
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f a i l  to respond to a schistosomicide are considered as 
to lerant, or innately resistant.
From its  e a r l ies t  days, the development of 
chemotherapy for bovine trypanosomiasis has been 
accompanied by the development of drug resistance 
(Williamson, 1979).
Drug resistance appears to be acquired by exposure of 
trypanosomes to sub-therapeutic levels , thereby 
fa c i l i ta t in g  selection of a drug-resistant subpopulation 
(Whiteside, 1962a; Leach and Roberts, 1981).
Sub-therapeutic drug levels may occur because of incorrect 
dosage (d ire c t ly  or because of incorrect body weight 
estimation), a high incidence of trypanosomiasis, irregular  
treatment with prophylactics or stopping the usage of a 
prophylactic whilst animals are s t i l l  at r isk  (Davey, 1950, 
1957; Whiteside, 1960).
Since diminazene aceturate is quick acting, rapidly  
broken down and excreted (Bauer, 1958), subcurative 
concentrations exist for only a short period. This may 
account for the small number of reports describing 
resistance to the drug.
Resistance to diminazene aceturate to at least the 
level of 3.5mg kg-1 in c a tt le  has been described. The 
majority of reports concern infections with West African 
T.vivax (Jones-Davies, 1967a,b; Graber, 1968; MacLennan and 
Na'Isa, 1970; Gray and Roberts, 1971; MacLennan, 1971,
1972) although resistance in East African T.vivax has been
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reported (Mwambu and Mayende, 1971a,b). Reports of 
resistance to diminazene aceturate at 3.5mg kg-1 by 
T.congolense are much fewer (Jones-Davies, 1958; Gray and 
Roberts, 1971; Gitatha, 1979). Thus, T.vivax appears to 
express a higher level of innate resistance to diminazene 
aceturate than T.congolense (Williamson, 1960).
In contrast, resistance to homidium appears to occur 
more commonly in T.congolense than T .v ivax . Widespread 
resistance to homidium has been described in Nigeria 
associated with T.congolense (Jones-Davies and Folkers, 
1966b; Na'Isa, 1967; Folkers, Van Hoeve and Buys, 1968; 
Williamson, 1970). Homidium-resistant T.congolense have 
also been described in the Sudan (Gadir, Tahir, Razig and 
Osman, 1972), Ethiopia (Scott and Pegram, 1974) and Kenya 
(Gitatha, 1979). Reports of expression of homidium- 
resistance by T.vivax (Ilemobade and Buys, 1970) are 
lacking. This would suggest that T.congolense expresses a 
higher level of innate resistance to homidium than T.vivax  
(Williamson and Stephen, 1960).
Of the chemoprophylactics, widespread resistance to 
quinapyramine (Whiteside, 1960; Cockbill, 1967) lead to the 
withdrawal of i ts  usage for bovine trypanosomiasis. 
Considerable resistance to quinapyramine was expressed by 
both T.congolense and T.vivax in c a tt le  a f te r  a single 
treatment (Wilson, 1949) indicating how readily  resistance 
could be acquired.
Folkers (1966) showed that resistance to isometamidium 
did not appear to develop readily  when repeatedly using
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0.25mg kg-1 isometamidium chloride under f ie ld  conditions 
of high trypanosomiasis r isk . In contrast, Lewis and 
Thomson (1974) in Rhodesia reported resistance to lmg kg- 1 
a fte r  4 years exposure to lmg kg-1 isometamidium chloride 
administered every 12 weeks. Other workers have reported 
putative resistance in the f ie ld  because of "early  
breakthroughs" when using 0.5-1.0mg kg-1 prophylactic 
regimes (Lewis and Thomson, 1974; Scott and Pegram, 1974; 
Kupper and Wolters, 1983; Pinder and Authie, 1984).
Elucidation of the level of resistance to 
isometamidium has been conducted by some of the above 
authors, and others, in c a tt le  (see table 3 ) ,  sheep 
(Arowolo and Ikede, 1980) and mice (Scott and Pegram, 1974; 
Arowolo and Ikede, 1977; Omwero-Wafula and Mayende, 1979; 
Pinder and Authie, 1984). Detection of resistant strains  
in small laboratory animals has its  lim itations because 
they are often not susceptible to infection with resistant  
strains (Williamson and Stephen, 1960). The same authors 
advocated the use of sheep as a homidium-resistance model. 
Sheep were infected by application of infected tsetse f l ie s  
and then treated with a subcurative dose of homidium. The 
interval between treatment and relapse was taken as an 
index of the degree of homidium-resistance.
Extrapolation of results from sens it iv ity  studies in 
mice and sheep to the cow cannot be d ire c t ly  made because 
of large differences in metabolic body weights (Arowolo and 
Ikede, 1977, 1980). Hawking (1963a) attempted to find a 
consistent relationship between the drug se n s it iv ity  of
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Table 3
BOVINE STUDIES ON THE SENSITIVITY OF TRYPANOSOME POPULATIONS TO THE
THERAPEUTIC ACTIVITY OF ISOMETAMIDIUM
LACK OF 
SENSITIVITY 
AT (mgkg-1)
TRYPANOSOME
SPECIES
REGION AUTHORS YEAR
0.25-0.80* T.conoolense N. Nigeria Jones-Davies and Folkers 1966a
0.8* T .congolense N. Nigeria Na'Isa 1967
0.5 T.congolense Nigeria Gray and Roberts 1971
1.0 T.congolense Rhodesia Lewis and Thomson 1974
0.5-2.0 T.congolense Kenya Gitatha 1979
0.5 T.vivax(Y58)^ Nigeria Ilemobade 1979
0.5-1 .0+ T.congolense 
T.vivax
N.Ivory Coast Kupper and Wolters 1983
* = Cross resistance studies. 
#= Rodent adapted population. 
+ = Field report.
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trypanosome populations in mice and in c a t t le ,  but was 
unable to do so.
S ensitiv ity  studies in mice have used various terms to 
define the s e n s it iv ity . The MED (minimal e ffec tive  dose) 
denotes the minimal dose required to clear the blood of 
trypanosomes (Hawking, 1963a) and the subscript x in MEDX 
refers to the percentage of animals the MED value refers  
to . The MCD (minimal curative dose) is a more commonly 
used term (Mwambu, Mayende and Masinde, 1969; Walker and 
Watts, 1970; Scott and Pegram, 1974) and denotes the dosage 
of drug required to cure an infection. Again, the 
percentage of animals the term refers to is always stated.
Care must be taken in a ll  therapeutic drug sens it iv ity  
studies to ensure that treatment occurs s u ff ic ie n t ly  soon 
a fte r  infection to rule out the p o ss ib ility  of relapses 
occurring from sites inaccessible to drug (Jennings et a l . .  
1977a,b, 1979).
STABILITY OF DRUG RESISTANCE
The level of resistance of a T.conoolense population 
resistant to quinapyramine decreased a fte r  65 days repeated 
passage in ra ts , (Unsworth, 1954). In a s im ilar manner, 
resistance to diminazene aceturate (expressed by a 
T.conoolense population) appeared to be unstable during 
repeated bovine passages (Whiteside, 1963). In contrast, 
the s en s it iv ity  of a T.vivax population to quinapyramine 
a fte r  cyclical transmission through Glossina palpalis was 
stable. Gray and Roberts (1971) demonstrated the s ta b i l i ty
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of a drug-resistant T.congolense (resistant to diminazene 
aceturate at 7mg kg-1, homidium chloride at 2mg kg-1 and 
isometamidium chloride at 0.5mg kg-1) and T.vivax  
(resistant to diminazene aceturate at 7mg kg-1 and 
quinapyramine at 5mg kg-1) a fte r  repeated cyclical 
transmission.
In the f ie ld ,  i f  c a tt le  are withdrawn from an area and 
the use of the drug in question is stopped, drug-resistant 
strains of T.congolense and T.vivax tend to disappear from 
tsetse within 6-9 months (Whiteside, 1960).
CROSS RESISTANCE
With the appearance of resistance to trypanocides, the 
use of chemically unrelated trypanocides to tre a t  relapses 
has not always effected a cure (Wilson, 1949; Karib, Ford 
and Wilmshurst, 1954; Whiteside, 1960). A fter extensive 
cross-resistance studies (1400 tests) in c a t t le ,  Whiteside 
(1960) formulated a cross-resistance table (see table 4).  
Most of the tests were conducted with T.congolense. The 
quinapyramine work was repeated with T.vivax and produced 
identical results. Of particu lar importance was the fact  
that trypanosomes resistant to quinapyramine were 
cross-resistant to diminazene. Thus, one reported case of 
diminazene resistance has been attributed to residual 
quinapyramine resistance (Mwambu and Mayende, 1971b).
Because of the cross-resistance problem, Whiteside 
(1958) introduced the term "sanative drug pair" to denote 
pairs of drugs that do not induce resistance to the other.
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Table 4
CROSS RESISTANCE STUDIES 
( a f te r  Whiteside, 1960)
TRYPANOSOMES 
RESISTANT TO
CROSS-RESISTANCE
CURATIVE DOSAGES HIGHER DOSAGES
ANTRY-
CIDE
HOMI­
DIUM
META­
MIDIUM
BERENIL HOMI­
DIUM
2*
META­
MIDIUM
2
BERENIL
5 - 7
PROTH-
IDIUM
2
QUINAPYRAMINE R + + + + 0 + 0?
HOMIDIUM + R + 0 R 0 0 0?
METAMIDIUM + + • R 0 + R 0 0?
DIMINAZENE 0 0 0 R (0) 0 R (0)
* Figures = mg kg-i.
R = Direct resistance.
0 = No cross-resistance.
+ = Cross-resistant.
0? = cross resis tant to lmg kg-1, but not to 2mg kg-1. 
(0) = no observations.
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On the basis of his work the only sanative pairs are 
homidium/diminazene and metamidium/diminazene. Thus, the 
use of an alternating programme of diminazene aceturate and 
isometamidi urn chloride has been recommended for the f ie ld  
(F in e lle , 1974).
TRYPANOSOMIASIS CHEMOTHERAPY/IMMUNITY
Immunity associated with chemotherapy may e ither be 
non-sterile  or s te r i le .
Bevan (1928, 1936) was the f i r s t  to describe 
non-sterile  immunity or "tolerance" following the use of 
trypanocidal drugs. A laboratory attenuated T.congolense. 
originating from the area experimental c a tt le  were to be 
exposed, was inoculated into c a tt le  and treated with 
potassium antimony! ta r t ra te .  Cure was rare ly  effected, 
however the c a tt le  remained in good health despite 
re infection. Bevan termed this phenomenon "tolerance". I f
the trypanosomes were inoculated into fu l ly  susceptible 
c a tt le ,  fu l l  pathogenic effects were observed.
The tolerance was maintained by frequent challenge and
i f  the to lerant c a tt le  were "cured" they were fu l ly  
susceptible to subsequent in fection. Tolerance breakdown 
also occurred under the following circumstances; infection  
with a heterologous trypanosome species, starvation, 
excessive work, intercurrent infection and mineral or 
vitamin deficiences.
Other workers have also produced non-sterile  immunity 
experimentally (Wilson, Cunningham and Harley, 1969;
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Wilson, 1971). Bourn and Scott (1978) described a sim ilar  
phenomenon in which a phenanthridinium-resistant 
T.congolense appeared in oxen. Despite the presence of 
parasitaemia the oxen remained in good condition whilst 
remaining on isometamidium prophylaxis. Whether th is  was 
true tolerance is questionable since trypanosome 
populations exhibiting resistance appeared to exhibit  
decreased pathogenicity (Goble, Ferrell and S t ie g l i tz ,
1959; Stephen, 1962a).
The production of non-sterile immunity in the f ie ld  is 
not a favourable state since the c a t t le ,  by v irtue  of 
remaining parasitaemic, act as a constant source of 
infection for the vector (Ruchel, 1975).
Experimentally, s te r i le  immunity to homologous 
T.congolense and T.brucei challenge has been read ily  
conferred by a strategy of infection and cure (Wilson et 
al.., 1969; Akol and Murray, 1983). The resultant 
protective antibody response has been shown to la s t  up to 
7 months following treatment (Wilson and Cunningham, 1972).
Development of immunity in c a tt le  in the f ie ld  has 
been assessed in d irec tly , by observing changes in (a) the 
need for trypanocidal drug treatment, (b) the a b i l i t y  to 
maintain normal blood values, (c) the a b i l i t y  to withstand 
prolonged periods of parasitaemia, (d) the acquired a b i l i ty  
to gain weight in face of v iru lent trypanosome challenge 
when drug treatment is discontinued, (e) changes in serum 
immunoglobulin levels and ( f )  immunoflourescent antibody 
test in assessing the immune status on a herd basis
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(Wilson, LeRoux, Dar, Paris, Davidson and Gray, 1975a; 
Wilson, 1976).
Wilson and his colleagues conducted a series of 
experiments to examine the development of immunity in the 
f ie ld ,  using d if fe re n t trypanocidal regimes. Indirect  
evidence for the development of immunity in calves, in 
contrast to adults, was presented by Wilson, Dar and Paris 
(1973). Zebu c a tt le  were kept in an area of high tsetse-  
challenge in Uganda (South Busoga) for 2 years and treated  
on an individual basis with 7mg kg-1 diminazene aceturate 
when c l in ic a l ly  i l l .  The adults required an average of 8.4  
treatments per year whilst the calves, 5.5 per year.
In a second experiment, Zebu ca tt le  were again 
maintained in an area of high tsetse-challenge in South 
Busoga. Cattle were treated on an individual basis, as in 
the f i r s t  experiment. No s ign ificant resistance to 
trypanosomiasis developed in e ither the calves or the 
adults during 2 years of exposure. 'However, the number of 
abortions and c a lf  m ortality  decreased (Wilson, Paris and 
Dar, 1975c).
Wilson et a l . (1975b, 1976) compared three 
trypanocidal regimes; diminazene aceturate administered on 
an individual or group basis, and isometamidium chloride  
administered on a group basis. Boran steers were used and 
kept in a tsetse area of Kenya for l l / z  years. The 
challenge was medium or high for the f i r s t  two years and 
low for the fina l 6 months.
Group 1 contained 20 ca ttle  which were treated on an
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individual basis with 5mg kg- 1 diminazene aceturate e ither  
when severely affected by trypanosomiasis on a c lin ica l  
basis, or when the PCV fe l l  below 20%.
Group 2 contained 20 c a tt le  which were treated on a
group basis with 5mg kg-1 diminazene aceturate when 
trypanosomiasis was diagnosed in one animal.
Group 3 contained 20 ca tt le  which were treated on a
group basis with 0.5mg kg-1 isometamidi urn chloride when 
trypanosomiasis was diagnosed in one animal.
Group 1 showed evidence for acquisition of immunity; 
the period between diminazene aceturate treatments 
increased from a mean of 50-60 days a fte r  the f i r s t  3 
treatments to 132 days a fte r  the ninth treatment and the 
period when trypanosomes were in the peripheral blood 
without side e ffec t increased. However, of the three 
groups, group 1 had the lowest growth rate , emphasising the 
stunting e ffec t of trypanosomiasis.
Group 2 showed no evidence for acquisition of 
immunity; there was no increase in time between drug 
treatments and no a lteration  in sens it iv ity  to trypanosome 
pathogenicity a fte r  drug withdrawal. There were no 
anti-trypanosoma! antibodies and only minor immunoglobulin 
changes. However, the group had a better growth rate  
compared to group 1 but worse than group 3.
Group 3 showed evidence for the acquisition of some 
immunity; the need for drug administration did not 
decrease, however i f  drug was removed, despite the presence 
of trypanosomes, the growth of c a tt le  was the same in drug-
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treated and untreated animals. No antibodies were detected 
and serum immunoglobulin changes were minimal. Group 3 had 
the best growth rate.
This work indicated that, provided a closely  
controlled drug regime was used, development of immunity 
was not a prerequisite for successful maintenance of c a tt le  
in a tsetse area (Leach and Roberts, 1981). Also, that for  
acquisition of immunity to occur, trypanosomes must be 
allowed to develop in the host before drug-treatment.
Investigations into the acquisition of immunity in 
c a tt le  whilst under chemoprophylactic cover are lacking. 
Whiteside (1962a) stated that part of the observed 
prophylactic period was due to an immune response by the 
host and suggested that the animal was antigenically  
primed during part or a l l  of the protective period. 
Cunningham (1966), in referring to this subject, stated 
that "even a s light immune response would probably enhance 
the action of a prophylactic drug". L i t t l e  experimental 
evidence currently exists for these suppositions.
GENERAL MATERIALS AND METHODS
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1) EXPERIMENTAL ANIMALS
(a) CATTLE
Yearling Boran steers were obtained from Kapiti Plains 
Ranch, situated in the Athi River area of Kenya. This 
region is free from tsetse, and trypanosomiasis is absent. 
On arriva l at ILRAD a ll  animals were administered ora lly  
5mg kg-1 fenbendazole (Pancur; Hoechst). In addition, a ll  
c a ttle  were screened serologically for antibodies to (a) 
Theileria  parva schizonts and Theileria  parva piroplasms 
using an IFA test (Goddeeris, Katende, Irv in  and Chumo, 
1982), (b) Anaplasma marqinale and Babesia biqemina using 
an ELISA (V o lle r, Bidwell and B a rt le t t ,  1975) and (c) 
T.congolense. T.vivax and T.brucei using an ELISA (Voller  
et a l . .  1975) and IFA test (Katende, Musoke, Nantulya and 
Goddeeris, 1987). The percentage of the c a tt le  
seropositive to each antigen were as follows:
T.parva schizonts - 40%
T.parva piroplasms - 46%
A.marginale - 2 2 %
B.biaemina - 32%
T.congolense - 0%
T.vivax - 0%
T.brucei - 0%
Rhipicephalus appendiculatus. the vector of T.parva 
parva. does not occur on Kapiti Ranch. The high antibody 
t i t r e s  specific for T.parva schizonts and piroplasms are
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thought to be due to cross-reactiv ity  to a benign Theiler ia  
species, possibly T .tau ro trao i♦
All c a tt le  were walked through a spray race on a 
weekly basis and sprayed with 3% Delnav DFF (Cooper), a 
phosphatic insecticide, to eliminate ticks . Spraying of 
c a tt le  was stopped for every 2 week period prior to being 
fed on by infected tsetse.
Prior to entering an experiment some control animals 
were kept in a f ie ld .  Maintenance of c a tt le  on this  
pasture had previously been shown to result in nu tritional 
muscular dystrophy. Thus, a ll  ca tt le  maintained outside 
were intramuscularly administered 1ml MU-SE (Burns Biotec), 
containing the equivalent of 5mg selenium and 6 8  i .u .  of 
vitamin E (as d-alpha-tocopheryl acetate), every 6 weeks.
Every 4 months, a l l  c a tt le ,  were subcutaneously 
inoculated with 3ml of an inactivated quadrivalent 
(0 /A/SATI/SAT2) foot and mouth disease vaccine (Wellcome 
Kenya Ltd ., Cooper).
At the beginning of each experiment a ll  c a tt le  weighed 
approximately 2 0 0  kg.
For s im plification of individual animal reference, 
each animal has been allocated a code indicating the 
animals' group and number, e .g . ,  A3 denotes group A, animal 
number 3. Keys to the codes used for animals in each 
chapter are given in each chapter's appendix.
(b) GOATS
Adult East African x Gall a goats were obtained from
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the Naivasha/Nakuru region of the Kenyan r i f t  valley, an 
area known to be free from trypanosomiasis. On arriva l at 
ILRAD goats were administered 7.5mg kg-1 rafoxanide and 
44mg kg-1 thiabendazole (Ranizole Drench; MSD Agvet) for  
helminths and nasal bots (Oestrus ovish  and 50mg powder of 
amprolium (Amprol 20%, MSD) daily  for three days for 
coccidiosis. On entry into fly -p roo f isolation units a ll  
goats were administered 5mg kg-1 fenbendazole (Panacur 
2.5%, Hoechst) and a second three day course of amprolium 
(50mg powder per day).
(c) MICE
Inbred male and female C57, C3H, A/J, BALB/c, Swiss 
(derived from MF1) and C57B16XCsH/He( F I) were obtained from 
the ILRAD breeding colonies. All were o r ig in a lly  derived 
from O.L.A.C. (Oxfordshire Laboratory Animal Colonies) '76 
strains. All mice weighed approximately 20g and were 
between 8  and 12  weeks old at the beginning of each 
experiment.
(d) GUINEA-PIGS
These were multicoloured, English type, obtained from 
the ILRAD breeding colony.
2) FEEDING AND HOUSING
(a) CATTLE
When housed for experiments, c a tt le  were kept in 
groups of at most 16 animals on concrete, in a loose shed.
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Cattle used in T.vivax experiments were housed in f ly -p roo f  
isolation units. Cattle were bedded with wood shavings and 
cleaned out twice weekly. They were fed a d iet of hay and 
commercial concentrate (2kg per day of young stock pencils; 
M/s Belfast M illers  Ltd., Nairobi), supplemented on a 
daily  basis with approximately 25g mineral mix per animal 
(Cooper, Wellcome Kenya Ltd). Cattle had free access to 
water.
All c a tt le  were moved to insect-proof units for each 
experimental ts e ts e -f ly  challenge.
(b) GOATS
Goats were housed in f ly -p roo f isolation units on a 
concrete f lo or and bedded with wood shavings. All were 
cleaned out twice weekly. They were fed hay and 200-300g 
of concentrate per day (Belfast M illers  Ltd., Nairobi).  
Water was readily  available at a l l  times.
(c) MICE
All animals were housed in p lastic  cages with metal 
tops and kept in the mouse room of the ILRAD small animal 
unit. Sawdust bedding was changed twice weekly. Mice were 
fed on an ad libitum d ie t of maize-based mice pencils (Unga 
Feeds Ltd., Nairobi). Drinking water was continually  
available in p lastic  water bottles. No medication, of any 
type, was administered to the mice.
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3) TSETSE FLIES
Tsetse f l ie s  were infected by allowing them to feed on 
infected goats or ca tt le  with a patent parasitaemia.
Except for the East African T.vivax populations which were 
inoculated into Boran calves, a ll other trypanosome 
populations were inoculated into goats for infecting  
tsetse. Approximately three days a fte r  trypanosomes were 
detected in the peripheral blood c ircu la tion , teneral male 
Glossina morsitans c e n tra l is , obtained from the ILRAD 
tsetse colony, were fed on them. The tsetse f l ie s  were 
maintained by da ily  feeding (except Sundays) on the 
infected animals. From day 25 following the f i r s t  feed of 
tsetse on animals infected with T.congolense. f l ie s  were 
monitored for infection by microscopic examination of 
salivary probes (Burtt, 1946). Those f l ie s  extruding 
metacyclic trypanosomes in th e ir  saliva were used to 
challenge c a t t le .
Id en tif ica tion  of tsetse infected with T.vivax by 
examination of salivary probes proved very in e f f ic ie n t  
since only a small number of infected f l ie s  extruded 
metacyclics in th e ir  probe. Thus, for challenge of ca tt le  
with L_yi_vax-infected tsetse, each f ly  that fed on an 
animal was dissected. Each non-infected f ly  was replaced 
with another until a to ta l of ten infected f l ie s  had fed on 
each animal.
4) TRYPANOSOMES
The following populations were used:
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(a) T.congolense ILNat 3.1 (IL  1180)
(b) T.congolense IL 2642
(c) T.vivax IL 2968 (Zaria, Nigeria)
(d) T.vivax IL 2969 ( K i l i f i ,  Kenya)
(e) T.vivax IL 2982 (Galana, Kenya)
( f )  T.vivax IL 2986 (Likoni, Kenya)
(g) T.congolense IL 2856
T.congolense ILNat 3.1 is a homogeneous VAT population 
and has also been designated IL 1180. I t  is a 
doubly-cloned derivative of an isolate (LR 11/C9) made in 
the Serengeti National Park by Geigy and Kauffman (1973). 
The derivation of ILNat 3.1 from the original isolate is 
shown in figure 1, appendix V.
T.congolense IL 2642 is a doubly-cloned derivative of 
an isolate  made from a cow in Busoga d is t r ic t ,  Uganda,
1962. I ts  derivation is shown in figure 2, appendix V.
T.vivax IL 2968 is a trebly-cloned derivative of an 
isolate  made from a cow in Zaria, Nigeria, 1973 (Leeflang, 
Buys and Blotkamp, 1976). I t  is naturally  
rodent-infective. The derivation of IL 2968 is shown in 
figure 3, appendix V.
T.vivax IL 2969 is a non-rodent-infective T .vivax. 
o rig in a lly  isolated in K i l i f i ,  Coastal Province, Kenya 
(figure 4, appendix V). I t  has been cloned once, in v i t r o .
T.vivax IL 2982 is a non-cloned derivative of an 
isolate made in Galana, Coastal Province, Kenya (figure 5, 
appendix V). I t  is non-infective for rodents.
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T.vivax IL 2986 is a non-cloned derivative of an 
isolate made in Likoni, Coastal Province, Kenya (figure 6, 
appendix V). I t  is non-infective for rodents.
T.congolense IL 2856 is rodent in fective and was 
o r ig in a lly  isolated in Banankeladaga, Burkina Faso. The 
original isolate was termed Banankeladaga 83/CRTA/67 
(Pinder and Authie, 1984) and the derivation of IL 2856 is 
shown in figure 7, appendix V.
5) ENUMERATION OF TRYPANOSOMES
Two methods were used to quantify the number of 
trypanosomes per m i l l i l i t r e  of body flu ids:
(a) Blood buffy-coat phase-contrast (BC) technique 
(Murray, Murray and McIntyre, 1977). This technique was 
used to determine the level of parasitaemia in c a t t le .  
Following measurement of the haematocrit in plain  
microhaematocrit cap illa ry  tubes (see section 14, Packed 
Cell Volume), using heparinised blood, the cap il la ry  tube 
was cut approximately 1mm below the lower end of the buffy 
coat with a diamond pointed pen, thereby incorporating the 
uppermost region of red blood c e lls . Using a 
microhaematocrit cap illa ry  tube holder, the erythrocyte 
layer, buffy coat, and approximately 3mm of plasma were 
gently expressed onto a clean microscope s lide , mixed well 
and covered with a 22x22mm covers!ip. The preparation was 
then examined with a Leitz (Le itz  Wetzlar) SM Lux 
microscope with a combination of a periplan NF xlO 
eyepiece, a Phaco 2 NPF 25/0.50 objective and a Zernicke
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402 condenser (Le itz  Wetzlar, Germany).
The scoring system developed for correlating the 
number of trypanosomes counted to the level of parasitaemia
(Paris, Murray and McOdimba, 1982) is shown below:
SCORE TRYPANOSOMES/FIELD* ESTIMATED PARASITAEMIA 
(TRYPANOSOMES ml-i)
6+ Swarming 100 5x106
5+ 10 5x105
4+ 1-10 104 . 5x105
3+ 1/2 f ie ld s  to 1/10 f ie lds 5x103 - 5x104
2+ 1-10 per preparation 103 - 104
1+ 1 per preparation 102 - 103
* Magnification = x250
(b) NEUBAUER HAEMOCYTOMETER
Bovine and rodent-derived bloodstream forms, and in  
v i t r o -derived metacyclic trypanosomes were counted in a 
Neubauer haemocytometer, as described by Lumsden, Herbert 
and McNeill age (1973). Bloodstream forms were counted for  
subsequent isometamidium sens it iv ity  studies in mice, and 
cultured metacyclics for intradermal inoculation into 
c a tt le  and serological tests to detect the presence of 
anti-metacyclic antibodies. Only motile trypanosomes were 
counted, and dividing stages counted as one trypanosome.
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6) DRUGS
All experiments described in this thesis were 
conducted with the drug isometamidi urn chloride (Samorin,
May and Baker Ltd., Dagenham, England). Lot No. DP 3947 
was used throughout the experiment described in chapter 1 
with T.congolense ILNat 3.1 and T.congolense IL 2642, both 
in c a tt le  and mice. Lot No. DM 4532 was used in a ll  other 
experiments. The drug was freshly prepared in s te r i le  
d is t i l le d  water. In c a t t le ,  a 4% w/v solution was used for  
a dosage of lmg kg-1 and a 2% w/v solution for a dosage of 
0.5mg kg-1, as recommended by the manufacturers. The 
concentrations used for isometamidium s e n s it iv ity  studies 
in mice on bovine breakthrough populations, and murine 50% 
curative dose (CD50) determinations, were as described in 
section 16 and the materials and methods section of chapter 
5.
Diminazene aceturate (Berenil, Farbwerke, Hoechst 
A.G., Frankfurt, W. Germany; Lot No. 095D575) was freshly  
prepared as a 7% w/v solution in s te r i le  d is t i l le d  water 
and administered to c a tt le  at a dosage of 3.5mg kg-1.
7) TREATMENT OF CATTLE
Isometamidium chloride was administered as a deep 
intramuscular in jection in the middle th ird  of the side of 
the neck using an 18 guage, P / 2  inch needle. Care was 
taken that none of the drug was deposited subcutaneously. 
Prior to in jection the injection s ite  was washed thoroughly 
with 70% methanol. Diminazene aceturate was administered
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in a sim ilar manner.
Cattle bodyweights were accurately determined prior to 
the administration of drug.
8) INFECTION OF TSETSE
For fly-pickups, goats were inoculated intramuscularly 
with T.congolense ILNat 3 .1 , T.congolense IL 2642 or 
T.vivax IL 2968, and Boran ca tt le  intravenously inoculated 
with T.vivax IL 2969, T.vivax IL 2982 or T.vivax IL 2896. 
Both goats and ca tt le  were bled daily  (except on Sundays) 
from an ear vein. Thin blood films and the buffy-coat were 
examined for the presence of trypanosomes. Three to four 
days a fte r  trypanosomes were f i r s t  detected, teneral male 
Glossina morsitans centralis  from the ILRAD tsetse colony 
were allowed to feed on clipped flanks of the animals, in 
Geigy 1 cages. Tsetse were fed every day (except Saturdays 
and Sundays) over a period of 25 days. From day 25 onwards 
tsetse were monitored for infection by microscopic 
examination of salivary probes (Burtt, 1946) for the 
presence of metacyclic trypanosomes. With T.congolense 
populations and the Zaria T.vivax only those f l ie s  with 
positive salivary probes were used to challenge c a t t le .
Every challenge with T.congolense was conducted with 5 
in fective  tsetse, whilst every challenge with T.vivax was 
conducted with 10 infected tsetse. When f l ie s  refused to 
feed they were replaced with f l ie s  that would. In contrast 
to a high infection rate obtained following dissection of 
tsetse infected with T.vivax populations, a very low
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apparent infection rate was obtained (in the same f ly  
populations) following examination of salivary probes.
Thus, when c a tt le  were challenged with T.vivax IL 2968,
T.vivax IL 2969, T.vivax IL 2982 or T.vivax IL 2986, every 
f ly  that fed on an animal was dissected. Non-infected 
f l ie s  were replaced with others until a to ta l of ten 
infected f l ie s  had fed on each animal.
9) CHALLENGE OF CATTLE
(a) FLY CHALLENGE
Cattle were clipped on one flank and for experiments 
where skin thickness changes were to be measured, localised  
areas (approximately 3cm2) were closely shaven with a 
scalpel blade to serve as tsetse feed sites (one tsetse per 
s i te ) .  So as not to discourage tsetse from feeding, the 
shaved s ite  was not washed with soap or any type of 
solvent. For experiments involving skin thickness 
observations, single infected tsetse, in 7x3cm transparent 
plastic  tubes with netting at one end, were placed singly 
on each shaved s ite  and allowed to feed until completely 
engorged. The point of entry of the probosis was marked 
with a large marker pen. Infected tsetse were only used 
once.
In experiments where skin thickness changes were not 
measured, tsetse were fed as a group in Geigy 1 cages.
Tsetse were starved for two days prior to being used 
to challenge c a t t le .
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(b) I N  VITRO-DERIVED METACYCLIC CHALLENGE
See materials and methods section of chapter 1.
10) SKIN THICKNESS
Measurement of the skin thickness at tsetse b ite  sites  
was conducted daily  (except Sundays) until 30 days 
following each challenge. The skin was raised with the 
thumb and forefinger and the width measured with vernier 
calipers.
In contrast to the classical chancre skin reaction (a 
raised, hot indurated swelling) that occurred in 
non-treated control ca tt le  following tsetse-transmission of 
both T.congolense ILNat 3.1 and T.congolense IL 2642, skin 
thickness changes in c a tt le  administered isometamidium 
chloride, and susceptible to challenge, were in many cases 
much less pronounced. Skin thickness changes were 
therefore calculated by comparing the maximal skin 
thickness at the s ite  of a tsetse b ite  with the average of 
the skin thickness measurements taken at the same s ite  on 
days 0, I and 2. Skin thickness changes of between 0 and 
20% have been taken as non-significant since variation in 
daily  measurement lay within this range. A skin thickness 
change of 20-40% was termed a "slight" increase, 41-64% as 
a "moderate" increase and 65+% as a "large" increase.
11) DRAINAGE LYMPH NODE BREADTH
The breadth of the drainage prefemoral lymph node was 
measured da ily , except Sundays. Because of the in a b i l i ty
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in some animals to raise the prefemoral lymph node 
s u ff ic ie n t ly  to determine its  breadth d ire c tly  with 
calipers, the breadth was f i r s t  determined with the thumb 
and forefinger. Keeping the two aforementioned d ig its  in a 
fixed position, the distance between the two was measured 
with vernier calipers.
Changes in drainage prefemoral lymph node breadth were 
calculated in a sim ilar manner to that described for the 
skin (section 10). Percentage increases in breadth below 
30% were considered non-significant.
12) TEMPERATURE
The deep body temperature of c a tt le  was measured 
da ily , except Sundays. A Schot glass thermometer was 
inserted into the rectum, with the thermometer bulb 
adjacent to the rectal wall, and l e f t  in place for at least 
30 seconds.
13) BLOOD SAMPLES
Jugular blood samples were collected, every 2-3 days, 
into 10ml ethylenediamine te tra -a c e tic  acid (EDTA)-treated 
vacutainer tubes (Greiner) for determination of PCV and the 
level of parasitaemia.
All c a tt le  were bled on a weekly basis into e ither  
10ml EDTA-treated vacutainer tubes for plasma (T.congolense 
c a tt le  experiment), or 10ml plain vacutainer tubes 
(Monoject) for collection of serum (a l l  other experiments). 
Serum was collected a fte r  leaving the blood to stand for 6
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hours at room temperature and then centrifugation at l,200g  
for 10 minutes. Both serum and plasma were stored at -70°C 
until required for serological investigations.
14) PACKED CELL VOLUME
Tubes of blood were placed on a rotary mixer, prior to 
f i l l i n g  plain microhaematocrit cap illa ry  tubes (75mm x 
1.5mm). Approximately 70ul of blood was added to cap illa ry  
tubes which were then sealed at one end with Crystaseal 
(Hawksley, England). Capillary tubes were centrifuged for  
5 minutes in an IEC MB microhaematocrit centrifuge and the 
PCV determined on a Hawksley micro-haematocrit reader.
15) DETERMINATION OF LOW LEVEL PARASITAEMIAS 
In a l l  c a tt le  experiments conducted with
rodent-infective trypanosomes, bovine blood was inoculated 
into mice in an attempt to detect trypanosomes not detected 
by the buffy-coat phase-contrast technique. Twelve and 
twenty-four days following every challenge, 0.2ml of 
EDTA-containing blood (from every cow challenged) was 
inoculated in traperitoneally  ( i . p . )  into each of two mice. 
Mouse t a i l  blood was examined twice weekly for a 30-day 
period to detect the presence of trypanosomes.
16) ISOMETAMIDIUM THERAPEUTIC SENSITIVITITY SCREENING 
Determination of the isometamidium therapeutic
s e n s it iv ity  of bovine trypanosome populations was conducted 
in isometamidium prophylaxis experiments that used
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rodent-infective trypanosome populations.
Subsequent to each challenge, trypanosome populations 
from control c a t t le ,  along with a ll  breakthrough 
populations in drug-administered animals, were examined for  
sen s it iv ity  to isometamidium in mice. Each trypanosome 
population was inoculated into 2 series of mice consisting 
of 4 groups of 6 mice each, along with one group of 6 
control mice. Series 1 was treated 6 hours a fte r  i .p .  
infection with 0 .5 , 1.0, 2.0 and 4.0mg kg-1 isometamidium 
chloride. Series 2 was treated in the same manner when the 
parasitaemia attained 107 trypanosomes per ml of mouse ta i l  
blood. Mice were monitored for 30 days a fte r  treatment for  
the presence of trypanosomes.
The quantity of isometamidium administered to mice was 
calculated by assuming the mouse weight to be 20g and the 
inoculation volume 0.2ml, i . e . ,  0.2ml of a solution 
containing 400mg dnr3 isometamidium chloride equated to a 
dosage of 4mg kg-1.
17) ANTIBODY ASSAYS
Plasma, and serum inactivated at 56°C for 30 minutes, 
were assayed for anti-trypanosoma! antibody.
For T.congolense serological investigations, in v i t r o - 
derived metacyclic trypanosomes were used.
For T.vivax studies, bovine bloodstream forms (from 
tsetse-infected c a tt le )  were used.
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(a) In fe c t iv i tv  neutralisation test (T.congolense)
Trypanosomes and plasma were diluted in phosphate
saline glucose (PSG), 0.15M pH 8 .0 , containing 10% foetal 
bovine serum. Two-fold dilutions of each plasma sample in 
0.75ml were added to an equal volume of a trypanosome 
suspension containing 7.5xl03 organisms. A fter incubation 
for 30 minutes at 4°C, each plasma-trypanosome mixture was 
inoculated i .p .  into a group of 6 mice, each receiving 
0.2ml of the suspension. Mice ta il-b lood  was examined 
twice weekly for the presence of trypanosomes for one 
month. I f  a l l  mice within a group remained aparasitaemic 
throughout the observation period, complete neutralisation  
was said to have occurred.
In i t i a l  screening of plasma samples was conducted at a 
dilu tion  of 1:2. I f  complete neutralisation occurred at 
th is d i lu t io n , two-fold dilutions of the plasma sample were 
made until an end point d ilu tion  for complete 
neutralisation was determined.
(b) Trvpanolvsis test (T.congolense)
The trypanolysis test used was a modification of the 
technique described by Lumsden et a l . .  1973: Metacyclic
trypanosomes were washed once in PSG and a metacyclic 
trypanosome suspension containing 2 .5x l07 trypanosomes per 
ml of PSG, pH 8 .0 , prepared. 10.8ml of fresh guinea-pig 
serum was added to 1.2ml of trypanosome suspension 
(resultant trypanosome suspension = 2 .5x l06 ml-1) as a 
source of complement. lOul of plasma, diluted in PSG, pH
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8.0 , was added to three d iffe ren t wells of a round-bottomed 
m icrotitre  plate at dilutions of 1:1, 1:5 and 1:25. To 
each well was then added 40ul of trypanosome suspension 
(1x10s trypanosomes) thereby resulting in f ina l plasma 
dilutions of 1:5, 1:25 and 1:125. After incubation at room 
temperature for one hour the contents of each well were 
expressed onto a microscope slide and examined under a 
covers!ip using x400 phase-contrast optics. The percentage 
of lysed trypanosomes was determined and the end point of a 
positive plasma sample taken as the d ilu tion  of plasma at 
which over 90% of trypanosomes were lysed.
(c) Trypanolvsis test (T .vivax)
Bovine-derived trypanosomes were used for antigen in 
the trypanolysis te s t.  Parasites were collected for tests  
when the level of parasitaemia in a control steer 
(f ly -transm itted  infection) was such that approximately 10 
trypanosomes were observed per f ie ld  of a wet blood film  
(x400) (approximately SxlOSml"1) .  Blood was collected  
into a 10ml Heparin-treated vacutainer tube (Greiner) and 
mixed with fresh guinea-pig serum in the ra tio  of 1 part 
blood to 10 parts guinea-pig serum. 50ul of trypanosome 
suspension was added to each lOul aliquot of test serum in 
the well of a round-bottomed m icrotitre  p late . After  
incubation at room temperature for 30 minutes the contents 
of each well were expressed onto a microscope s lide,  
examined under x400 magnification, and the percentage of 
lysed trypanosomes determined.
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(d) Indirect Immunofluorescent antibody test (T .v ivax) 
Separation of T.vivax bloodstream forms from bovine 
blood (collected as described in part (c )) was conducted as 
follows: 40ml of RPMI 1640, with the addition of 20mM 
Hepes, lOmM NaHC03 and 1% (v/v) L-Glutamine (29.2mg ml-1 
RPMI 1640), was placed in a Falcon 50ml p lastic  centrifuge  
tube. 10ml of bovine blood, collected in heparin (Novo 
Industri A/S) was added (f in a l concentration 10 i .u .  ml-1) .  
After centrifugation at 330g for 15 minutes, 45ml was 
removed, leaving behind most erythrocytes and the buffy 
coat. The supernatant, in 50ml Falcon centrifuge tubes, 
was centrifuged at l,300g for 15 minutes. A fter removal of 
the supernatant the p e lle t  was resuspended in l-2ml of PSG, 
pH 8 .0 , and pooled with the contents of a ll  other 
centrifuge tubes. The trypanosome suspension was then 
placed onto 2cm depth of DEAE-cellulose (DE52, Whatman), 
newly packed in a small glass funnel with PSG, pH 8.0 .  
Approximately 50ml of eluate was collected and centrifuged 
at 380g for 10 minutes. To prepare antigen to screen for  
variant specific antibody responses, the resultant pe lle t  
was resuspended in PSG, pH 8.0 , containing 1% w/v 
formaldehyde. The mixture was le f t  for l / z  hour to allow 
for complete f ixa tion  of trypanosomes and then centrifuged 
at 380g for 15 minutes. The resultant p e lle t  was 
resuspended in phosphate buffered saline (PBS) containing 
1% v/v rabbit serum so as to produce a trypanosome 
suspension of approximately 5xl06 ml-1. "P.T.F.E.-coated
multi spot microscope slides" (Wellcome) were coated with
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trypanosome antigen using a lOOul pipette and placed in a 
non-humidified 37°C incubator to dry out. Antigen-coated 
slides were wrapped in paper, then t in  f o i l ,  and placed in 
polythene bags containing dessicated S il ica  gel, and stored 
at -70°C until required.
20ul of each serum sample was mixed with 180ul of 
lymphocyte lysate (Katende et a l . .  1987) and l e f t  for 30 
minutes to absorb out non-specific binders. In i t ia l  
screening was conducted at a d ilu tion  of 1:10. I f  antibody 
was detected at th is  d ilu tio n , further dilutions (1:50, 
1:250 and 1:1250) were examined. The serum/lymphocyte 
lysate mixture was diluted with PBS containing 0.2% w/v 
bovine serum albumin (BSA) for non-specific reactants.
25ul of each serum d ilu tion  was added onto each antigen 
coated well. A positive and negative control serum sample 
were placed on each s lide . The slides were placed over 
water in a Gelman moisturising chamber to decrease 
evaporation, and l e f t  at room temperature for 30 minutes.
Fluid was removed from over the slides (avoiding 
cross-contamination) and the slides then placed in PBS, 
0.01M pH 7.2, including 0.2% w/v sodium azide. Two f if te e n  
minute washes were carried out in this buffer, changing the 
buffer each time.
Sheep anti-bovine IgGi, IgG2 and IgM fluorescein 
isothiocyanate conjugate (FITC) was prepared as described 
by Goddeeris et a l . (1982). A working d ilu tion  of 
conjugate was prepared by d ilu ting  i t  1:50 in PBS, 0.01M, 
pH 7.2 + 0.2% BSA, containing Evans blue dye diluted 1:100
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w/v for counter staining. After placing 20ul on each well 
the slides were placed over water in a moisturising chamber 
for 30 minutes.
A fter washing, slides were mounted using buffered 
glycerol (glycerol diluted 1:1 with PBS, 0.01M, pH 8.0) and 
22mmx50mm covers!ips.
Slides were viewed in an incident fluorescence optical 
system, using a x60 fluorescent o il phase-contrast 
objective N.A. 1.30 and a x6.3 periplan eyepiece. For 
fluorescence observation, l ig h t  was supplied by an HBO 200 
mercury arc lamp with a Leitz ploemopak 12/3 f i l t e r  block.
An IFA test for a n t i -T.congolense common antigen 
antibody was conducted in an identical manner except that 
trypanosomes were fixed in normal saline containing 80% v/v 
acetone and 0.25% w/v formaldehyde (Katende et a l . .  1987) 
and the following serum dilutions used; 1:20, 1:100, 1:500 
and 1:2,500.
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I N  VITRO MATERIALS AND METHODS
1) FEEDER LAYERS
(a) Bovine aorta endothelial cells
Bovine endothelial cultures were in it ia te d  as follows: 
The dorsal aorta was aseptically removed from a freshly  
k il le d  cow and placed into Hanks' balanced sa lt  solution 
(BSS) (GIBCO, U.K.) supplemented with p e n ic i l l in  (200 units 
ml-1)-streptomycin (200 units ml-1) .  Using aseptic 
techniques, the outer layers of the aorta were removed with 
scissors and a scalpel. The aorta was then washed several 
times with Hanks' BSS, keeping the in te r io r  surface wet, 
and cut into pieces approximately 2cm2, avoiding areas 
where vessels enter the aorta. The internal surface of 
each piece was then placed on a large drop of collagenase 
solution (containing lmg ml-1 of Type IV-S collagenase (168 
units mg-1, Sigma, London) in Dulbecco's PBS) on a s te r i le  
glass petri-d ish  and incubated for 10-15 minutes at 37°C. 
The loosened endothelial cells  were detached by gently 
pipetting collagenase over the internal surface. . The 
resultant suspensions of endothelial ce lls  were pooled and 
collected by centrifugation at 160g for 5 minutes. The 
p e lle t  was then resuspended in unsupplemented Medium 199 
(M199) with Hanks' sa lt solution (GIBCO, U.K.) and 
centrifuged at 160g for 5 minutes. The p e lle t  was 
resuspended in approximately 3ml of fresh M199 with Hanks' 
sa lt  solution containing 10% (v/v) tryptose phosphate broth 
(GIBCO, U.K.) (2.9mg 100ml-i M199), 20% (v /v)
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heat-inactivated (56°C for 30 minutes) foetal bovine serum 
(Flow Laboratories, Scotland), 300ug ml"1 endothelial cell 
growth supplement (ECGS) (Collaborative Research, Waltham, 
Mass.), 1% (w/v) L-Glutamine, and p e n ic i l l in  (100 units 
ml-1)-streptomycin (lOOug ml-1) .  0.5ml of culture medium
of the same composition was placed into the central 8 wells 
of Tissue Cluster Plates (24 wells per plate; Costar, 
Cambridge, Mass.). 50ul of cell suspension was added to 
each well containing medium. The plates were placed in a 
humidified incubator gassed with 3-4% CO2 in a ir  at 37°C.
On day 7 each well received an additional 0.5ml of medium. 
Medium was changed on a weekly basis for the following four 
weeks, by which time the cell layer had become confluent. 
Only those wells containing confluent endothelial cell 
layers, free of fibroblasts, were selected for further  
work.
Endothelial cells  were removed from the wells by 
trypsin-EDTA treatment (one part of (0.05% (w/v) Trypsin 
(1:250) and 0.02% (w/v) EDTA (Flow Laboratories)) to two 
parts of (Ca2+and Mg2+ - free Earle's BSS (GIBCO, U .K.)) 
at 37°C for 5 minutes and re-seeded into s im ilar plates. 
Culture medium identical in composition to that already 
described was used, except that for passages 1 to 3 the 
ECGS was reduced to 200ug ml-1. In passages beyond passage 
3, ECGS was not included. Passages were conducted every 4 
to 6 weeks. Cell monolayers used for experiments were 
those confluent with rounded ce lls , approximately 4 weeks 
post-passage.
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(b) M i c r o t u s  m n t a n u s  embryonic fib rob last (MER Cells
MEF cells  were derived as described by Brun, Jenni, 
Schoenberger and Schell (1981). MEF cells  were maintained 
in p lastic  25cm2 T-type flasks with MEM medium supplemented 
with 15% (v /v) foetal bovine serum, 1% (v /v) L-Glutamine 
(29.2mg ml-1 MEM medium) and 40ug ml-1 Gentamycin.
Passages were conducted every 10-20 days.
For experiments, 24 well Tissue Culture Cluster Plates 
were seeded with 1x10s viable cells  per w ell, 24 hours 
before addition of trypanosomes. Cell v ia b i l i t y  was 
assayed by eosin staining.
2) PREPARATION OF TRYPANOSOMES
(a) T . c o n g o l e n s e  ILNat 3.1
T.congolense ILNat 3.1 was repeatedly passaged every 7 
days in sublethally irradiated (650 rads) rats up to 
passage 15. Bloodstream trypanosomes for in v itro  assays 
were collected just prior to the f i r s t  parasitaemia peak. 
Rats were anaesthetised with ether then exsanguinated by 
cardiac puncture using a 20 guage I V 2 inch needle 
attached to a 20ml syringe containing s te r i le  heparin in 
Earle's BSS (f in a l concentration approximately 10 i .u .  
heparin- ml-1 of blood).
One part of T.congolense-infected rat blood was mixed 
with nine parts of HEPES (25mM)-buffered RPMI 1640 medium 
(GIBCO, U.K.) and centrifuged at 160g for 10 minutes to 
pe lle t most of the erythrocytes. The supernatant, 
containing the trypanosomes, was centrifuged at 1500g for
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10 minutes and the sediment resuspended in 500ul RPMI 1640 
medium. All sediment suspensions were pooled and the 
number of trypanosomes counted in an improved Neubauer 
haemocytometer counting chamber.
(b) T . v i v a x  IL 2968
T.vivax IL 2968 was isolated from bovine blood as 
follows: 40ml of RPMI 1640, with the addition of 20mM 
Hepes, lOmM NaHC03 and 1% (v /v) L-Glutamine (29.2mg ml-1 
RPMI 1640), was placed in a Falcon 50ml p lastic  centrifuge 
tube. 10ml of bovine blood, collected in Heparin (Novo 
Industri A/S) (10 i .u .  ml-1 blood), was added . After  
centrifugation at 330g for 15 minutes, 45ml was removed 
leaving behind most erythrocytes and the buffy coat. The 
supernatant, in 50ml Falcon centrifuge tubes, was 
centrifuged at l,300g for 15 minutes. A fter removal of the 
supernatant the p e lle t  was resuspended in l-2ml of PSG, pH
8.0 , and pooled with the contents of a l l  other centrifuge 
tubes. The trypanosome suspension was then placed onto 2cm 
depth of DEAE-cellulose (DE52, Whatman), newly packed in a 
small glass funnel with PSG, pH 8.0 . Approximately 50ml of 
eluate was collected and centrifuged at 380g for 10 
minutes. The resultant pe lle t  was resuspended in PSG, pH
8 .0 .
Isolation of T.vivax IL 2968 from ra t  blood was 
identical to that described for T.congolense ILNat 3.1.
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3) SCREENING OF PLASMA AND SERA FROM CATTLE ADMINISTERED 
ISOMETAMIDIUM CHLORIDE FOR TRYPANOCIDAL ACTIVITY 
USING T.CONGOLENSE ILNat 3.1 BLOODSTREAM FORMS
(a) 24 Hour Incubation
Cattle sera or plasma for screening were prepared by 
making 3ml of medium containing 20% (v /v) serum or plasma, 
1% (v /v) L-Glutamine (29.2mg ml-1 RPMI 1640) and 79% (v/v)  
RPMI 1640 medium, and f i l t e r - s t e r i l is e d  using a 0.2um 
f i l t e r .
Maintenance medium over each bovine endothelial cell  
monolayer was removed and replaced with 1.000ml of the 
above described medium. 1.000ml of each medium was placed 
into each of two wells, taking care not to cause disruption 
of the confluent monolayer.
For each animal's set of serum or plasma samples, 
collected a fte r  administration of isometamidium chloride, a 
control sample containing serum or plasma collected on the 
day of drug administration was also included.
Into each well was added 1 .OxlO6 T.congolense ILNat 
3.1 bloodstream forms, in a volume of 20-70ul RPMI 1640 
medium.
Immediately following addition of trypanosomes each 
well was examined for the presence of trypanosomes using a 
Nikon inverted microscope with a xlO Nikon DLL N.A. 0.30 
objective and a xlO Nikon HKW eyepiece. The 24 well plate  
was then placed in a humidified incubator, gassed with 3-4% 
CO2 in a ir  at 37°C, for 24 hours.
A fter incubation the medium in each well was
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vigorously flushed over the cell feeder layer of the same 
well with a pasteur pipette, so as to cause detachment of 
a ll  trypanosomes. In so doing some of the cell feeder- 
layer was also detached. The contents of pairs of wells 
containing the same serum or plasma sample were pooled and 
the trypanosome concentration determined using an improved 
Neubauer haemocytometer chamber. The percentage growth 
inh ib ition  was calculated by comparing the trypanosome 
concentration in each post-drug-administration sample with 
the control sample taken from the same animal.
Determination of trypanosome in fe c t iv i tv : Adult male 
Balb/c mice were used for in fe c t iv i ty  tests . For each 
trypanosome suspension 5 mice were inoculated i .p .  with 
lxlO5 trypanosomes. In some experiments, where lower 
numbers of trypanosomes were present, 5xl04 trypanosomes 
were inoculated into each mouse. In experiments where 
in su ff ic ien t trypanosomes were present to inoculate 5xl04 
trypanosomes into each of 5 mice, 0.30ml of suspension was 
inoculated into each mouse. Mouse t a i l  blood was examined 
twice weekly for parasitaemia for a 30 day period following 
inoculation.
(b) 24/48/72 hour incubations
This was conducted in a sim ilar manner to that  
described in the previous section except that 6 wells were 
f i l l e d  with the same medium. The contents of individual 
wells were counted (two at each time point) a f te r  intervals  
of 24, 48 and 72 hours. In fe c t iv i ty  of trypanosomes a fte r
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24 hours incubation was determined by i .p .  inoculation of 
lxlO6 trypanosomes into each of 5 mice for each 
serum-trypanosome mixture.
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SECTION 1 
STUDIES WITH T.CONGO!FNSF
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CHAPTER 1
A STUDY INTO THE FACTORS INFLUENCING THE DURATION OF 
ISOMETAMIDIUM PROPHYLAXIS IN CATTLE AGAINST EXPERIMENTAL
CHALLENGE WITH METACYCLIC FORMS OF TRYPANOSOMA CONGOLENSE
- 96 -
INTRODUCTION
The most widely used chemoprophylactic against bovine 
trypanosomiasis on the African continent is the 
phenanthridine, isometamidium chloride (Samorin, May and 
Baker Ltd., Dagenham, U .K .).
The factors which influence the effectiveness of the 
drug have not been c learly  defined; consequently, 
considerable uncertainty remains as to the most e ffective  
use of the drug in the f ie ld  situation.
In e a r l ie r  work, Whitelaw, B ell, Holmes, Moloo,
Hirumi, Urquhart and Murray (1986) showed that, at a dose 
of lmg kg-1 bodyweight, isometamidium chloride protected 
c a tt le  against monthly tsetse challenge with Trypanosoma 
congolense ILNat 3.1 for at least 5 months. At 6 months 
post-treatment, two thirds of the c a tt le  (16 of 24) 
successfully resisted infection, even when subjected to 
multiple tsetse challenge, or intradermal inoculation of as 
many as 500,000 in v i t r o -derived metacyclic trypanosomes. 
Anti-trypanosomal antibodies were not detected in any 
animals that successfully resisted challenge.
The work described in this chapter was undertaken to 
confirm the work of Whitelaw et a l . (1986), to test another 
serodeme of T.congolense and to investigate other factors 
which might influence the duration of chemoprophylaxis; 
namely the dose of drug, the level of challenge, and the 
effec t of treatment of an established infection on the 
subsequent duration of prophylaxis.
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MATERIALS AND METHODS
1) CATTLE
The age and breed of ca tt le  were as described in the 
general materials and methods. For ease of reference, 
c a tt le  have been allocated individual codes. The 
relationship between reference codes and animal numbers is 
shown in table 1, appendix I .
2) METACYCLIC TRYPANOSOMES
Metacyclic trypanosomes of T.congolense ILNat 3.1 and 
T.congolense IL 2642 were propagated in v i t r o . Cultures of 
both populations were in it ia te d  by inoculation of rodent- 
derived bloodstream forms into vitrogen (Vitrogen 100, 
Collagen corporation, Palo Alto, California)-containing  
cultures. Primary cultures were maintained at 28°C in 
HEPES (25mM)-buffered Eagle's MEM with Earle's BSS and 20% 
(v /v ) heat-inactivated foetal bovine serum. A fter  
approximately 35 days, transformation through procyclic and 
epimastigote stages to metacyclic forms had occurred 
(Hirumi, Hirumi and Moloo, 1982). Coated metacyclic 
trypanosomes were separated from uncoated procyclic and 
epimastigote forms by passing the bulk population through a 
DEAE-cellulose column (Lanham and Godfrey, 1970) suspended 
in PSG, 0.15M, pH 8 .0 .
E arlie r  work had shown in fe c t iv i ty  of T.congolense 
ILNat 3.1 metacyclics for mice to as low as approximately 
one trypanosome (H.Hirumi, personal communication).
T.congolense IL 2642 metacyclic trypanosomes had not
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been produced before. In fe c t iv i ty  of the metacyclics, for  
mice, was demonstrated down to the level of at least 5 
metacyclic forms a fte r  both DEAE-cellulose column and 
plasma separation (see table 2, appendix 1).
3) CHALLENGE OF CATTLE WITH I N  VITRO-DERIVED  METACYCLIC 
TRYPANOSOMES
Inoculation sites on c a tt le  flanks were prepared as 
described for the feeding of individual tsetse (see general 
materials and methods).
Metacyclic trypanosomes cultured in v itro  were diluted  
in culture medium (Hirumi et a l . .  1982) and inoculated 
intradermally, in a volume of 0.1ml, using a 25 guage 5/s  
inch needle. The production of skin blebs was indicative  
of intradermal, rather than subcutaneous, inoculation.
4) INFECTIVITY OF CATTLE METACYCLIC INOCULUM
Two suspensions of T.congolense ILNat 3.1 metacyclic 
trypanosomes were prepared in culture medium (Hirumi et 
al_., 1982) for intradermal inoculation of c a tt le ;  tube A 
contained 106 ml“1 and tube B contained 104 ml-1.
Immediately a fte r  inoculation of the metacyclic 
trypanosomes the remaining populations in each tube were 
diluted out in ten-fo ld  dilutions to provide in 0.1ml, 105, 
104, 103, 1 0 2 , ioi and 10° trypanosomes for tube A and 103, 
102, 101 and 10° trypanosomes for tube B. 0.1ml aliquots 
of each d ilu tion  were inoculated into 5 mice each. All 
metacyclic suspensions were kept on ice. Mice were
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monitored twice weekly for 2 months.
5) ANTIBODY ASSAYS
In v i t r o -derived metacyclic populations of both 
T.congolense ILNat 3.1 and T.congolense IL 2642 were used 
for serological investigations. Two antibody tests were 
conducted; an in fe c t iv i ty  neutralisation test and a 
trypanolysis te s t .  Both have been described in the general 
materials and methods.
6) INHIBITION OF T.CONGOLENSE ILNat 3.1 METACYCLIC 
TRYPANOSOME INFECTIVITY BY GAMMA-RADIATIQN
Metacyclic trypanosomes were suspended in PSG, 0.15M 
pH8.0, at a concentration of 5x105ml-1, and placed in two 
25cm2 T-type flasks. Both flasks were placed on ice for  
the entire  experimental period and one of the two flasks 
was exposed to between 5 and 15 kilorads of gamma-radiation 
delivered by a caesium source (137Cs). A fter every dose of 
5 kilorads, part of the trypanosome suspension was removed 
and inoculated i .p .  into mice; lxlO5 motile trypanosomes 
per mouse. S im ilarly , at each time point when irradiated  
trypanosomes were inoculated into mice, trypanosomes from 
the flask unexposed to gamma-radiation were also inoculated 
into mice (1x105 per mouse) to serve as controls. Mice 
were monitored twice weekly for one month a fte r  inoculation  
for the presence of parasitaemia.
- 100 -
7) INOCULATION OF CATTLE WITH IRRADIATED T.CONGOLENSE ILNat
3.1 METACYCLIC TRYPANOSOMES AND COLLECTION OF SERA
After exposure of in v i t r o -derived metacyclic 
trypanosomes to 15 kilorads of gamma-radiation, f ive  0.1ml 
aliquots of a suspension (in PSG, 0.15M pH8.0) containing 
2xl06 trypanosomes per ml were inoculated intradermally 
into each of 6 Boran steers (as described for syringe 
challenge of ca tt le  administered isometamidium chloride, in 
section 3 ) ) .
Since peak antibody responses to gamma-irradiated 
T.brucei bloodstream forms (at the level of between 106 and 
109) inoculated e ither subcutaneously or intravenously 
occurred on days 9 or 11 (Morrison et a l . .  1982a), serum 
was collected every second day from the day of inoculation 
until 16 days following inoculation. All sera collected  
from c a tt le  were screened for T.congolense ILNat 3.1 
anti-metacyclic specific antibody responses using 
in fe c t iv i ty  neutralisation and IFA tests.
8) HAEMATOLOGICAL AND PARASITOLOGICAL PARAMETERS
Haematological and parasitological parameters were 
measured as described in the general materials and methods.
EXPERIMENTAL DESIGN 
Twenty-four Boran steers were divided into 6 groups 
of 4 animals, (groups A-F, table 5). On a monthly basis, 
from 2 to 7 months a fte r  treatment with isometamidium 
chloride, the c a tt le  were challenged e ither with infected
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tsetse or in v i t r o -derived metacyclic trypanosomes. 
Challenges were repeated until the animals became 
parasitaemic or, for those ca ttle  refractory to challenge, 
the experiment was terminated a fte r  the 7 month challenge.
On day 0 (17.1.85) ca tt le  in groups A and B each 
received l.Omg kg-1 isometamidium chloride, and those in 
groups C to F, 0.5mg kg-1 (see table 5). With the 
exception of groups E and F, challenge was by infected  
tsetse. Groups, A, C and D were challenged with 
T.congolense ILNat 3.1 whilst group B was challenged with 
T.congolense IL 2642. Group C d iffered from group D in 
that the la t te r  was infected with T.congolense IL 2642 by 
tsetse 4 weeks prior to drug-treatment. Groups E and F 
were challenged with in v i t r o -derived metacyclic forms of 
T.congolense ILNat 3 .1 . At each challenge they received 
5xl03 and 5xl05 organisms, respectively.
For each challenge, 3 control c a tt le  were used to 
confirm trypanosome in fe c t iv i ty ,  i . e .  one for T.congolense 
ILNat 3.1-infected tsetse, one for T.congolense IL 
2642-infected tsetse and one for the in v i t r o -derived 
metacyclic inoculum administered to group E (5xl03) .
- 10.3 -
RESULTS
1) PARASITOLOGICAL DATA
( a ) ( i )  Onset of parasitaemia
Twenty-eight days before administration of 
isometamidium chloride a ll  4 animals in group D were 
f ly - in fec te d  with T.congolense IL 2642. The presence of 
trypanosomes in these animals, as detected by the 
buffy-coat phase-contrast (BC) technique and mouse 
inoculation, prior to challenge with 5 T.congolense ILNat 
3.1-in fected tsetse at 2 months post drug-administration, 
is shown in table 3, appendix I .  During the 2 month period 
following treatment ca tt le  were only detected parasitaemic 
on the day of treatment or at most one day following 
treatment. Trypanosomes occurring in c a tt le  on the day 
following treatment were non-infective for mice.
The development of infection in the c a tt le  following 
each challenge is shown in table 6.;
Following challenge at 2 and 3 months a fte r  drug 
administration none of the drug-administered animals were 
detected parasitaemic e ither by the BC technique or by 
mouse inoculation. In contrast, a ll  control animals were 
observed parasitaemic by day 16 following each challenge, 
as detected by the BC technique (see table 4, appendix I ) .  
In only one steer (the 2 month challenge control for groups 
E and F) was parasitaemia detected by mouse inoculation  
e a r l ie r  than by the BC technique. Parasitaemia was f i r s t
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detected by the BC technique on day 13 whilst inoculation 
of day 12 blood into mice revealed the presence of 
trypanosomes in the blood.
Following a ll  subsequent challenges a l l  challenge 
controls were detected parasitaemic by at the la tes t 14 
days following challenge, using the BC technique.
At the 4 month challenge, 3 drug-treated animals 
became parasitaemic; C4, E4 and F3. In each case the onset 
of parasitaemia was delayed by 2-7 days compared to th e ir  
respective controls (table 5, appendix I ) ,  i . e . ,  days 21, 
16, and 21, respectively. Inoculation of day 12 blood from 
each animal fa iled  to infect mice.
All other drug-administered ca tt le  were refractory to 
challenge and mice inoculated with th e ir  blood were not 
detected parasitaemic.
Following the 5 month challenge, 8 of the remaining 21 
drug-administered animals became parasitaemic (see table 5, 
appendix I ) ;  one in group A (A2), 2 in group C (Cl and C3), 
2 in group D (D1 and D4), one in group E (E2) and 2 in 
group F (F2 and F4). E2 was f i r s t  detected parasitaemic 
a fte r  only 7 days following the challenge. Since the group 
E control was f i r s t  detected parasitaemic on day 14 i t  is 
probable that this infection originated from the previous 
challenge. In only 2 out of the above 8 animals (A2 and 
D4) was parasitaemia delayed in onset as compared to 
controls.
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Of the 5 drug-administered animals f i r s t  detected 
parasitaemic by the BC technique on day 14, only one (C3) 
was shown to be parasitaemic on day 12 by inoculation of 
blood into mice.
All mice detected parasitaemic following inoculation 
of day 24 blood were inoculated with blood from c a tt le  that 
had been shown to contain trypanosomes by the BC technique.
At the 6 month challenge, 7 of the remaining 13 
drug-administered animals became parasitaemic (see table 6, 
appendix I ) ;  one in group A (A4), 2 in group B (B1 and B4),
2 in group D (D2 and D3) and 2 in group E (El and E3). In
5 of these animals (A4, B4, D2, El and E3) parasitaemia was 
delayed in onset as compared to controls. Inoculation of
blood from a ll  7 animals fa iled  to reveal the presence of
trypanosomes at an e a r l ie r  day than that detected by the BC 
technique.
Following the 7 month challenge only one of the 
remaining 6 drug-treated animals became parasitaemic (F I)  
(see table 6, appendix I ) .  In a s im ilar manner to animals 
in the previous month, inoculation of blood from this  
animal into mice fa ile d  to reveal the presence of 
trypanosomes at an e a r l ie r  date than that detected by the 
BC technique.
Throughout the course of the above described 
experiment a l l  challenge controls became infected with
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parasitaemia starting (as detected by the BC technique) on 
day 12.7 ± 1.0 (S.D.) for group A, C, D controls, day 12.2 
+ 1.0 (S.D.) for group B controls and day 14.2 + 1.1 (S.D.) 
for group E, F controls.
Parasitaemia onset was delayed in 11 of 19 
drug-administered animals susceptible to infection; 2 out
of 2 in group A, 1 out of 2 in group B, 1 out of 3 in group
C, 2 out of 4 in group D, 3 out of 4 in group E and 2 out
of 4 in group F. There appeared not to be a
group-associated relationship.
Following onset of parasitaemia in a l l  animals, both 
controls and those administered isometamidium chloride, the 
level of parasitaemia rose to a BC score of 4+ or 5+ (Paris 
et_aT., 1982) within 7 days of patency and remained at this  
level until treatment was required.
( i i )  Comparison of the s en s it iv ity  of mouse
inoculation and the BC technique
Nine steers were f i r s t  detected parasitaemic by the BC 
technique on day 12 (8 controls and one drug-administered). 
Blood collected on day 12 from only one of these animals 
(the drug-administered animal) fa iled  to produce infection  
in mice.
Inoculation of day 12 blood into mice from the 12 
steers f i r s t  detected parasitaemic by the BC technique on 
day 14 (6 controls and 6 drug-administered animals) 
revealed the presence of trypanosomes in the blood of only 
4 animals (3 controls and one drug-administered).
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In a l l  ca tt le  f i r s t  detected parasitaemic 16 or more 
days following challenge, inoculation of day 12 blood into 
mice fa i le d  to reveal the presence of trypanosomes.
F ina lly , f i r s t  detection of parasitaemia, using the BC 
technique, a fte r  day 24 occurred in 3 animals; D2 on day 
28; B4 on day 29 and D4 on day 30 (a l l  drug-administered 
animals). Mouse inoculation of day 24 blood from a ll  3 
animals fa ile d  to produce infection.
(b) In fe c t iv i ty  of i n  v i tro-derived metacyclic trypanosomes 
used to challenge c a tt le  in groups E and F
Subsequent to the administration of in v i t r o -derived 
T.congolense ILNat 3.1 metacyclic trypanosomes to c a t t le ,  
in fe c t iv i ty  t i t ra t io n s  were conducted with the same 
populations in mice. Table 7 shows the resultant data.
For each challenge inoculum, except that used for the 3 
month challenge, in fe c t iv i ty  was demonstrated down to the 
level of between one and 10 trypanosomes. At the level of 
103 trypanosomes the inoculum used for the group E three 
month challenge exhibited zero in fe c t iv i ty  for mice. In 
contrast, the control steer to which 5xl03 of the same 
trypanosome population was administered, developed 5 
chancres with diameters at least twice those e l ic i te d  in 
c a ttle  fed on by tsetse infected with the same serodeme, 
thereby indicating that the animal received a larger  
in fective  inoculum than that inoculated by 
tsetse-transmission (Dwinger, 1985a; Akol, Murray, Hirumi, 
Hirumi and Moloo, 1986). Possibly, in the time taken from
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inoculating c a tt le  to inoculating mice, the trypanosomes 
were exposed to undue stress.
2) CLINICAL DATA
(a) Skin thickness and lymph node breadth measurements
A summary of skin thickness changes that occurred in 
a ll controls and drug-administered c a tt le  susceptible to 
challenge is shown in table 8.
( i ) Challenge controls
In control animals, skin reactions developed at 100% 
of sites at which T.conqolense ILNat 3 .1-in fected tsetse 
had fed, 87% where T.congolense IL 2642-infected tsetse had 
fed and 84% where in v i t r o -derived T.congolense ILNat 3.1 
metacyclic trypanosomes were inoculated. In association 
with the pronounced skin thickness changes there occurred, 
in a l l  cases, a large increase in breadth of the prefemoral 
lymph node.
Figure 1 shows as an example the changes in skin 
thickness, lymph node breath, temperature and level of 
parasitaemia for the 2 month T.congolense ILNat 3.1 tsetse 
challenge control, during the 30 day period following 
in fection. Skin thickness began to increase on day 9, 
peaked on day 12 and then returned to i ts  original value by 
approximately day 20 (skin thickness values are the mean of 
5 measurements made on each day). The drainage prefemoral 
lymph node breadth f i r s t  increased on day 8 and attained  
maximal size on day 11. By day 18 the breadth had
- Ill -
Table B
SKIN THICKNESS AND DRAINAGE LYMPH NODE CHANGES IN ANIMALS 
SUSCEPTIBLE TO CHALLENGE
GROUP ANIMAL CHANGE IN SKIN THICKNESS AT (FIVE) 
CHALLENGE SITES
LARGE
INCREASE
65+%
MODERATE
INCREASE
41-64%
SLIGHT
INCREASE
20-40%
% INCREASE 
IN PREFEMORAL 
LYMPH NODE 
BREADTH
A,C,D control 
B control 
E,F control
A,C,D control 
B control 
E,F control
2 MONTH CHALLENGE (day 61)
5
5
3 MONTH CHALLENGE (day 91) 
5
3 1
5
410
400
220
250
170
290
C
E
F
A,C,D control 
B control 
E,F control
C4
E4
F3
4 MONTH CHALLENGE (day 119/120) 
1 1 120+
320
0
180
390
280
5 MONTH CHALLENGE (day 151)
A A2 - - 1 30+
C Cl 3 1 - 190
C C3 4 1 - 240
D D1 3++ 2++ - 230
D D4 1+ - 4+++ 0
E E2 - - 3+++ 0
F F2 1 4 - 160+
F F4 3 2 - 240
A,,C,D control 5 - - 300
B control 4 - - 270
E, F control 5 - - 240
6 MONTH CHALLENGE (day 181)
A A4 - - 2 0
B B1 - - - 0
B B4 - 2++ - 40+
D D2 1+ 1+ - 80+
D D3 2 2 1 160
E El 3 - 1 200
E E3 2 2 - 240
A,C,D control 3 2 - 220
B control 3 - - 240
E,F control 5 - - 340
7 MONTH CHALLENGE (day 210/211)
F FI 3 1+ - 110+
A,C control 5 - - 120
B control 5 ~ - 240
+Delay in maximal increase compared to control (greater than 2 standard 
deviations from control mean). The number of +'s indicate the number of 
measurements where attainment of maximal dimensions were delayed.
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DAYS AFTER INFECTION
Figure 1: 2 month T.congolense ILNat 3.1 tsetse challenge control.
Change in skin thickness at tsetse bite sites and width of 
draining lymph node; change in temperature and development 
of parasitaemia.
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decreased to approximately ha lf  the maximal value. 
Thereafter, the breadth decreased no further during the 
observation period, remaining enlarged in size compared to 
i ts  pre-infection dimension. Parasitaemia was f i r s t  
detected on day 12 and the 4 pyrexic temperature 
measurements (in  excess of 39.4°C) taken during the 30-day 
observation period were a ll  taken when the animal was 
parasitaemic.
A s im ilar progression of changes in the same 
parameters occurred in a ll other T.congolense ILNat 3.1 
tsetse challenge controls.
Changes in the same parameters for the 2 month 
T.congolense IL 2642 tsetse challenge control are shown 
graphically in figure 1, appendix I .  Both skin thickness 
and drainage lymph node breadth changes were less 
pronounced than those described for the 2 month 
T.congolense ILNat 3.1 tsetse challenge control. The skin 
thickness began to increase on day 10, peaked on day 12 and 
decreased to approximately the pre-infection value by day 
20. The drainage lymph node breadth f i r s t  increased on day 
9, attained maximal size on day 12 and decreased to 
approximately ha lf  i ts  maximal size by day 20. No further  
reduction in size occurred during the observation period. 
Parasitaemia was f i r s t  detected on day 11 and no pyrexia 
was detected.
A s im ilar progression in changes of the above 
described parameters occurred in a ll  other T.congolense IL 
2642 challenge controls.
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Figure 2, appendix I ,  depicts graphically the changes 
in the same 4 parameters for the 2 month T.congolense ILNat
3.1 metacyclic challenge control (challenged with 5xl03 in  
v i t r o -derived metacyclic trypanosomes). At the level of 
the skin only one "slight" increase in thickness occurred. 
In contrast, a large increase in lymph node breadth 
occurred, f i r s t  detected on day 9, peaking on day 13 and 
not decreasing to its  pre-infection size by the end of the 
observation period. Parasitaemia was f i r s t  detected on day 
13 and only one pyrexic temperature measurement was made, 
during the period of parasitaemia. The reason for the 
negligible changes at the level of the skin but pronounced 
changes at the level of the lymph node is unclear.
Possibly the metacyclic trypanosomes were inoculated 
subcutaneously rather than intradermally.
A s im ilar progression of changes in the above 
described parameters occurred in a ll  other T.congolense 
ILNat 3.1 metacyclic controls, except that more pronounced 
skin thickness changes occurred in other animals.
Shown in figure 3, appendix I ,  are changes in skin 
thickness, lymph node breadth, PCV and level of 
parasitaemia for the 3 month T.congolense ILNat 3.1 
metacyclic challenge contro l. Studies in mice on the 
in fe c t iv i ty  of the metacyclic inoculum administered to this  
animal demonstrated zero in fe c t iv i ty  at the level of 5xl03 
trypanosomes (table 7). I t  is clear that since pronounced 
changes in skin thickness and lymph node breadth occurred,
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along with the detection of parasitaemia, the inoculum was 
in fec tive , at least at the level of 5xl03 trypanosomes. As 
previously discussed, since the diameter of chancres 
produced in this animal were 2 to 3 times the diameter of 
chancres produced following tsetse-transmission of 
T.congolense ILNat 3 .1 , this would indicate that a much 
larger in fective metacyclic inoculum was administered than 
that inoculated by an in fective tsetse f ly  (Luckins et a l . .  
1981; Akol et a ! . .  1986).
Summaries of data concerning the day of maximal skin 
thickness and drainage lymph node breadth for control 
animals are shown in table 9.
( i i )  Cattle administered isometamidium chloride
In contrast to control c a tt le ,  many c a tt le  
administered isometamidium chloride, in addition to 
exhibiting less pronounced skin and lymph node changes 
following a successful challenge, exhibited a delay in 
attainment of maximal skin thickness and lymph node breath.
Data regarding changes in skin thickness and drainage 
lymph node breadth in animals susceptible to challenge is 
shown in table 8. Where attainment of skin and lymph node 
maximal changes were s ig n if ican tly  delayed, as compared to 
controls, th is is indicated. The time to development of 
maximal changes in these two parameters has only been taken 
as s ig n if ica n tly  d iffe ren t from controls when data lay 
outwith two standard deviations from the control mean.
The following text describes the atypical changes at
• - 116 -
Table 9
SUMMARIES OF CHALLENGE CONTROL SKIN AND LYMPH NODE DATA
MAXIMAL SKIN THICKNESS (DAY)
GROUP RANGE X S.D. 2 IS .D .) X+2IS.D.)
A, C, D 9-14 11.27 1.31 2.62 13.89
B 10-15 11.35 1.13 2.26 13.61
E, F 10-14 11.54 1.32 2.64 14.18
ATTAINMENT OF MAXIMAL DRAINAGE LYMPH NODE BREADTH (DAY)
GROUP RANGE X S.D. 2IS.D.) X+2IS.D.)
A, C, D 10-15 12.17 1.94 3.88 16.05
B 11-13 12.17 0.75 1.50 13.67
E, F 11-16 13.00 1.87 3.74 16.74
x = mean
S.D. = standard deviation
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the level of the skin and lymph node that occurred in 
animals both refractory and susceptible to challenge.
Where attainment of maximal size was s ig n if ican tly  delayed 
as compared to controls, th is  is denoted by (+2SD), i . e . ,  
the value lay outwith 2 standard deviations from the 
control mean.
Following the 2 month challenge; although no animal 
administered isometamidium chloride was detected 
parasitaemic, D4 developed 4 "slight" skin thickness 
changes, with maximal thicknesses occurring at a ll  sites on 
day 25 (+2SD). In the same animal, the drainage lymph node 
breadth increased by 40% with maximal size measured on day 
23 (+2SD).
Subsequent to the 3 month challenge, no animal 
administered isometamidium chloride became parasitaemic. 
However, skin and lymph node changes occurred in 3 animals; 
E2, F3 and F4:
E2 developed one "slight" skin thickness change with
maximal thickness occurring on day 8. No lymphadenomegaly
was detected.
F3 exhibited 4 "slight" skin thickness changes with 
maximal sizes attained on day 5 (+2SD). Lymph node breadth 
increased by 50% and maximal size was attained on day 5 
(+2SD).
F4 developed one "slight" skin thickness change with
maximal thickness attained on day 6 (+2SD). No
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lymphadenomegaly was detected.
Following the 4 month challenge, two drug-administered 
c a tt le  susceptible to challenge exhibited atypical changes 
at the level of the skin and/or lymph node; E4 and F3. 
Figures 4a and 4b, appendix I ,  show graphically skin, lymph 
node and parasitaemia data for E4, F3 and the group E,F 
contro l.
Two c a tt le  refractory to challenge developed 
sign ificant changes in skin thickness; E2 and F4:
E2 developed one "slight" increase in skin thickness 
with attainment of maximal thickness on day 21 (+2SD). No 
lymphadenomegaly was detected.
F4 developed one "slight" increase in skin thickness;
maximal dimension was attained on day 8. No
lymphadenomegaly was detected.
Subsequent to the 5 month challenge, atypical changes 
occurred at the level of the skin and/or lymph node in 5 
animals susceptible to challenge:
A2; maximal lymph node breadth was attained on day 19.
Dl; skin thickness changes occurred at a l l  5 sites at 
which tsetse had fed. Three "large" increases in skin 
thickness occurred and at 2 of these sites attainment of
maximal thickness was delayed; both day 15 (+2SD).
"Moderate" increases in thickness occurred at the other 2 
sites and attainment of maximal thicknesses at these 2 
sites was also delayed; both day 17 (+2SD).
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D4; skin thickness changes occurred at a ll  5 sites at 
which tsetse had fed. Time to maximal thickness of the one 
"large" increase was delayed; day 26 (+2SD). Of the 4 
"slight" increases, time to maximal thicknesses was delayed 
in 3; days 15, 16 and 17 (a l l  +2SD). No lymphadenomegaly 
was detected.
E2; time to maximal skin thickness of a l l  3 "slight"  
increases was delayed; days 18, 18 and 21 (a l l  +2SD). No 
lymphadenomegaly occurred.
F2; maximal lymph node breadth was attained on day 26 
(+2SD).
Skin thickness changes were also observed in 3 c a tt le  
refractory to challenge:
Bl; one "large" increase in skin thickness occurred 
with maximal thickness attained on day 23 (+2SD).
D2; two "slight" increases in skin thickness occurred.
E3; one "slight" increase in skin thickness occurred 
with maximal size attained on day 16 (+2SD).
In none of these 3 animals was lymphadenomegaly 
detected.
Following the 6 month challenge, time to attainment of 
maximal skin thickness and lymph node breadth was delayed 
in 2 animals susceptible to challenge:
B4; two "moderate" increases in skin thickness 
occurred and in both cases attainment of the maximal size 
was delayed; days 20 and 21 (both +2SD). Maximal 
lymphadenomegaly occurred on day 20 (+2SD).
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D2; skin thickness increases occurred at 2 sites; one 
"large" and one "moderate". Attainment of maximal sizes 
was in both cases delayed; day 19 for the large increase 
and day 26 for the moderate increase (both +2SD). Maximal 
lymphadenomegaly occurred on day 26 (+2SD).
In only one animal refractory to challenge were 
changes in skin thickness observed: FI developed one 
"large" increase with maximal size attained on day 28 
(+2SD) and one "slight" skin increase with maximal size 
attained on day 11. No lymphadenomegaly was detected.
Following the 7 month challenge, the one animal 
susceptible to challenge (F I) exhibited a delay in 
attainment of maximal skin thickness and maximal 
lymphadenomegaly. Changes in skin thickness occurred at 4 
sites and attainment of maximal thickness of the one 
"moderate" increase was day 26 (+2SD). Maximal 
lymphadenomegaly occurred on day 18 (+2SD).
Skin thickness changes were also observed in 2 animals 
refractory to challenge:
B3; one "slight" increase occurred with maximal size 
attained on day 10.
C2; one "slight" increase occurred with maximal size 
attained on day 10.
In both animals, lymphadenomegaly did not occur.
In conclusion; of the 19 c a tt le  administered 
isometamidium chloride and susceptible to challenge, 14
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developed less pronounced changes at the level of the skin 
and/or drainage lymph node as compared to th e ir  respective 
controls. Eight of the 14 animals developed less 
pronounced changes both at the level of the skin and lymph 
node. In the other 6 animals, less pronounced changes 
occurred only at the level of the skin.
In 10 of the 14 animals, f i r s t  detection of 
parasitaemia (by the BC technique) was delayed as compared 
to controls. In contrast, parasitaemia of delayed onset 
was not observed in any of the 5 c a tt le  that developed skin 
thickness and lymph node breadth changes comparable to 
controls.
In 9 of the 19 c a tt le  administered isometamidium 
chloride and susceptible to challenge, attainment of 
maximal skin thicknesses and/or lymph node breadth was 
delayed. In 3 of these animals a delay occurred at both 
the level of the skin and drainage lymph node, in 3 only at 
the level of the lymph node and in 3 only at the level of 
the skin. In 2 of the las t 3 animals described, 
lymphadenomegaly did not occur. In 6 of the 9 animals 
described above, parasitaemia onset was delayed.
Examination of a ll  the atypical changes that occurred 
at the level of the skin and/or lymph node in c a tt le  
administered isometamidium chloride indicated that there 
appeared not to be a group-associated relationship.
(b) Temperature measurements
Temperature measurements taken from the 3 challenge
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controls during the 30 day observation period following the 
2 month challenge are shown graphically in figures 1 and 2, 
appendix I and figure 1 (in  te x t ) .
Summaries of temperature measurements taken during the 
entire  experimental period are shown in tables 7, 8 and 9, 
appendix I .  (Pyrexic temperature measurements have been 
taken as any measurement in excess of 39.4°C.)
A tota l of 3,515 temperature measurements were taken 
during the entire  experiment of which 452 (12.9%) were made 
when animals were parasitaemic, as detected by the BC 
technique. Pyrexia was only detected on 88 occassions. Of 
these measurements, 76 (86%) were taken when animals were 
parasitaemic, and 12 (14%) when animals were 
non-parasitaemic. Thus, only 16.8% (76/452) of temperature 
measurements taken when animals were parasitaemic were 
pyrexic. Division of the same data into infections with 
either T.congolense ILNat 3.1 or T.congolense IL 2642 
showed that 13.9% of temperature measurements taken when 
animals were parasitaemic with T.congolense ILNat 3.1 were 
pyrexic, whilst 20% were pyrexic when animals were 
parasitaemic with T.congolense IL 2642.
In a ll  animals, pyrexic temperature measurements 
occurred in term itten tly ; animals were pyrexic on one day 
and non-pyrexic the next, rather than persistently  pyrexic 
over a series of consecutive days.
3) HAEMATQLOGICAL DATA
In a ll  controls and drug-administered ca tt le
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susceptible to challenge, the in i t ia l  decline in PCV always 
coincided with the f i r s t  detection of parasitaemia.
Figures 3, 5 and 6, appendix I ,  show graphically the 
changes in PCV and level of parasitaemia in the three 
challenge controls used for the 3 month challenge. The 
in i t i a l  PCV decline in a ll 3 animals coincided with the 
f i r s t  detection of parasitaemia.
(In  a l l  c a tt le  experiments the cr ite r io n  used for  
treatment of infected animals with 7mg kg-1 diminazene 
aceturate was when the PCV fe l l  below 16%.) Without any 
exception the PCV in a ll  c a tt le  infected with T.congolense 
ILNat 3.1 and a ll ca tt le  infected with T.congolense IL 2642 
f e l l  below 16% and therefore a ll  infected animals had to be 
treated. In no animal was self-cure observed.
E arlie r  workers in the f ie ld  of chemotherapy have 
stated that trypanosomes "breaking through" the 
chemoprophylactic period are less pathogenic than the same 
challenge administered to c a tt le  that have never received a 
prophylactic drug (Stephen, 1960, 1962a; Stephen and Gray, 
1960). Table 10 has been constructed from the assumption 
that pathogenicity equates with the time taken for the PCV 
in experimental animals to decline by 30% following  
parasitaemia onset. All figures are the number of days 
taken for the PCV at parasitaemia onset to decline by 30%. 
For comparative purposes; shown in table 11 are the mean 
values for the number of days taken for the PCV at 
parasitaemia onset to decline by 30% in challenge controls.
From the data shown in table 11 there appears to be no
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Table 10
TIME (DAYS) FOR PCV AT PARASITAEMIA ONSET TO DECLINE BY 30%
GROUP
CHALLENGE
2 MONTHS 3 MONTHS 4 MONTHS 5 MONTHS 6 MONTHS 7 MONTHS
A - - - 34* 30* -
B - - - - 25*,31* -
C - - 2 2 0 10,19 - -
D - - - 10,19 12,47*
E - - 23 0 2 3 0 1 4 ,2 3 0
F - - 18 14,26* — 28*
CONTROLS
A, C, D 17 23 14 16 10 13
B 14 13 16 12 16 14
E, F 16 19 21 14 14 NO CONTROL
* Greater than 2 standard deviations from mean control value.
(*) Greater than 1 but less than 2 standard deviations from mean 
control value.
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Table 11
MEAN VALUE (DAYS) FOR PCV AT PARASITAEMIA ONSET TO DECREASE 
BY 30% IN CHALLENGE CONTROLS
TRYPANOSOMA STANDARD
CONGOLENSE DEVIATION
GROUP SERODEME MEAN(X) (SD) X+SD X+2ISD)
A,C,D ILNAT 3.1 15.5 4.4 19.9 24.3
B IL 2642 14.2 1.6 15.8 17.4
E,F ILNat 3.1 16.8 3.1 19.9 23.0
A,C,D,E,F ILNat 3.1 16.1 3.8 19.9 23.7
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sign ificant difference in pathogenicity of infections in 
the 3 groups of challenge controls; in particu lar , no 
sign ificant difference in the pathogenicity of T.congolense 
ILNat 3.1 and T.congolense IL 2642.
Of the 19 c a tt le  that were administered isometamidium 
chloride and susceptible to challenge, the time taken for  
the PCV to decline by 30% following parasitaemia onset was 
greater than 2 standard deviations from the mean control 
value in 7 animals, and greater than one but less than 2 
standard deviations from the mean control value in 4 other 
animals.
The 7 animals with 30% PCV decline rates greater than 
2 standard deviations from the mean control value were 
composed of 0 out of 3 ca tt le  susceptible to the 4 month 
challenge, 2 out of 8 c a tt le  susceptible to the 5 month 
challenge, 4 out of 7 ca tt le  susceptible to the 6 month 
challenge and 1 out of 1 susceptible to the 7 month 
challenge.
4) IMMUNOLOGICAL DATA
(a) Trypanolvsis test
Data from trypanolysis tests using T.congolense ILNat
3.1 metacyclic trypanosomes as antigen is shown in tables 
12, 13 and 14.
All eleven T.congolense ILNat 3.1 challenge controls 
developed anti-metacyclic specific trypanolytic antibody 
following in fection; 7 by day 14 and a ll 11 by day 21. The 
maximal antibody t i t r e s  attained during each 28 day
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sampling period were 1:5 for one animal, 1:25 for 6 animals 
and 1:125 for 4 animals.
Incubation of T.congolense ILNat 3.1 metacyclic 
trypanosomes in day 28 plasma from T.congolense IL 2642 
challenge controls produced no lys is , thereby indicating  
there to be no metacyclic isotypes in the mVAT repertoires  
of the two serodemes. S im ilarly , T.congolense IL 2642 
metacyclic trypanosomes were not lysed when incubated in 
day 28 plasma from T.congolense ILNat 3.1 challenge 
controls.
During the period when animals in groups A, C, D and E 
remained refractory to challenge, anti-metacyclic  
antibodies were not detected. However, antibodies were 
always detected, without delay in onset, following the 
development of parasitaemia. Four exceptions to this  
generalisation were as follows:
A2 was f i r s t  detected parasitaemic 24 days following 
the 5 month challenge. Trypanolytic antibody was f i r s t  
detected on day 21 following the 5 month challenge (at a 
t i t r e  of 1 :5 ), 3 days e a r l ie r .
E2 was f i r s t  detected parasitaemic 7 days following 
the 5 month challenge. Trypanolytic antibody was f i r s t  
detected on day 0 of the same month. Both the presence of 
antibody on day 0 and the early onset of parasitaemia would 
suggest that the parasites detected on day 7 originated  
from the 4 month challenge, rather than the 5 month 
challenge.
A4 was f i r s t  detected parasitaemic 24 days following
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the 6 month challenge, however antibody was not detected up 
until and including day 28.
D2 was f i r s t  detected parasitaemic 28 days following 
the 6 month challenge. Seven days e a r l ie r ,  on day 21, an 
antibody t i t r e  of 1:5 was detected.
Unlike a ll  the ca tt le  in groups A, C, D and E, a l l  4 
animals in group F (challenged at monthly intervals with 
5xl05 metacyclic trypanosomes) developed low an ti-  
metacyclic antibody t i t r e s  1 to 4 months before being 
susceptible to challenge:
(F I) Antibody was f i r s t  detected, at a t i t r e  of 1:5, 
in plasma from FI fourteen days following the 3 month 
challenge. FI did not become infected until following the 
7 month challenge.
(F2) In plasma from F2, trypanolytic antibody was 
f i r s t  detected 14 days following the 3 month challenge at a 
t i t r e  below 1:5. A t i t r e  of 1:5 was detected in plasma 
collected 7 days following the 4 month challenge and in 
weekly samples collected thereafter. However, the animal 
was not susceptible to infection until the 5 month 
challenge.
(F3) Trypanolytic antibody at a t i t r e  of 1:5 was f i r s t  
detected in plasma from F3 fourteen days following the 2 
month challenge. F3 did not become infected until  
following the 4 month challenge.
(F4) Not until following the 4 month challenge was 
trypanolytic  antibody detected in plasma from F4; below a
t i t r e  of 1:5 on day 7 and at a t i t r e  of 1:5 on day 14. The 
animal did not succumb to infection until following the 5 
month challenge.
Following f i r s t  detection of antibody in a ll  4 
group F animals, low antibody t i t r e s  were detected in a ll  
subsequent plasma samples until each animal became 
parasitaemic.
Thus, despite the presence of low anti-metacyclic 
antibody levels , a ll group F animals were susceptible to 
challenge. In no animal did the trypanolytic antibody 
t i t r e  r ise above 1:5 before parasitaemia was detected.
Once the animals became parasitaemic the antibody t i t r e  
rose to 1:25 in 2 animals (FI and F3) and to 1:125 in the
other 2 (F2 and F4).
(b) In fe c t iv i ty  neutralisation test
( i ) T.congolense ILNat 3.1
The results of in fe c t iv i ty  neutralisation tests using 
T.congolense ILNat 3.1 metacyclic trypanosomes are shown in 
table 15.
Because of the large number of mice required to 
conduct neutralisation tests only plasma samples collected  
on the days of successful challenges were examined for the 
presence of in fe c t iv i ty  neutralising antibody. In i t ia l  
screening was carried out at a d ilu tion  of 1:2. At this  
d ilu t io n , complete neutralisation was produced by plasma
from only 4 animals; the 4 animals in group F; F3 had a
complete neutralising antibody t i t r e  of 1:20 on the day
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of the 4 month challenge, F2 and F4 both had complete 
neutralising t i t r e s  of 1:2 on the day of the 5 month 
challenge and FI had a complete neutralising t i t r e  of 1:5 
on the day of the 7 month challenge. In contrast, plasma 
collected from a 5 month challenge control, 28 days a fte r  
infection with T.congolense ILNat 3 .1 , produced complete 
neutralisation of in fe c t iv i ty  at a t i t r e  of 1:80.
( i i )  T.congolense IL 2642
Data from in fe c t iv i ty  neutralisation tests conducted 
with T.congolense IL 2642 metacyclic trypanosomes is shown 
in table 16.
All 4 animals in group D were infected with 
T.congolense IL 2642 by fly-transmission 28 days prior to 
day 0, when isometamidium chloride was administered; a ll  
had high neutralising antibody t i t r e s  on day 0. Complete 
neutralisation t i t r e s  on this day were 1:20 for Dl, 1:80 
for D2, 1:80 for D3 and 1:40 for D4.
By the end of the c a tt le  experiment only 2 of the 4 
animals in group B had become infected; B1 and B4. Both 
animals became infected following the 6 month challenge. 
Plasma collected from B4 on the day of the 6 month 
challenge did not neutralise metacyclic in fe c t iv i ty .  
However, plasma collected on the same day from B1 produced 
complete neutralisation of in fe c t iv i ty  at a t i t r e  of 1:2. 
Worthy of note are the observations that although B1 was 
not detected parasitaemic until 14 days following the 6 
month challenge, no changes occurred at the level of the
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skin or lymph node subsequent to the 6 month challenge. 
However, following the 5 month challenge one "large" 
increase (100%) in skin thickness did occur; attainment of 
maximal thickness was delayed. These observations suggest 
that the parasitaemia observed in B1 following the 6 month 
challenge may infact have originated from the 5 month 
challenge.
Subsequent to the 7 month challenge 2 animals in group 
A (A1 and A3), 2 animals in group B (B2 and B3), and one 
animal in group C (C2) remained refractory to challenge. 
In fe c t iv i ty  neutralising antibody was not detected in 
plasma collected from any of the 5 animals on the day of 
the 7 month challenge.
(c) Indirect immunofluorescent antibody f I  FA) test
Results from screening plasma samples for antibodies 
to T.congolense common antigens are shown in table 17. The 
same set of plasma samples that were used for metacyclic 
in fe c t iv i ty  neutralisation tests were examined.
Plasma collected from a ll  4 group D animals on day 0 
produced strong nuclear staining at a t i t r e  of 1:20 or 
more. All 4 animals were infected with T.congolense IL 
2642 twenty-eight days e a r l ie r  and 3 of them were 
parasitaemic on day 0. Other workers have described the 
phenomenon of nuclear staining when conducting IFA tests  
for antibody to common antigen (Zwart, Perie, Keppler and 
Goedbloed, 1973; Katende et_al_., 1987). Nuclear staining
-  137 -
TABLE 17
I FA TEST FOR ANTI-T .C O N G O LE N SE  COMMON ANTIGEN ANTIBODIES
PLASMA DILUTION
SAMPLE ANIMAL GROUP DATE 1:20 1:100 1:500
Day 0 D1 D 17.1.85 +N _
D2 D 17.1.85 +N +N
D3 D 17.1.85 +N +N +N
D4 D 17.1.85 +N +N +N
4 month C4 C 17.5.85 _
challenge E2 E 16.5.85 -
Day 0 E4 E 16.5.85 -
F3 F 16.5.85 +N +N
5 month A2 A 17.6.85 _
challenge Cl C 17.6.85 -
Day 0 C3 C 17.6.85 -
D1 D 17.6.85 (+ /-) -
D4 D 17.6.85 (+/-) -
F2 F 17.6.85
F4 F 17.6.85 +N -
6 month A4 A 17.7.85 _
challenge B1 B 17.7.85 -
Day 0 B4 B 17.7.85 -
D2 D 17.7.85 -
D3 D 17.7.85 + + +
El E 17.7.85 + -
E3 E 17.7.85 -
7 month A1 A 15.8.85 _
challenge A3 A 15.8.85 -
Day 0 B2 B 15.8.85 -
B3 B 15.8.85 -
C2 C 15.8.85 -
. FI F 16.8.85 +N -
6 month B1 B 14.8.85 + +
challenge D3 D 14.8.85 + + +
Day 28 A,C,D
(positive control 14.8.85 +N +N +N
controls) B
control 14.8.85 +N -
Negative B4 17.1.85 _
controls E,F control 17.1.85 -
+ = positive staining.
- = negative staining.
N = nuclear staining only.
(+ / - )  = staining not as marked as positive samples but more than 
negative samples.
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appears to be more commonly observed when screening for  
antibody responses to T.congolense common antigen than for 
sim ilar responses to T.vivax or T.brucei (J.Katende, 
personal communication). Since, in the work described by 
Katende et a l . (1987), antinuclear antibodies could not be 
removed by absorption with a lymphocyte lysate containing 
bovine nuclear m aterial, i t  was unlikely that the a c t iv ity  
was due to antibody directed towards host DNA (Katende et 
a l . ,  1987). Thus, in the following text the term "antibody 
t i t r e "  includes both whole trypanosome, and nuclear, 
staining.
Three of the 4 animals in group F (F I ,  F3 and F4) had 
an IFA t i t r e  of 1:20 on the day of successful challenge.
No common antigen antibody response was detected in plasma 
collected from F2 on the day of successful (5 month) 
challenge although both trypanolytic and in fe c t iv i ty  
neutralising anti-metacyclic antibody were detected in the 
same plasma sample.
Of the 4 animals in group D, a ll  of which had common 
antibody t i t r e s  on the day of drug-administrati on, 3 had a 
common antibody t i t r e  on the day of successful challenge. 
Since neither trypanolytic nor in fe c t iv i ty  neutralising  
anti-metacyclic antibodies were detected in the la t te r  
samples, the anti-common antigen antibody detected in 
plasma collected on the day of successful challenge 
probably originated from the animals' e a r l ie r  infection  
with T.congolense IL 2642.
Apart from positive controls, the only other sample in
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which anti-common antigen antibody was detected was that 
from El, on the day of the 6 month challenge. Although an 
IFA t i t r e  of 1:20 was detected in the sample, neither 
trypanolytic nor in fe c t iv i ty  neutralising anti-metacyclic  
antibody was detected.
5) SCREENING OF BREAKTHROUGH TRYPANOSOME POPULATIONS FOR 
THEIR I N  VIVO SENSITIVITY TO ISOMETAMIDIUM 
All trypanosome populations arising in 
drug-administered ca tt le  and controls were screened for  
th e ir  s e n s it iv ity  to the therapeutic a c t iv ity  of 
isometamidi urn in mice.
Since no bovine administered isometamidium chloride  
became infected following the 2 month or 3 month challenge, 
drug s e n s it iv ity  screening was not carried out with 
trypanosome populations arising in control animals used for 
these two challenges.
Data from isometamidium s en s it iv ity  experiments 
conducted with trypanosome populations arising as a result  
of the 4, 5, 6 and 7 month challenges is shown in tables 
10, 11, 12 and 13, appendix I ,  respectively.
Of the infections in mice derived from breakthrough 
populations occurring in 19 drug-administered steers, a ll  
appeared to be sensitive to treatment, both 6 hours 
post-infection and when parasitaemia attained 107 parasites 
per ml, with isometamidium chloride at dosages of 0 .5 , 1.0, 
2.0 and 4.0mg kg-1. A s im ilar level of s e n s it iv ity  was 
expressed by trypanosome populations arising in controls.
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Thus, no trypanosome population aris ing in a drug- 
administered animal showed any evidence fo r  the expression 
of an a ltered level of s e n s it iv i ty  to the therapeutic  
a c t iv i ty  of isometamidium.
The timing of treatment did, however, appear to a f fe c t  
the level of s e n s it iv i ty  expressed by the trypanosome 
populations, i . e . ,  a s l ig h t ly  lower level of s e n s it iv i ty  
appeared to be expressed when in fections were treated at 
peak parasitaemia rather than 6 hours post in fec tio n .
6) DETERMINATION OF THE ANTIBODY RESPONSE OF BORAN CATTLE 
TO INTRADERMAL INOCULATION OF 1.0x106 IRRADIATED 
T.CONGOLENSE ILNat 3.1 METACYCLIC TRYPAN0S0MES 
Since the quantity of gamma-radiation required to 
completely in h ib it  in fe c t iv i ty  of T.congolense metacyclic 
trypanosomes had not previously been described, a 
preliminary experiment was conducted in mice to determine 
the quantity of gamma-radiation required to completely 
in h ib it  the in fe c t iv i ty  of in v i t r o -derived T.congolense 
ILNat 3.1 metacyclic trypanosomes. Table 14, appendix I ,  
shows the results  from th is  experiment. A fte r  exposure to 
5 kilorads there was p a r t ia l  in h ib it io n  of in fe c t iv i ty ,  
w hils t at 10 and 15 kilorads there was complete in h ib it io n  
of in fe c t iv i ty .  A repeat of th is  experiment produced 
s im ilar  resu lts .
Thus, fo r  the c a t t le  experiment, metacyclic 
trypanosomes were exposed to 15 kilorads of gamma-radiation 
before inoculation into c a t t le .
Sera were collected from each of 6 c a tt le  every second 
day from the day of inoculation until 16 days following 
inoculation.
In fe c t iv i ty  neutralisation tests were carried out at a 
serum d ilu tion  of 1:2 using in v i t r o -derived T.congolense 
ILNat 3.1 metacyclic trypanosomes. The in fe c t iv i ty  of each 
metacyclic population for mice, a f te r  incubation in serum, 
is shown in table 15, appendix I .  No serum sample produced 
complete neutra lisation. Thus there'appeared not to be a 
s ign ificant neutralising antibody response by any of the 6 
c a tt le .
Data from IFA tests is shown in table 16, appendix I .  
Only in serum collected on day 8 was antibody detected.
Day 8 serum from a ll  6 animals stained between 5% and 48% 
of the T.congolense ILNat 3.1 metacyclic population.
Thus, subsequent to tntradermal inoculation of lxlO6 
irrad iated T.congolense ILNat 3.1 metacyclic trypanosomes 
to 6 Boran c a t t le ,  only a s light transient indirect  
immunofluorescent antibody response was detected in each 
animal (a complete neutralising antibody response was not 
detected in any animal).
These findings are consistent with those of Morrison 
et a l . (1982a) who detected low neutralising a c t iv ity  in 
sera of c a tt le  intravenously administered 106 irradiated  
T.brucei bloodstream forms (antigen ica lly  homogenous to the 
level of 104) but no a c t iv ity  i f  the same inoculum was 
administered subcutaneously. The same workers conducted 
immunofluorescence studies on l iv e  trypanosomes using
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fluorescent conjugates specific for e ither bovine IgG or 
bovine IgM. Only in animals administered 107 or more 
trypanosomes was antibody detected. In the work described 
here a very s light indirect immunofluorescent antibody 
response was detected on day 8. The fluorescein conjugate 
used in this work, unlike that described by Morrison et a l . 
(1982a), recognised both bovine IgG and IgM and may 
therefore, because of antibody isotype po lyspecific ity , 
have been more sensitive. This may account for the 
detection of antibody subsequent to intradermal 
administration of lxlO6 T.congolense metacyclic 
trypanosomes.
Metacyclic trypanosomes inoculated by feeding tsetse 
f l ie s  are extruded in association with many non-metacyclic 
antigens (E l l is ,  Shapiro, ole MoiYoi and Moloo, 1986).
That the host may become sensitised to these non-metacyclic 
antigens has been demonstrated by the occurrence of 
hypsensitivity reactions in rabbits subsequent to repeated 
bites by non-infected tsetse (E l l is  et a l . .  1986). By 
analogy, i f  the above described experiment had been 
repeated with metacyclic trypanosomes suspended in 
serum-containing culture medium (as used to suspend 
metacyclic trypanosomes for administration to groups E and 
F) i t  might be expected that the presence of serum antigens 
would, by antigenic competition, negate the s ligh t antibody 
response detected with the indirect immunofluorescence 
tes t.
DISCUSSION
In work conducted by White!aw et al (1986) a single 
intramuscular in jection of l.Omg kg-1 isometamidium 
chloride was shown to confer complete protection in c a tt le  
for at least 5 months against single or repeated challenge 
with tsetse-transmitted T.congolense ILNat 3 .1 . No animal 
which resisted infection developed skin reactions at the 
s ite  of inoculation or produced anti-metacyclic  
trypanosomal antibodies, indicating that prophylaxis was 
en tire ly  drug-mediated.
In the present study, the duration of complete 
protection with the same drug dosage against repeated 
monthly tsetse challenge was 4 months with the serodeme 
previously investigated (ILNat 3.1; group A) 
and 5 months with an unrelated T.congolense serodeme (IL  
2642; group B) (Table 6 ). In a similar manner to the work 
described by Whitelaw et a l . (1986), isometamidium 
protected a s ign ificant proportion of c a tt le  beyond 6 
months.
Isometamidium chloride is frequently recommended for  
f ie ld  administration at 0.5mg kg-1 and at this lower dosage 
(group C), the period of complete prophylaxis was reduced 
to 3 months. Thereafter, 3 out of 4 c a tt le  were 
susceptible to challenge during the following 2 months. 
Analyses of these results indicated a s ign ificant (P<0.06) 
dose-dependent relationship for the duration of 
isometamidium prophylaxis against drug-sensitive strains of 
T.congolense and showed that within th is  dose range
(0.5-1.0mg kg-1) ,  3 to 5 months protection might be 
expected.
Work from the f ie ld  in Rhodesia has demonstrated a 
sim ilar dose-dependent relationship. Using isometamidium 
chloride at a dosage of 1 or 2mg kg-1 in an area of high 
tsetse challenge (Berenil Index 13), Boyt et a l . (1962) 
indicated that the higher dosage conferred a longer mean 
period of protection than the lower; the mean period of 
protection for 4 animals administered lmg kg-1 was 187
days, while of 5 animals administered 2mg kg-1, 3 were
s t i l l  uninfected at 282 days, giving a mean protection 
period of over 245 days. The period of complete protection 
for the same animals was 147 days at lmg kg-1 and 173 days 
at 2mg kg-1. A sim ilar relationship has been described for  
ethidium bromide, another member of the phenanthridine 
group of compounds (Leach et a l . .  1955) to which 
isometamidium belongs.
Since i t  has been suggested that the duration of
protection afforded by a prophylactic drug is d ire c t ly
related to the in tensity of tsetse challenge (Fiennes,
1953; MacOwan, 1955, 1956; Davey, 1957; Whiteside, 1958, 
1962a,b), 2 groups of 4 c a tt le  (groups E and F) were 
administered 0.5mg kg-1 and subsequently challenged at 
monthly intervals with e ither 5xl03 or 5xl05 in 
v i t r o -derived metacyclic trypanosomes. I f ,  as discussed by 
Whitelaw et a l . (1986), i t  could be assumed that the 
maximum inoculum of a T.congolense-in fe c tive  tsetse is 100 
metacyclic trypanosomes, i t  would be concluded that the
c a tt le  in groups E and F were exposed each month to the 
equivalent of 50 and 5,000 in fective  tsetse respectively. 
The duration of complete prophylaxis in both groups E and F 
was found to be the same, i . e . ,  3 months. This was s im ilar  
to group C, which was challenged with 5 in fective tsetse 
per month. That the duration of prophylaxis is unaffected 
by this wide range of challenge conflicts with previous 
f ie ld  observations, although is consistent with previous 
experimental findings (Whitelaw et a l . ,  1986). However, 
two differences between the experimental conditions 
described and those in the f ie ld  may have contributed to 
th is inconsistency. The f i r s t  was that both populations of 
T.congolense used in this experiment have been well
characterised in terms of th e ir  sens it iv ity  to
isometamidium at normal therapeutic doses, whereas in the 
f ie ld  c a tt le  might encounter strains of trypanosomes less 
sensitive to the drug. The second was that the challenge 
was administered on a single day each month, whereas in the 
f ie ld ,  challenge probably occurs more frequently at a lower 
in tensity . An understanding of the in terre lationship  
between such variables is central to the proper use of
prophylactic drugs in the f ie ld .
When isometamidium chloride was used to tre a t  an 
existing infection (group D) the period of prophylaxis 
against subsequent challenge was the same as in c a tt le  
previously uninfected (group C). This observation is of 
practical importance, since i t  might have been expected 
that the duration of prophylaxis would have been shorter
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due to drug uptake by the large number of c irculating  
trypanosomes, as-suggested by Davey (1957). However, in 
studies with 14C-ethidium bromide, no difference was 
observed in e ither drug distr ibution or drug excretion 
between normal and T.congolense-infected calves (G ilbert,  
Curtis and Newton, 1979).
Results from previous investigations (Whitelaw et a l . .  
1986) and those from 5 of the 6 groups of c a tt le  in the 
experiment described here (groups A, B, C, D and E), have 
indicated that prophylaxis was mediated solely by the drug 
since no antibody was detected in any animal until i t  
became parasitaemic. Furthermore, none of the breakthrough 
trypanosome populations occurring in the 19 c a tt le  
administered isometamidium chloride and susceptible to 
challenge showed evidence for the expression of a decreased 
level of se n s it iv ity  to isometamidium. An exception to the 
above conclusion, regarding absence of antibody, was group 
F in which a ll  4 animals (which received the largest 
inoculum of in v i t r o -derived metacyclic trypanosomes) had 
low anti-metacyclic antibody t i t r e s  for 1 to 4 months 
before becoming parasitaemic, when antibody levels rose 
f iv e - fo ld .  Thus, i t  would appear that the repeated 
administration of 5xlQ5 T.congolense metacyclic parasites 
was su ffic ien t to induce an antibody response in 
drug-administered c a tt le  but not at a level that conferred 
protective immunity.
In none of the 4 animals in group F was trypanolytic  
antibody detected until following the administration of at
least two inoculae of 5xl05 metacyclic trypanosomes. Since 
no in fe c t iv i ty  neutralising antibody and only a very s light  
indirect immunofluorescent antibody response were detected 
in c a tt le  a fte r  intradermal inoculation of lxlO6 irradiated  
T.congolense ILNat 3.1 metacyclic trypanosome, i t  would 
appear that the antibody response occurring in group F 
animals was an anamnestic, rather than a primary, response.
As to why the trypanolytic antibody t i t r e  rose no 
higher than 1:5 in the group F animals until they became 
parasitaemic is unclear. Possibly isometamidium exerted an 
immunosuppressive e ffec t , e ither by d irect action on the 
mononuclear phagocytic system or by binding to the surface 
of trypanosomes and rendering them less immunogenic. 
A lternative ly , a n t i -T.congolense ILNat 3.1 metacyclic 
antibody may have bound to the metacyclic antigens, and 
because of the re la t iv e ly  small quantity of antigen 
administered, masked most, i f  not a l l ,  of the antigen load. 
In the same manner, Morrison et a l . (1982a) found that 106 
irrad iated (non-infective) T.b.brucei gave r ise  to a 
detectable antibody response in c a tt le  when inoculated 
intravenously. The antibody response did not resu lt in 
complete protection; for this a minimum of 107 parasites 
was required.
I t  is therefore concluded that acquisition of immunity 
to metacyclic variable antigen types of T.congolense whilst 
under chemoprophylactic cover is unlikely to play any 
sign ificant protective role in animals maintained by a 
chemoprophylactic regime, as the size of the metacyclic
inoculum required to stimulate a protective immune response 
is excessively large in re la tion to what is l ia b le  to be 
encountered in the f ie ld .
Dwinger (1985a) has shown that as many as 105 
irrad iated T.congolense ILNat 3.1 in v i t r o -derived 
metacyclic trypanosomes did not e l i c i t  a skin reaction when 
inoculated intradermally (at one s i te ) .  Further work has 
indicated that the intradermal inoculation of at least 107 
irrad iated metacyclic trypanosomes was required before a 
change in skin thickness occurred (R.H.Dwinger, personal 
communication). I t  must therefore be concluded that only 
when metacyclic trypanosomes multiply to the level of 107 
at the s ite  of inoculation that a skin thickness change is 
e l ic i te d .
The absence of skin thickness and lymph node changes 
in almost a l l  drug-adminstered c a tt le  when refractory to 
challenge, and the absence of detectable antibody in a ll  
animals in groups A, B, C, D and E prior to onset of 
parasitaemia, would indicate that protection against 
challenge in groups A-E was mediated solely by drug and 
that protection occurred at the level of the skin. I t  must 
therefore be concluded that isometamidium excerted its  
trypanocidal a c t iv ity  in these animals at the level of the 
skin; inh ib iting  m ultip lication of the trypanosome inoculum 
e ither immediately or before trypanosome numbers required 
to e l i c i t  a skin and antibody response were attained.
Since homidium, another member of the phenanthridine 
group of compounds, is reported to manifest i ts
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trypanocidal a c t iv ity  in  vivo a fte r  a la tent period of 24 
hours (Hawking and Sen, 1960), i t  is possible that 
trypanosomes exposed to isometamidium are also able to 
multiply for a limited number of times before the drug's 
trypanocidal a c t iv ity  is manifested. Thus, a short period 
of trypanosome m ultiplication may have occurred a fte r  
inoculation.
In many of the ca tt le  administered isometamidium 
chloride and susceptible to challenge there were pronounced 
differences, as compared to controls, at the level of the 
skin, lymph node and in time to onset of parasitaemia.
There appeared not to be a group-association with regard to 
these differences. Akol and Murray (1983, 1985) have shown 
that in c a tt le  immune to homologous rechallenge with 
cyclica lly -in fec ted  tsetse, skin thickness changes at the 
s ite  of infected-tsetse bites did not occur. Furthermore, 
the presence of partia l immunity to the intradermally  
inoculated trypanosome population can result in 
parasitaemia of delayed onset (R.H.Dwinger, personal 
communication). In none of the c a tt le  administered 
isometamidium chloride, except those in group F, could 
trypanolytic  or in fe c t iv i ty  neutralising antibody be 
detected on the day of successful challenge. In the same 
animals there was also no evidence for a lteration  in 
s e n s it iv ity  of breakthrough trypanosome populations to 
isometamidium as compared to populations arising in 
controls. Possibly drug and/or antibody was present, but 
at levels below the level of detection in the antibody and
drug s e n s it iv ity  tests; levels su ff ic ien t to in h ib it  growth 
and in fe c t iv i ty  of a large part of the metacyclic inoculum, 
but not a l l .
The appearance of trypanosomes in the peripheral blood 
of c a tt le  at the end of the chemoprophylactic protective  
period has been described as being often scanty and 
sporadic (Smith, 1959; Stephen, 1960). These 
"breakthrough" trypanosomes appear to be less pathogenic 
than the same parasites in animals that have never received 
a prophylactic drug (Stephen, 1960, 1962a; Stephen and 
Gray, 1960). In none of the 19 breakthrough trypanosome 
populations occurring in drug-administered c a tt le  described 
in th is  chapter could the parasitaemia be described as 
"interm ittent and sporadic". All parasitaemias increased 
to the level of (BC)4+ or (BC)5+ over a period of no more 
than 7 days (s im ilar to controls) and remained at this  
level until treatment was required. Although a ll  animals 
that became infected, both drug-administered and controls, 
required treatment, the rate of PCV decline in at least 7 
of the 19 c a tt le  administered isometamidium chloride 
indicated the presence of s ign if ican tly  less pathogenic 
trypanosome populations. The mechanisms involved in 
alteration  of pathogenicity are unknown.
In conclusion, the results from this experiment 
support previous findings (Whitelaw et a l . .  1986) and, in 
addition, indicate that the duration of isometamidium 
chemoprophylaxis is a function of the dose of drug used and 
not of the level of metacyclic challenge or the presence of
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an existing parasitaemia. They further indicate that 
antibody responses against challenge by metacyclic forms of 
T.congolense do not occur in ca tt le  under isometamidium 
prophylaxis.
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CHAPTER 2
STUDIES WITH T.CONGOLENSE I N  V ITRO
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INTRODUCTION
The f i r s t  stage of T.congolense to be successfully 
cultured in v itro  was the procyclic trypomastigote 
(Cunningham, 1973, 1977; Steiger, Steiger, Trager and 
Schneider, 1977; Brun, 1982). Gray, Cunningham, Gardiner, 
Taylor and Luckins (1981) were the f i r s t  to describe the 
production of metacyclic forms in v i t r o . Cultures were 
in it ia te d  by placing infected Glossina proboscides beside a 
bovine dermal collagen explant. Hirumi et a l . (1982) 
described a sim ilar technique in which the bovine dermal 
collagen explant was replaced with vitrogen.
Bloodstream forms of T.congolense have proven the most 
d i f f i c u l t  of the l i f e  cycle stages to cu lt iva te . By 
transferring dermal explants from T.congolense-infected  
skin into culture, the in fe c t iv i ty  of trypanosomes was 
retained for up to 21 days (Gray, Brown, Luckins and Gray, 
1979). Five years la te r  Hirumi and Hirumi (1984) described 
a continuous culture system for T.congolense bloodstream 
forms. They used a confluent bovine endothelial feeder 
layer with HEPES-buffered RPMI 1640 medium supplemented 
with 16% heat inactivated adult goat serum and 4% foetal 
goat serum. Trypanosomes maintained in this system were 
shown to possess a surface coat and were in fective  for  
mice.
A s im ilar technique to that described by Hirumi and 
Hirumi (1984) was used in the present studies in 
conjunction with freshly isolated T.congolense ILNat 3.1 
bloodstream forms to screen c a tt le  sera for trypanocidal
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a c t iv ity .
Subsequent to the synthesis of isometamidium chloride
only a very few assays have been developed to quantify the
levels of drug present in body flu ids  and tissues.
Philips, Sternberg, Cronin, Sodergren and Vidal (1967)
described a spectrophotometric technique, u t i l is in g  the
fluorescent properties of isometamidium. Braide and
Eghianruwa (1980) and Ali and Hassan (1984) employed the
same technique to investigate isometamidium
pharmacokinetics in goats and camels, respectively. All
three papers reported a drug detection l im i t  of 
A*
approximately 1 g ml-1 serum and drug was undetectable in
A
serum collected a fte r  24 hours following intravenous 
inoculation of lmg kg-1 drug. For tissue samples the lower 
l im it  of detection was 2.3ug g_1 tissue. Appreciable 
concentrations of isometamidium were s t i l l  detected in the 
l iv e r  and kidneys 12 weeks a fte r  intravenous administration 
of lmg kg-1 (Braide and Eghianruwa, 1980).
Perschke and Vollner (1985) described an HPLC 
technique for assaying spiked serum samples; the lower 
l im i t  of isometamidium detection was 20ng ml-1 when 10ml of 
serum was analysed. Attempts to repeat this work have not 
been successful and in addition some reservations have been 
expressed about the experimental protocol employed (W.R. 
Fish, personal communication).
In the absence of any sensitive technique for  
detecting isometamidium, i t  was decided to investigate the
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s u ita b i l i ty  of in v itro  trypanosome culture techniques for  
th is  purpose.
Whitelaw and Murray (1984) described the results of a 
preliminary study using a biological assay in which 
bloodstream forms, tsetse-extruded metacyclic trypanosomes 
and cultured metacyclic trypanosomes of T.congolense ILNat
3.1 were incubated for 1 hour in plasma from ca tt le  
administered isometamidium chloride, and injected into 
mice. No anti-trypanosoma! a c t iv ity  could be detected in 
plasma collected beyond 4 weeks a fte r  administration of lmg 
kg-1 isometamidium chloride.
In v itro  trypanocidal a c t iv ity  of a compound has been 
determined by assessing the uptake of radiolabelled  
precursors (Desjardins, Casero, W il le t ,  Childs and 
Canfield, 1980) or by,examination of trypanosome m o til i ty ,  
and in fe c t iv i ty  for mice (Williamson and Scott-Finnigan, 
1978). The technique used by the la t te r  authors has been 
u ti l is e d  in the studies described here.
Using currently employed in v itro  culture techniques, 
experiments undertaken in this chapter were conducted to 
determine whether or not periods of incubation longer than 
1 hour proved more sensitive than the technique described 
by Whitelaw and Murray (1984). In in i t i a l  studies 24 hour 
incubation periods were used. Further studies were 
conducted to ascertain whether or not 48 hours incubation 
further enhanced the sen s it iv ity  of the bioassay.
Because T.congolense ILNat 3.1 appeared to express a 
high level of in vivo sen s it iv ity  to isometamidium
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(personal observation), i t  was decided to use this  
population for screening sera from ca ttle  that had been 
administered drug.
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MATERIALS AND METHODS
1) EXPERIMENT 1 - A PRELIMINARY STUDY -
I N  VITRO ANALYSES OF PLASMA SAMPLES COLLECTED FROM 
CATTLE ADMINISTERED lmg kg-* ISOMETAMIDIUM CHLORIDE 
Plasma samples collected from 7 animals described by 
Whitelaw et a l . (1986) were examined fo r th e ir  e f fe c t  on 
fresh ly  isolated T.congolense ILNat 3.1 bloodstream forms 
with regard to th e ir  e f fe c t  on in v i t ro  growth and rodent 
in fe c t iv i ty .
The 7 c a t t le  belonged to 4 of the phase 1 experimental 
groups described by Whitelaw et a l . (1986):
CODE
Group A : C513 W1
Group C : C502 W2
: C514 W3
Group D : C504 W4
Group E : C489 W5
: C510 W6
: C511 W7
On day 0, isometamidium chloride was administered to 
a l l  7 animals at a dosage of lmg kg-1. C att le  were 
challenged with 5 tsetse infected with T.congolense ILNat 
3 .1 ; groups C, D and E on one occasion at 2, 3 and 4 
months, respective ly , a f te r  drug adm inistration, and group 
A every month (tab le  18).
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Table 18
CHALLENGE OF BORAN CATTLE WITH TSETSE-TRANSMITTED T.C O N G O LE N S E  
ILNat 3.1 ONE TO FIVE MONTHS AFTER ADMINISTRATION OF
lmaka-i ISOMETAMIDIUM CHLORIDE
DRUG
CHALLENGE: MONTHS AFTER DRUG ADMINISTRATION
STATUS GROUP 1 2 3 4 5
Treated A X  X X X  X
Treated C X - -
Treated D - X -
Treated E - - X
x = challenged 
- = not challenged
Subsequent to a ll  challenges, none of the c a tt le  
became infected. Thus, a ll  plasma samples collected from 
c a tt le  up to and including the 5 month challenge were from 
c a tt le  refractory to challenge.
In phase 2 of the experiment, 6 months a fte r  
drug-administration, ca ttle  were reallocated into new 
experimental groups, as outlined in table 19. Only one of 
the 7 animals (W7) was refractory to the 6 month challenge.
Monthly c a tt le  challenges took place on the following
drug administration day 0
1 month challenge day 27
2 month challenge day 58
3 month challenge day 83
4 month challenge day 118
5 month challenge day 148
6 month challenge day 181
Plasma samples collected on these days were examined. 
When a particu lar plasma sample was not available, plasma 
samples collected a week before and a week a fte r  the 
missing sample were examined. Only in the case of Boran W4 
were weekly-collected plasma samples examined.
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Table 19
CHALLENGE OF BORAN CATTLE WITH T.CONGOLENSE ILNat 3.1 SIX MONTHS AFTER 
ADMINISTRATION OF ISOMETAMIDIUM CHLORIDE. AND OUTCOME OF THE CHALLENGE
GROUP
C A T T L E  A D M IN IS T E R E D  
IS O M E T A M ID IU M  C H L O R ID E
U N TR E A T E D
CONTROLS C H A LLE N G E
1 W l* AS 5 tsetse flies on 1 occasion
3 W 3», W 4S BS 5 x 1 0 ^  metacyclic forms
4 W 2S, W7R Cs 5 x 1 0 ^  metacyclic forms
5 W 6S Ds 5x10^ metacyclic forms
6 W 5S Es 5x10 metacyclic forms
s « susceptible to challenge. 
R = re fractory  to challenge.
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2) EXPERIMENT 2 -
I N  VITRO SCREENING FOR TRYPANOCIDAL ACTIVITY IN SERA 
FROM CALVES ADMINISTERED Q.25mq kq.-i ISOMETAMIDIUM 
CHLORIDE
(a) PART A
Experiment 2 was conducted to ascertain how closely  
results  from the in v i t ro  bioassay correlated with 
s u s c e p tib i l i ty  of animals to challenge. Thus, more 
frequently collected samples were examined than in 
experiment 1, i . e . ,  weekly. So as to reduce the number of  
samples requiring examination, samples from calves 
administered 0.25mg kg-1 isometamidium chloride were 
examined.
In th is  experiment serum rather than plasma was 
examined with regard to i ts  s u i ta b i l i t y  fo r  screening for  
trypanocidal a c t iv i ty  in v i t r o .
Three Boran calves (X I,  X2 and X3), aged 6 months, 
were administered 0.25mg kg-1 isometamidium chloride (1% 
w/v solution in s te r i le  water) by a deep mid-cervical 
intramuscular in je c tio n . Serum was collected on days 0, 1, 
3, 7 and th e rea fte r  at weekly in te rv a ls . On day 42, 6 
weeks a f te r  drug adm inistration, the 3 calves along with 
one control (to which isometamidium chloride had not been 
administered) were challenged by subcutaneous inoculation  
of lx lQ 5 T.conoolense ILNat 3.1 bloodstream forms. Unlike 
the control animal which was observed parasitaemic w ith in  2 
weeks following challenge, a l l  3 drug-administered animals
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were refractory to challenge.
On day 84 the same 3 drug-administered calves, along 
with a d if fe ren t control c a lf ,  were inoculated 
subcutaneously with 1x10s T.congolense IL 2642 bloodstream 
forms. All 4 animals were detected parasitaemic within 14 
days following challenge.
T.congolense ILNat 3.1 bloodstream forms were 
incubated in v itro  for 24 hours in media containing 20% 
serum collected on days 0 to 49. Given that pronounced 
trypanocidal a c t iv ity  was not detected in day 49 samples, 
sera collected a fte r  day 49 were not examined.
(b) PART B
In this part of the experiment, in v itro  incubation 
periods were increased from 24 hours to 48 hours to 
ascertain whether or not lengthening the incubation period 
enhanced the sen s it iv ity  of the in v itro  bioassay. Sera 
from calves XI and X2 were examined in such a manner.
(c) PART C
I n  v i t r o  screening of sera from calves XI. X2 and X3 for  
trypanocidal effects on T . v i v a x  IL 2968 bloodstream forms 
of bovine and murine origin  
Please re fe r  to chapter 4 ( in v itro  studies with T .vivax) 
part B.
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RESULTS
1) EXPERIMENT 1 -
I N  VITRO ANALYSES OF PLASMA SAMPLES COLLECTED FROM 
CATTLE ADMINISTERED lmq kq-i ISOMETAMIDIUM CHLORIDE
Results from experiments carried out with plasma 
collected from 7 of the c a t t le  described by Whitelaw et a l . 
(1986) are shown in tables 1 - 7 ,  appendix I I .  Wherever 
experiments were repeated th is  is indicated by the le t t e r  
"a" or "b" by the sample number ( i . e . ,  la denotes sample 1, 
f i r s t  te s t  and lb denotes sample 1, repeat t e s t ) .  A ll 
samples with the same te s t l e t t e r  were a l l  analysed in the 
same te s t .  The growth of trypanosomes in each te s t  were 
expressed as a percentage of the growth of trypanosomes in 
the control sera used fo r  each te s t .
Table 20 is a summary of growth in h ib it io n  and 
in fe c t iv i ty  data produced by each of the 7 animals' sera.
Day 0 samples from only 3 of the animals (W5, W6 and 
W7) supported trypanosome growth and rodent in fe c t iv i ty  
a f te r  24 hours incubation, and were used as control samples 
fo r  these animals:
(a) W5
Boran W5 was re fractory  to the 4 month challenge but 
susceptible to the 6 month challenge.
Since plasma collected on the day of the 6 month
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Table 20
24 HOUR IN VITRO INCUBATIONS OF BORAN PLASMA WITH T.CONGOLENSE ILNat 3.1 
BLOODSTREAM FORMS; EFFECTS ON GROWTH AND INFECTIVITY
DAY ANIMAL: W1 W2 W3 W4 W5 W6 W7
0 NT NT NT NT + + +
27-34 NTr NT NT NT - NT NT
58 NTr
r
NT (NT)r - - +/- NT
83 NTr NT NT NTr NT - NT
118 NTr NT NT NT
r
NT
r
NT
r
148-153
r
+ NT NT NT NT NT -
174-181
s+
s
+ s+
s
+ +/-S
s
+ +/-r
NT = No trypanosomes counted.
(NT) = Greater than 95% growth inhibition.
+ = No inhibition of infectivity (i.e., all mice inoculated became parasitaemic).
+/- = Partial inhibition of infectivity (i.e., only some of inoculated mice 
became parasitaemic).
= Complete inhibition of infectivity. 
r = Refractory to challenge, 
s = Susceptible to challenge.
challenge was not available, plasma collected one week 
before and one week a fte r  the 6 month challenge was 
examined. Trypanocidal a c t iv ity ,  as detected by inhib ition  
of growth and in fe c t iv i ty ,  was detected in samples 
collected from 1 to 5 months a fte r  drug administration 
(table 1, appendix I I ) .  Trypanocidal a c t iv ity  was not 
detected in plasma collected 1 week before the 6 month 
challenge.
Unexpectedly, plasma collected 7 days a fte r  the 6 
month challenge produced 100% growth in h ib it ion . A sim ilar  
phenomenon was observed with plasma collected from Boran 
W4; plasma collected on the day of the 6 month challenge 
did not in h ib it  trypanosome in fe c t iv i ty  whilst that  
collected 7 days la te r  did (see tables 7a and 7b, appendix
I I )  (W4 was susceptible to the 6 month challenge).
(b) W6
Boran W6 was refractory to the 4 month challenge but 
susceptible to challenge 2 months la te r .
Of the plasma samples that were analysed, only that 
collected on the day of the 6 month challenge did not 
produce greater than 25% growth inh ib ition  (table 2, 
appendix I I ) .  Trypanocidal a c t iv ity ,  as measured by 
inh ib ition  of growth and/or in fe c t iv i ty ,  was detected in 
samples collected on the day of each challenge except the 6 
month challenge.
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(c) W7
Boran W7 was refractory to both the 4 month challenge 
and the 6 month challenge.
Plasma collected on the days of the 1, 2 and 3 month 
challenges produced 100% growth inh ib ition , i . e . ,  less than 
lxlO4 trypanosomes ml-1 remained a fte r  24 hours incubation 
(table 3, appendix I I ) .  Although plasma collected on the 
days of the 4, 5 and 6 month challenges did not produce 
appreciable growth in h ib it ion , the presence of trypanocide 
in these samples was indicated by inh ib ition  of trypanosome 
in fe c t iv i ty ;  plasma collected on the days of the 4 and 5 
month challenges completely inhibited in fe c t iv i ty  whilst 
that collected on the day of the 6 month challenge 
p a r t ia l ly  inhibited in fe c t iv i ty .  Since the parasitaemia 
prepatent period in mice inoculated with the 6 month 
plasma-trypanosome mixture was 10.7 + 0.9 (S.D.) days and 
the parasitaemia prepatent period in mice inoculated the 
day 0 plasma-trypanosome mixture was 4.0 ± 0 days, this  
provided further evidence that the 6 month plasma sample 
exerted an inhib itory e ffect on trypanosome in fe c t iv i ty .
In contrast to plasma samples collected from W5, W6 
and W7, plasma collected on day 0 (day of drug- 
administration) from Wl, W2, W3 and W4 a ll  produced 100% 
growth inh ib ition  a fte r  24 hours incubation. Because of 
th is anomalous result a la te r  collected sample, that 
supported growth to the greatest extent, was taken as the 
control for each animal's samples. In 3 sets of animals'
- 167 -
plasma samples (Wl, W2 & W3) this was the 6 month challenge 
sample. Unfortunately, only a very small quantity of the 6 
month challenge sample from W4 was available. Thus, in one 
set of experiments plasma collected 7 days before the 6 
month challenge was used as the control, and in a second 
set, foetal bovine serum was used.
All 4 animals were susceptible to the 6 month 
challenge.
(d) Wl
All plasma samples from Wl, except those collected on 
the days of the 5 and 6 month challenges, produced 
pronounced growth inh ib it ion . Plasma samples collected on 
the days of the 5 and 6 month challenges, in addition to 
not exerting a growth inhib itory e ffec t, did not in h ib it  
trypanosome in fe c t iv i ty  (table 4, appendix I I ) .  Wl was 
refractory to the 1, 2, 3, 4 and 5 month challenges but 
susceptible to the 6 month challenge.
(e) W2 and W3
Of the 7 plasma samples from W2 that were analysed, 
a ll  except that collected on the day of the 6 month 
challenge produced pronounced growth inh ib ition  (table 5, 
appendix I I ) .  The same was true with the samples from W3 
(table 6, appendix I I ) .  Both W2 and W3 were susceptible to 
the 6 month challenge.
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(f) W4
Data from experiments conducted with plasma from W4 
has been presented in two tables since plasma collected 1 
week before the 6 month challenge served as a control for  
one series of experiments (table 7a, appendix I I )  and 
foetal bovine serum served as a control for a second series 
of experiments (table 7b, appendix I I ) .
W4 was refractory to the 3 month challenge but 
susceptible to the 6 month challenge.
Twenty-one d iffe ren t plasma samples, collected from 
day 0 to 4 weeks following the 6 month challenge, were 
examined. In only 3 samples were the trypanosome numbers, 
remaining a fte r  24 hours incubation, greater than 50% of 
the number remaining in the control sample; that collected  
3 days before the 2 month challenge, 7 days before the 6 
month challenge and on the day of the 6 month challenge. 
Trypanocidal a c t iv i ty ,  as detected by inhib ition  of 
trypanosome in fe c t iv i ty ,  was only detected in the f i r s t  of 
these 3 samples. Of note is the fact that plasma collected  
7, 15 and 21 days a fte r  the 6 month challenge produced 100% 
growth in h ib it io n . In contrast, plasma collected 28 days 
following the 6 month challenge, although exerting 
pronounced growth inh ib it ion , produced only s light  
inh ib ition  of trypanosome in fe c t iv i ty .
With reference to the above finding i t  should be noted 
that of 12 plasma samples collected from the 7 c a tt le  on 
days they were refractory to challenge, only one did not
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have any pronounced negative e ffect on growth or rodent 
in fe c t iv i ty  (the plasma sample collected from Wl on the day 
of the 5 month challenge). Of these 12 samples, 9 exerted 
pronounced growth inh ib it ion . Of the remaining 3 samples, 
a ll of which produced less than 15% growth in h ib it ion , 2 
exerted inhib itory effects on trypanosome in fe c t iv i ty  for  
mice. Only with the remaining one sample was no 
trypanocidal a c t iv ity  detected.
Five of the plasma samples examined were collected on 
days when c a tt le  were susceptible to challenge; a ll  
supported trypanosome growth. In addition, a ll  mice 
inoculated with each plasma-trypanosome mixture (29/29) 
became infected.
Since 4 out of the 7 c a t t le 's  day 0 plasma samples 
(taken prior to drug-administration) completely inhibited  
growth and in fe c t iv i ty  of T.congolense ILNat 3.1 
bloodstream forms, further studies were conducted only on 
samples from c a tt le  in which pre-drug-administrati on 
samples did not exert inhib itory effects on growth or 
in fe c t iv i ty .
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2) EXPERIMENT 2 -
I N  VITRO SCREENING FOR TRYPANOCIDAL ACTIVITY IN SERUM 
FROM CALVES ADMINISTERED 0.25mq kg-* ISOMETAMIDIUM 
CHLORIDE
(a) PART A - 24 HOUR INCUBATION
T.congolense ILNat 3.1 bloodstream forms were 
incubated in v i t ro  for 24 hours in media containing 20% 
serum collected from day 0 to day 49 from 3 calves 
administered 0.25mg kg-1 isometamidium chloride, 
intramuscularly. (Drug was administered on day 0 . )  
In h ib ito ry  e ffects  on growth and rodent in fe c t iv i ty  are 
shown in table  21.
( i )  Growth in h ib it io n
Trypanosome numbers remaining in a l l  
post-drug-administration sera from bovine XI were lower 
than numbers remaining in the day 0 sample.
With the exception of one sample, the same was true  
with sera from bovine X2, although trypanosome numbers 
remaining in days 1, 3 and 35 sera were only very s l ig h t ly  
less. In only the day 49 serum sample were there greater  
trypanosome numbers than in the control sample ( i . e . ,  
negative growth in h ib it io n ) ;  the d ifference from the 
control was only s l ig h t  (3.2%).
Of the 9 post-drug-administration samples from bovine 
X3 that were examined, trypanosome numbers in 3 were 
greater than in the control, although in one the d ifference
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was only very s light (less than 5% greater).
( i i ) Mouse in fe c t iv i ty
All mice inoculated with trypanosomes incubated in day 
0 sera became parasitaemic.
Sera collected on day 1 from XI and X3 completely 
inhibited trypanosome in fe c t iv i ty  whilst mice inoculated 
with trypanosomes incubated in day 1 serum-trypanosome 
mixture from X2 a ll  became parasitaemic. Thereafter, sera 
collected from a ll  3 animals up until day 14 completely 
inhibited trypanosome in fe c t iv i ty .
From day 21 onwards, sera did not completely in h ib it  
in fe c t iv i ty  of trypanosomes. All mice inoculated with 
trypanosomes incubated in sera collected on days 35, 42 and 
49 from XI and X2 became parasitaemic. However, 
parasitaemia onset was delayed in mice inoculated with 
trypanosomes incubated in day 35 and day 42 sera from the 
same two animals.
Sera from X3 d iffered from other sera examined in that 
a ll mice inoculated with trypanosomes incubated in day 21 
and day 28 sera became parasitaemic. In addition, the 
level of parasitaemia in mice inoculated with the day 42 
serum-trypanosome mixture, unlike that from XI and X2, was 
no lower than controls on the f i r s t  day parasitaemia was 
detected.
Although a ll  3 animals were refractory to challenge on 
day 42, a ll  mice inoculated with trypanosomes incubated for  
24 hours in day 42 sera became parasitaemic. However, as
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mentioned above, the occurrence of lower parasitaemia, 
compared to controls, on the f i r s t  day parasitaemia was 
detected in mice inoculated with XI or X2 day 42 
serum-trypanosome mixtures, indicated the presence of 
trypanocidal a c t iv ity  in these sera.
(b) PART B - LENGTHENING THE INCUBATION PERIOD
In an attempt to increase the sens it iv ity  of the in  
v itro  system the incubation period was increased from 24 to 
48 hours. The e ffect on in fe c t iv i ty  and growth inh ib ition  
using sera from XI and X2 is shown in table 22.
( i )  Calf XI
A fter 48 hours incubation, a ll  sera collected up to 
day 35 completely inhibited trypanosome in fe c t iv i ty .  
Trypanosomes incubated in the day 42 sample infected one 
out of 5 mice. After 24 hours incubation in the day 42 
sample, trypanosomes were in fective for 5 out of 5 mice 
(see table 21).
Of the 9 post-drug-administration sera examined, 8 
produced greater growth inh ib ition  when the incubation 
period was increased from 24 to 48 hours. The mean 
increase in percentage growth inhib ition  as a result of 
doubling the incubation period was 20.4% ± 16.8% (S .D .) .
Thus, a fte r  48 hours incubation, expression of 
trypanocidal a c t iv ity  appeared to be more pronounced than 
that occurring a fte r  24 hours incubation.
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(ii) Calf X2
After 24 hours incubation, complete inh ib ition  of 
in fe c t iv i ty  occurred in sera collected up until day 14 
(table 21). By lengthening the incubation period to 48 
hours a ll  sera collected up until day 35 completely 
inhibited trypanosome in fe c t iv i ty .  Trypanosomes incubated 
in day 42 serum were in fective for only 1 out of 5 mice.
In a s im ilar manner to the day 42 serum sample from XI, 
th is  indicated the presence of trypanocidal a c t iv ity  in the 
serum and is consistent with resistance of the animal to 
challenge on the same day. I t  must be noted, however, that 
in in fe c t iv i ty  experiments conducted with sera from both XI 
and X2, mouse inoculae were smaller a fte r  48 hours 
incubation than a fte r  24 hours incubation. This may have 
accounted for some of the difference in in fe c t iv i ty  
occurring between the two incubation periods.
Increasing the incubation period also increased the 
growth inhib ition  produced by 8 of the 9 
post-drug-administration sera; a 12.7% + 12.8% (S.D.) 
increase in growth inhib ition occurred as a resu lt of 
increasing the incubation period from 24 to 48 hours.
- 176 -
• DISCUSSION
The development of in v itro  culture systems has 
provided the opportunity to examine the effects of 
trypanocides on trypanosomes in v i t r o . Borowy, Fink, and 
Hirumi (1985a) and Borowy, Hirumi, Waithaka and Mkoji 
(1985b) evaluated the s u ita b i l i ty  of a T.b.brucei 
continuous cu ltivation  system described by Hirumi, Doyle 
and Hirumi (1977a,b) for use in screening a series 
compounds for th e ir  trypanocidal a c t iv ity .  Using " fu l ly  
susceptible" T.b.brucei clones, 21 compounds were tested. 
Minimum e ffec tive  concentrations of a ll  commonly used 
trypanocides f e l l  within the range of drug concentrations 
measured in blood, serum or plasma of drug-administered 
animals.
Waithaka, Borowy, Gettinby and Hirumi (1985) described 
an in v itro  drug screening system for T .v ivax . The workers 
used a culture system for T.vivax described by ILRAD (1984) 
along with in v i t r o -derived second generation bloodstream 
forms (bloodstream forms resulting from cyclical 
transformation in v i t r o ) . Second generation bloodstream 
forms were used since they were said to exhibit more 
predictable growth patterns in v itro  than trypanosomes 
isolated d ire c t ly  from blood. However, no comparative drug 
s e n s it iv ity  data was presented concerning the sens it iv ity  
of second generation bloodstream forms derived from culture  
as compared to freshly isolated murine bloodstream forms.
Borowy et a l . (1985b) described a series of 
comparative sen s it iv ity  studies conducted with th e ir
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T.b.brucei system and concluded that the level of drug 
s en s it iv ity  expressed by the trypanosome populations they 
used bore no relationship to the source from which 
parasites were obtained.
As well as providing an indication of the trypanocidal 
a c t iv ity  of compounds the above described system of Borowy 
et a l . (1985b) also provided information on the level of 
s e n s it iv ity  of each trypanosome population to the d if fe re n t  
compounds.
In a ll  the work so fa r  described, trypanosomes were 
incubated in optimal growth-supportive media spiked with 
drug. In no case were any of the drugs administered to 
animals and trypanocidal a c t iv ity  in the animals' sera 
examined in v i t r o .
The work described in this chapter was conducted to 
examine the s u i ta b i l i ty  of a T.congolense continuous 
cultivation  system described by Hirumi and Hirumi (1984) 
for screening for trypanocidal a c t iv ity  in sera from c a tt le  
administered isometamidium chloride. T.congolense ILNat
3.1 was used for screening purposes since i t  has been shown 
to be highly sensitive to the prophylactic and therapeutic 
a c t iv ity  of isometamidium chloride (Whitelaw et a l . ,  1986; 
Sones, Njogu and Holmes, 1987). Earlie r  workers have used 
second generation bloodstream forms for drug s e n s it iv ity  
screening. However, because of lo g is tica l problems in 
obtaining s u ff ic ien t numbers of T.congolense second 
generation bloodstream forms for assays, freshly isolated  
bloodstream forms of T.congolense ILNat 3.1 were used to
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screen plasma and sera for trypanocidal a c t iv ity .
Of 7 sets of monthly-collected plasma samples from 7 
of the animals described by White!aw et a l . (1986), day 0 
samples from 4 animals appeared to exert a trypanocidal 
action; no trypanosomes remained a fte r  24 hours incubation 
in media containing 20% plasma. S im ilarly , sera collected  
from non-infected goats on a weekly basis can vary widely 
from one week to the next in th e ir  growth-supportive 
property (N.K. Borowy, personal communication).
Godfrey (1958) showed that feeding animals on a d iet  
containing cod-1iver o il markedly depressed T.congolense 
infections, and that a T.vivax infection maintained in rats  
with a sheep serum supplement was completely suppressed by 
cod-1iver o i l .  The toxic a c t iv ity  was shown to be 
associated with the presence of certain polyunsaturated 
fa t ty  acids (Godfrey, 1958). I t  may thus be that 
individual variation in the dietary intake of the 7 animals 
described by Whitelaw et a l . (1986) could possibly account 
for the differences in growth supportive properties of day 
0 plasma samples. These observations indicate that in the 
absence of markers for the growth supportive property of 
any given plasma or serum sample, there can be no true  
control sample for any plasma or serum sample collected  
a fte r  administration of isometamidium chloride. However, 
not withstanding th is ,  a summary of results from 
experiments conducted on plasma from animals described by 
Whitelaw et a l . (1986) showed the following: 100% of
samples collected on days when treated animals were
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susceptible to challenge supported growth of trypanosomes 
in v itro  and had no apparent e ffect on trypanosome 
in fe c t iv i ty .  In contrast, 75% (9/12) of samples collected  
on days animals were refractory to challenge produced 
greater than 90% growth inh ib it ion . In addition, 92% 
(11/12) of the same samples exerted an inhib itory  e ffec t on 
growth and/or in fe c t iv i ty ,  i . e . ,  only 8% (1/12) of samples 
produced a false negative resu lt. Thus, 24 hour in v itro  
incubations of plasma from ca ttle  administered lmg kg-1 
isometamidium chloride with T.congolense ILNat 3.1 
bloodstream forms has shown there to be a close correlation  
between effects on trypanosome growth and rodent 
in fe c t iv i ty ,  and the susceptib ility  of treated animals to 
fly-challenge with the same trypanosome population.
The occurrence of trypanocidal effects in v itro  in the 
form of loss of in fe c t iv i ty  for mice in the absence of 
gross morphological e ffects , at the time of inoculation, 
has been described for quinapyramine and suramin (Hawking 
and Sen, 1960) and the aromatic diamidine DAPI (Borowy et 
a l . ,  1985a). Inh ib ition  of T.congolense ILNat 3.1 
in fe c t iv i ty  a f te r  in v itro  incubation appears to be a more 
re lia b le  and sensitive indicator than growth inh ib ition  for  
the presence or absence of trypanocidal a c t iv ity  in plasma 
or sera from an animal administered isometamidium chloride.
Examination of sera from 3 animals administered 0.25mg 
kg-1 isometamidium chloride using T.congolense ILNat 3.1 
bloodstream forms showed that s light growth inhib itory  
effects that occurred a fte r  24 hours incubation became more
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pronounced a fte r  48 hours incubation. The same was true 
for inh ib ition  of trypanosome in fe c t iv i ty .  Plasma 
collected on day 42, when animals were refractory to needle 
challenge with T.congolense ILNat 3.1,  fa i le d  to in h ib it  
in fe c t iv i ty  of the trypanosomes a fte r  24 hours incubation. 
However, a fte r  48 hours incubation two of the same plasma 
samples produced almost complete inhib ition  of trypanosome 
in fe c t iv i ty .  These findings are consistent with those of 
Borowy et a l . (1985a) who, from work conducted with the 
diamidine DAPI, showed that the minimum exposure time 
required for expression of anti-trypanosoma! a c t iv ity  was 
dependent on the drug concentration. Thus to produce the 
same trypanocidal action with a low drug concentation that 
occurred with a re la t iv e ly  high drug concentration, a 
longer incubation period was required.
Variation in the innate growth supportive properties 
of individual animals' serum is a major hindrance to use of 
the in v itro  technique described in this chapter. Future 
investigations should be directed towards isolation and 
characterisation of the serum constituent(s) responsible 
for the trypanocidal a c t iv ity .  Similar work should be 
conducted to iden tify  trypanosomal growth factors and the 
quantities of these required for optimal growth of the 
d iffe re n t species of trypanosome. Only with th is  knowledge 
can a rational interpretation be made of trypanocidal 
a c t iv ity  expressed in v itro  by sera from drug-treated 
animals.
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SECTION I I  
STUDIES WITH T . V I V A X
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CHAPTER 3
THERAPEUTIC AND PROPHYLACTIC ACTIVITY OF ISOMETAMIDIUM IN 
BORAN CATTLE AGAINST TRYPANOSOMA VI VAX OF WEST AND EAST 
AFRICAN ORIGIN. TRANSMITTED BY GLOSSINA MORSITANS CENTRALIS
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INTRODUCTION
Work conducted with T.congolense (chapter 1) has shown 
that at a dose of 0.5mg kg-1 body weight, isometamidium 
chloride protected ca tt le  against tsetse-transmitted  
challenge with e ither of 2 unrelated T.congolense serodemes 
for at least 3 months (table 6 ). Furthermore, acquisition  
of immunity to metacyclic variable antigen types of 
T.congolense. whilst under chemoprophylactic cover, 
appeared unlikely to play any s ign ificant protective role  
in animals maintained by an isometamidium prophylactic 
regime.
The work described in this chapter was conducted to 
determine the therapeutic and prophylactic a c t iv ity  of 
isometamidium, in Boran c a t t le ,  against four 
tsetse-transmitted T.vivax populations; one cloned 
population from Zaria, Nigeria ( IL  2968), one cloned
population from K i l i f i ,  Kenya (IL  2969), an uncloned
population from Galana, Kenya (IL 2982) and an uncloned
population from Likoni, Kenya (IL  2986). In addition,
work was conducted to ascertain whether or not immunity to 
metacyclic variable antigen types of T.vivax may be 
acquired whilst under chemoprophylactic cover.
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MATERIALS AND METHODS
1) CATTLE
The age, breed, maintenance and feeding of ca tt le  were 
as described in the general materials and methods.
All c a tt le  have been allocated reference codes. The 
relationship between reference codes and animal numbers is 
shown in table 1, appendix I I I .
2) ANTIBODY ASSAYS
Trypanolysis and indirect immunofluorescent antibody 
tests were u t i l is e d  to examine for the presence of 
a n t i -T.vivax antibodies in ca ttle  sera. Both tests have 
been described in the general materials and methods.
3) HAEMATOLOGICAL AND PARASITOLOGICAL PARAMETERS
Haematological and parasitological parameters were 
measured as described in the general materials and methods.
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EXPERIMENT 1 
STUDIES USING T . V I V A X  IL 2968 (ZARIA) AND 
T . V I V A X  IL 2969 (K ILIF I)
PART A
EXPERIMENTAL DESIGN
1) DETERMINATION OF THE SENSITIVITY OF THE ZARIA T . V I V A X  
AND THE KILIFI T . V I V A X  TO THE THERAPEUTIC ACTIVITY OF 
ISOMETAMIDIUM
Two groups of 5 c a tt le  were infected, each with one of 
the 2 T.vivax populations, using 10 infected Glossina 
morsitans centralis  per animal. Eleven days la te r ,  when 
a ll c a tt le  had a parasitaemia of approximately 5xl04 ml"1, 
a ll were treated with 0.5mg kg-1 isometamidi urn chloride.
For a period of 200 days following treatment jugular blood 
was collected from each animal three times weekly and 
examined for the presence of trypanosomes by the buffy-coat 
phase-contrast (BC) technique.
2) DETERMINATION OF THE SENSITIVITY OF THE ZARIA T . V I V A X  
AND THE KILIFI T . V I V A X  TO THE PROPHYLACTIC ACTIVITY OF 
ISOMETAMIDIUM
To determine the duration of prophylaxis isometamidium 
conferred against the Zaria T.vivax and the K i l i f i  T .v ivax.
10 Boran steers were administered 0.5mg kg-1 isometamidium 
chloride. The ca tt le  were, thereafter, challenged at 
monthly intervals using G.m.centralis infected with e ither  
T.vivax clone (5 c a tt le  per clone, 10 in fective  f l ie s  per
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animal) .  See table 23.
At each challenge 2 control animals for each group, to 
which isometamidium chloride had not been administered, 
were challenged in a similar manner.
In preliminary work, conducted prior to the f i r s t  
challenge, dissection infection rates of almost 100% were 
obtained in tsetse that had fed on animals infected with 
either the Zaria T.vivax or the K i l i f i  T .v ivax . When 
salivary probes from the same f ly  populations were 
examined, apparent infection rates of a much lower order 
were obtained, thereby indicating a poor correlation  
between results from salivary probes and f ly  dissection. 
Thus, for the f i r s t  challenge (day 32), p lastic  mesh cages 
containing 13 f l ie s  were placed on each animal that was to 
be challenged. Thirteen f l ie s  were placed into each cage 
so that each animal would be fed on by at least 10 tsetse. 
All f l ie s  that fed were dissected. The number of infected 
f l ie s  that fed on each animal is shown in table 2, appendix 
I I I .  Unlike e a r l ie r  experiments, a low infection rate was 
obtained in tsetse infected with e ither of the T.vivax  
populations. Thus although a ll animals were fed on by at 
least 10 tsetse, some were bitten by as few as 4 infected 
tsetse. Because of th is , a ll  animals that had not received 
10 infected f ly  bites were rechallenged 3 days la te r  with 
additional f l i e s  until a ll had received at least 10 
infected f ly  bites (see table 2, appendix I I I ) .
The 4 controls used for the f i r s t  challenge were 
challenged by allowing individual tsetse to feed at
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separate s ites . After feeding, tsetse were dissected and 
a ll  non-infected tsetse were replaced by others until one 
infected tsetse had fed at each of the 10 skin s ites . This 
was conducted so as to ascertain the skin reaction 
associated with tsetse-transmission of both the Zaria and 
the K i l i f i  T .v ivax.
In a ll  subsequent challenges tsetse were not fed at 
individual s ites .
The exact days following drug-administration on which 
each of the f ive  challenges took place were as follows:
Drug administration - day 0
1 month challenge - day 32
2 month challenge - day 60
3 month challenge - day 91
4 month challenge - day 119
5 month challenge - day 151
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RESULTS
1) DETERMINATION OF THE SENSITIVITY OF THE ZARIA T . V I V A X  
AND THE KILIFI T . V I V A X  TO THE THERAPEUTIC ACTIVITY OF 
ISOMETAMIDIUM CHLORIDE AT A DOSAGE OF Q.5ma kq-i
Of the 5 animals infected with the Zaria T .v iv ax . only 
one relapsed, 84 days a f te r  treatment, whereas relapse was 
not detected in any of the animals infected with the K i l i f i  
T.vivax during the 200-day post-treatment period.
2) DETERMINATION OF THE SENSITIVITY OF THE ZARIA T . V I V A X  
AND THE KILIFI T . V I V A X  TO THE PROPHYLACTIC ACTIVITY OF 
ISOMETAMIDIUM
(a) Parasitological data
The time of appearance of parasites in a l l  
experimental animals is shown in table 24. Of the 5 
drug-administered animals challenged with the Zaria T .vivax  
( IL  2968), 2 became infected following challenge at 
3-months and one following the fourth monthly challenge.
The remaining 2 animals remained aparasitaemic fo r the 
120-day observation period following the f i f t h  challenge.
In contrast, of the 5 animals challenged with the K i l i f i  
T.vivax ( IL  2969), 3 became parasitaemic following the 
f i r s t  challenge and 2 following the second challenge.
A ll 3 animals susceptible to challenge with the Zaria  
T.vivax had parasitaemia prepatent periods s im ila r  to 
controls. In contrast, of the 3 group H animals detected
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Table 24
DEVELOPMENT OF INFECTION IN CATTLE CHALLENGED WITH T . V I V A X -INFECTED
TSETSE AFTER ADMINISTRATION OF 0..5maka-i ISOMETAMIDIUM CHLORIDE
Animal TrvDanosoma 
vi vax
Challenge: months a f te r  
isometamidium chloride administration
1 2 3 4 5
G1 IL 2968w - - _ _
G2 If - - - - -
G3 II - - 11
G4 1 - - - 11
G5 It - - 11
Control a+ II 10* 11 11 11 11
Control b+ II 10 11 9 11 9
HI IL 2969x - 7
H2 ii - 9
H3 ii 12
H4 it 23
H5 ii 24
Control a+ ii 10 11
Control b+ ii 9 11
*  Numbers correspond to the day following challenge when parasites  
were f i r s t  detected.
- Refractory to challenge.
+ D if fe re n t  animals used fo r  each challenge. 
w Zaria T .v iv a x . 
x K i l i f i  T .v ivax.
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parasitaemic following the f i r s t  challenge with the K i l i f i  
T.vivax, 2 had extended prepatent periods. The remaining 2 
group H animals were both f i r s t  detected parasitaemic 
following the second challenge and since one of them (HI) 
was f i r s t  detected parasitaemic 7 days following the 
challenge, e a r l ie r  than in any control, i t  is probable that 
the infection originated from the f i r s t  challenge.
Twelve and twenty-four days following every challenge 
blood from c a tt le  challenged with the Zaria T.vivax was 
inoculated into mice. (Blood from c a tt le  challenged with 
the K i l i f i  T.vivax was not inoculated into mice since this  
population was not in fective for mice.) Tables 3 and 4, 
appendix I I I ,  are comparisons of data resultant from 
examination of blood by the BC technique and mouse 
inoculation. In no animal did mouse inoculation result in 
the detection of parasites at an e a r l ie r  time than th e ir  
detection by the BC technique. In a ll cases where 
inoculation of c a tt le  blood into mice produced mouse 
infections, trypanosomes were detected in the same blood 
sample by the BC technique.
In animals susceptible to challenge (both controls and 
drug-administered) the f i r s t  peak of parasitaemia always 
occurred within 7 days following f i r s t  detection of 
parasitaemia (see figures 1, 2 and 3, appendix I I I ) .
The level of parasitaemia at f i r s t  peak of 
parasitaemia was 6+ (greater than SxlOSml”1) ,  as defined
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by Paris et a l . (1982), in a ll  challenge controls (both IL 
2968 and IL 2969). The same level of f i r s t  peak 
parasitaemia was attained in a ll  3 animals administered 
isometamidium chloride that were susceptible to challenge 
with the Zaria T .v ivax . In contrast, the level of f i r s t  
peak parasitaemia in a l l  5 drug-administered ca tt le  
susceptible to challenge with the K i l i f i  T.vivax was 5+ 
(greater than 5xl05 ml-1 but less than 5xl06 ml-1) (figure  
3, appendix I I I ) .
In contrast to infections with both T.conoolense ILNat 
3.1 and T.conoolense IL 2642 where persistent high levels  
of parasitaemia followed the f i r s t  peak of parasitaemia, 
parasitaemia associated with e ither the Zaria T.vivax or 
the K i l i f i  T.vivax remitted within one to 4 days following 
the f i r s t  peak. This finding is consistent with 
parasitaemia profiles  of c a tt le  intravenously infected with 
T.vivax ILDat 1.3 and T.vivax IL 2133 (Nantulya, Musoke and 
Moloo, 1986); populations belonging to the same trypanosome 
lineages as the Zaria T.vivax and the K i l i f i  T .v ivax . 
respectively.
(b) C lin ical data
Following the f i r s t  challenge, skin thickness at the 
10 tsetse b ite  s ites, drainage lymph node breadth and 
temperature were measured daily  in the four challenge 
controls. Changes in these 3 parameters, along with PCV 
and parasitaemia, over the 30 day observation period, are 
shown graphically for the Zaria T.vivax control ( la )  and
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the K i l i f i  T.vivax control ( la )  in figures 1 and 2, 
appendix I I I ,  respectively. A summary of skin thickness 
and lymph node breadth measurements from the 4 controls is 
shown in table 5, appendix I I I .  In contrast to the 
pronounced increase in skin thickness that occurred 
following tsetse-transmission of T.congolense ILNat 3.1 and 
T.conoolense IL 2642, tsetse-transmission of the Zaria  
T.vivax and the K i l i f i  T.vivax resulted in only very s light  
changes. F ly-in fection of 2 animals with the Zaria T.vivax  
resulted in a complete absence of skin thickness changes at 
a ll 10 sites in control lb (D331) and only one "slight"  
(20-40%) increase in control la (D330). Exactly the same 
was observed with 2 animals fly - in fec ted  with the K i l i f i  
T.v ivax; control la (D332) developed only one "slight"  
increase in skin thickness and control lb (D334) fa iled  to 
develop any skin thickness changes . In a ll  4 animals the 
percentage increase in drainage prefemoral lymph node 
breadth ranged from 110% to 140%.
Since only very minor skin thickness changes occurred 
in a l l  1 month challenge controls following 
tsetse-transmission of both the Zaria T.vivax and the 
K i l i f i  T .v ivax . skin thickness measurements were not made 
following subsequent challenges. However, because drainage 
lymphadenomegaly occurred in a ll  4 controls following the 
f i r s t  challenge, drainage lymph node breadth measurements 
were continued in a ll  experimental animals following a ll  
further challenges.
The percentage increase in prefemoral lymph node
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breadth in c a tt le  susceptible to the second, th ird , fourth 
or f i f t h  challenge is shown in table 6, appendix I I I .  Of 
the 3 group G animals susceptible to in fection, a ll  
exhibited lymph node changes that differed by more than 2 
standard deviations from the control mean. In one (G4), 
lymphadenomegaly was not detected.
Lymphadenomegaly in group H controls was less 
pronounced than that which occurred in group G controls.
In both of the group H animals in which lymph node breadth 
measurements were made following successful challenge (HI 
and H2), maximal lymphadenomegaly was less than the H 
control mean; in HI i t  was greater than 2 standard 
deviations from the control mean.
Temperature measurements were taken from only controls 
following the f i r s t  challenge. After a ll  subsequent 
challenges, temperature measurements were taken from a ll  
experimental animals. Tables 7 and 8, appendix I I I ,  show a 
summary of the results. Of 811 temperature measurements 
taken during the entire course of the experiment, 326 were 
taken when animals were parasitaemic. Of these 326 
measurements, 122 (37%) were in excess of 39.4°C. 
Subdivision of this last figure into c a tt le  infected with 
the Zaria T.vivax and those infected with the K i l i f i  
T.vivax showed that 41% of measurements taken when ca tt le  
were parasitaemic with the Zaria T.vivax were in excess of 
39.4°C, whilst 31% were in excess of 39.4°C when c a tt le  
were parasitaemic with the K i l i f i  T .v ivax . In su ffic ien t
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data was available to make any valid comparison between 
drug-administered animals and controls.
(c) Haematolooical data
In a s im ilar manner to a ll experimental c a tt le  in the 
T.conoolense experiment, the f i r s t  decline in PCV in a ll  
c a tt le  susceptible to challenge with e ither the Zaria 
T.vivax or the K i l i f i  T.vivax coincided with the onset of 
parasitaemia. Packed cell volume and parasitaemia data for  
a group G control, a group H control and 3 group H animals, 
a ll susceptible to the f i r s t  challenge, are shown 
graphically in figures 1, 2 and 3, appendix I I I ,  
respectively.
Both the Zaria T.vivax (IL  2968) and the K i l i f i  
T.vivax (IL  2969) are derived from populations which 
self-cure in c a tt le  8 to 12 weeks a fte r  f i r s t  detection of 
parasitaemia (Barry, 1986; Nantulva et a l . .  1986). 
Furthermore, parental populations of both T.vivax IL 2968 
and T.vivax IL 2969 have also been observed to self-cure in 
c a tt le  (P.R. Gardiner, personal communication). Thus, 
unlike T.conoolense ILNat 3.1 and T.conoolense IL 2642, 
because of the frequent occurrence of se lf-cure, no valid  
comparisons of the pathogenicity of the two T.vivax  
populations (with regard to rate of PCV decline) could be 
made.
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(d) Immunological data
( i ) Indirect immunofluorescent antibody fIFAl test
Data from IFA tests using Zaria T.vivax ( IL  2968) 
antigen and sera from ca tt le  challenged with the Zaria  
T.vivax is shown in tables 25 and 26. Table 27 shows the 
results of sim ilar tests using K i l i f i  T.vivax (IL  2969) 
antigen and sera from c a tt le  challenged with the K i l i f i  
T.v ivax .
In no animal was antibody detected until following the 
onset of parasitaemia. One exception to this was H5 which 
although not detected parasitaemic until day 24 following 
the f i r s t  challenge, sera collected on day 21 produced 
strong f la g e l la r  staining at a t i t r e  of 1:10.
Although challenge controls for groups G and H were 
a ll  detected parasitaemic by 11 days following challenge, 
indirect immunofluorescent antibody was detected in day 14 
sera from only 2 animals. However, indirect  
immunofluorescent antibody was detected in day 21 sera from 
a ll animals.
Only 2 animals in group G (G1 and G2) were refractory  
to a l l  5 challenges. Examination of sera collected from 
both animals during the entire  course of the experiment 
fa i le d  to reveal the presence of indirect immunofluorescent 
antibody in any sample.
F ina lly , incubation of day 28 sera from Zaria T.vivax  
controls with K i l i f i  T.vivax antigen, and day 28 sera from 
K i l i f i  T.vivax controls with Zaria T.vivax antigen ( i . e .  
heterologous antigen) fa iled  to produce any staining,
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Table 25
I FA TEST USING T . V I V A X  IL 2968 ANTIGEN AND SERA FROM GROUP G 
CATTLE (CHALLENGED WITH T . V I V A X  IL 2968)
1 MONTH C H A L LE N G E
A N IM A L DAY 0 DAY 7 DAY 1 4 DAY 2 1 DAY 2 8
G1
G2 - - - - -
G3 - - - - -
G4 - - - - -
G5 - - - - -
CONTROLS
a _ 1 : 5 0 1 : 2 5 0
b - - 1 : 1 0 1 : 5 0 1 : 5 0
2 MONTH C H A L LE N G E
A N I M A L DAY 0 DAY 7 DAY 14 DAY 21 DAY 2 8
G1 - - - - -
G2 - - - - -
G3 - - - - -
G4 - - - - -
G5 - - - - -
CONTROLS
a _ _ _ 1:250 1:250
b - - - 1:50 1:50
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Table 26
I FA TEST USING T . V I V A X  IL 2968 ANTIGEN AND SERA FROM GROUP G 
CATTLE (CHALLENGED WITH T . V I V A X  IL 2968)
3 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1
G2 - - - - -
G3 - - - 1:250 1:250
G4 - - - - -
G5 - - - 1:50 1:250
CONTROLS
a - - 1:10 1:250 1:250
b - - - 1:250 1:250
4 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1
G2 - - - - -
G4 - - 1:10 1:50 1:50
CONTROLS
a - - - 1:50 1:250
b - - - 1:50 1:250
5 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1
a?
- - - - -
CONTROLS
a
b
1:50
1:50
1:250
1:250
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Table 27
I FA TEST USING T . V I V A X  IL 2969 ANTIGEN AND SERA FROM GROUP H 
CATTLE (CHALLENGED WITH T . V I V A X  IL 2969)
1 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
HI
H2
H3
H4
H5
-  -  -
1:10*
1:10
1:50
1:10*
CONTROLS
a
b - ■
1:50
1:50
1:50
1:50
2 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
HI 1:50 1:50 1:50
H2 - - - - 1:10
H3 1:10 1:50
H4 1:50 1:50
H5 1:10* 1:10*
CONTROLS
a - - - 1:250 1:50
b - - - 1:50 1:250
*  = strong f la g e l la r  staining.
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thereby indicating the absence of isoVATs in ca tt le  
bloodstream populations occurring within 4 weeks following 
tsetse-transmission of the Zaria T.vivax and the K i l i f i  
T.v ivax .
( i i )  Trvpanolvsis test
Trypanolysis data resulting from analyses on sera from 
c a tt le  challenged with the Zaria T.vivax (IL  2968) is shown 
in tables 9a and 9b, appendix I I I .  Data resulting from 
analyses of sera from ca tt le  challenged with the K i l i f i  
T.vivax (IL  2969) is shown in table 10, appendix I I I .  
Background levels of lysis  are indicated by the percentage 
lys is  occurring in control samples. In tables 9a and 9b, 
appendix I I I ,  the figures represent the number of 
trypanosomes lysed out of 100 counted. Since the K i l i f i  
T.vivax did not a tta in  as high a level parasitaemia in 
c a tt le  as the Zaria T.vivax. the data in table 10, appendix 
I I I ,  is the number of trypanosomes lysed out of 50 counted.
In a l l  instances, greater than 20% lysis  only occurred 
in sera collected subsequent to the onset of parasitaemia 
in an animal.
Analyses of a ll  sera collected from G1 and G2 (group G 
animals refractory to a ll  5 challenges) fa iled  to reveal 
the presence of trypanolytic antibody in any sample.
(e) Screening of breakthrough trypanosome populations 
for th e ir  sens it iv ity  to isometamidium 
Since the K i l i f i  T.vivax was non-infective for mice,
- 201 -
isometamidium sen s it iv ity  studies were only conducted on 
trypanosome populations arising in ca tt le  challenged with 
the Zaria T.vivax ( i . e . ,  group G animals).
Two drug-administered animals in group G became 
infected following the th ird  challenge and one following 
the fourth challenge. Results from drug sen s it iv ity  
studies conducted in mice on the 3 breakthrough trypanosome 
populations, as well as on populations occurring in the 
respective controls, are shown in table 11, appendix I I I .  
Trypanosome populations arising in c a tt le  administered 
isometamidium chloride did not appear to express a 
decreased level of sens it iv ity  to the therapeutic a c t iv ity  
of isometamidium as compared to populations from challenge 
controls.
In a s im ilar manner to isometamidium s e n s it iv ity  
experiments conducted with T.conoolense populations arising  
in c a tt le  in the T.conoolense experiment, treatment of mice 
when parasitaemia attained 107 trypanosomes per ml, as 
compared to 6 hours post-infection, resulted in an apparent 
slight decrease in the drug-sensitiv ity  of each trypanosome 
population.
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EXPERIMENT 1 
PART B
INTRODUCTION
In the T.conoolense experiment described in chapter 1 
i t  was shown that a single intramuscular in jection of 0.5mg 
kg-1 isometamidium chloride conferred complete protection 
to c a tt le  for at least 3 months against repeated monthly 
challenge with tsetse-transmitted T.conoolense ILNat 3 .1 .
Since the group H c a tt le  (challenged with the K i l i f i  
T.vivax) became infected following the 1 or 2 month 
challenges, i t  was decided to rechallenge them with 
tsetse-transmitted T.conoolense ILNat 3 .1 , three months 
a fte r  administration of isometamidium chloride. I f  the 
c a ttle  were refractory to challenge this would indicate  
that they had not been underdosed with isometamidium 
chloride, and that the K i l i f i  T.vivax expressed a much 
higher level of resistance to the prophylactic a c t iv ity  of 
isometamidium than T.conoolense ILNat 3 .1 .
EXPERIMENTAL DESIGN
All 5 group H animals were treated with 3.5mg kg-1 
diminazene aceturate 12 days following the second K i l i f i  
T.vivax challenge. Diminazene aceturate is a curative  
trypanocide with negligable prophylactic a c t iv ity  
(Fairclough, 1963b; Van Hoeve and Cunningham, 1964a,b). 
Three uninfected c a tt le  to which isometamidium chloride had
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not been administered and 2 c a tt le  with primary infections 
with the same T.vivax clone were also administered 
diminazene aceturate to serve as controls. A sixth 
control, non-infected and not administered diminazene 
aceturate, was also included (table 28). Eighteen days 
following diminazene aceturate treatment (3 months a fte r  
administration of isometamidium chloride) a ll  c a tt le  were 
challenged with tsetse-transmitted T.conoolense ILNat 3.1 
(5 in fective  f l ie s  per animal).
RESULTS
In contrast to the 6 controls, a l l  of which were 
detected parasitaemic (using the BC technique) by 17 days 
post-challenge, none of the 5 c a tt le  previously susceptible 
to challenge with the K i l i f i  T.vivax were observed 
parasitaemic during the 100-day post-challenge observation 
period (table 28). Furthermore, inoculation of mice with 
blood taken from c a tt le  12 and 24 days following challenge 
with T.conoolense ILNat 3.1 fa iled  to reveal the presence 
of parasitaemia in c a tt le  that was not detected by the BC 
technique. Mice only became parasitaemic i f  inoculated 
with blood detected parasitaemic by the BC technique (see 
table 12, appendix I I I ) .
F ina lly , following challenge of c a tt le  with 
T.conoolense ILNat 3 .1 , measurement of the skin thickness 
at the 5 sites at which tsetse had fed and the drainage 
lymph node breadth was conducted da ily . In contrast to a l l  
6 controls which developed pronounced skin thickness
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Table 28
DEVELOPMENT OF T.CONGOLENSE  ILNat 3.1 INFECTION IN CATTLE 
PREVIOUSLY SUSCEPTIBLE TO CHALLENGE WITH T . V I V A X  IL 2969
Days following Samorin administration
Animal 0 32 47 60 74 75 93 110 193
HI Samorin T.v - T.v + Berenil T.c -
H2 Samorin T.v - T.v + Berenil T.c -
H3 Samorin T.v + + + Berenil T.c -
H4 Samorin T.v + + + Berenil T.c ■ -
H5 Samorin T.v + + + Berenil T.c -
Control 1 T.v + + + Berenil T.c +
2 T.v + + + Berenil T.c +
3 Berenil T.c +
4 Berenil T.c +
5 Berenil T.c +
6 T.c +
Samorin = 0.5mg kg-1 isometamidium chloride administered.
Berenil = 3.5mg kg-1 diminazene aceturate administered.
T.v = challenge by 10 tsetse infected with T.vivax IL 2969 ( K i l i f i ,  
Kenya).
T.c = challenge by 5 tsetse infected with T.conoolense ILNat 3 .1 .
+ = parasitaemia.
- = no parasitaemia.
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changes and pronounced lymphadenomegaly, 20-40% skin 
thickness changes occurred in only 2 group H animals and 
lymphadenomegaly was not detected in any animal (see table  
13, appendix I I I ) .
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EXPERIMENT 2 
STUDIES USING T . V I V A X  IL 2982 (GALANA) AND 
T . V I V A X  IL 2986 (LIKONI)
INTRODUCTION
In T.vivax experiment 1, part A, a cloned T.vivax  
population from K i l i f i ,  Kenya (IL  2969) was shown to be 
sensitive to the therapeutic a c t iv ity  of isometamidium but 
resistant to the prophylactic a c t iv ity  of the drug, as 
defined in the f ie ld .  In an attempt to ascertain whether 
or not this finding was restric ted to one East African 
T.vivax population, two other T.vivax populations 
originating from East Africa were examined in an identical 
manner to T.vivax experiment 1, part A. Two uncloned 
populations were used; T.vivax IL 2982 (a derivative of an 
isolate  made in Galana, Kenya) and T.vivax IL 2986 (a 
derivative of an isolate made in Likoni, Kenya).
EXPERIMENTAL DESIGN
1) DETERMINATION OF THE SENSITIVITY OF THE GALANA T . V I V A X  
AND THE LIKONI T . V I V A X  TO THE THERAPEUTIC ACTIVITY OF 
ISOMETAMIDIUM
Two groups of 5 c a tt le  were infected, each with one of 
the two T.vivax populations, using 10 infected  
G.m.central is per animal. Eleven days la te r ,  when a ll  
c a ttle  had a parasitaemia of approximately SxlO^^ml"1, a ll  
were treated with 0.5mg kg-1 isometamidium chloride. For a
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200-day period following treatment jugular blood was 
collected from each animal three times weekly and examined 
for the presence of trypanosomes using the BC technique.
2) DETERMINATION OF THE SENSITIVITY OF THE GALANA T . V I V A X  
AND THE LIKONI T . V I V A X  TO THE PROPHYLACTIC ACTIVITY OF 
ISOMETAMIDIUM
To determine the duration of prophylaxis isometamidium 
conferred against the Galana T.vivax and the Likoni 
T.vivax . 0.5mg kg-1 isometamidium chloride was administered 
to 10 Boran steers. Thereafter, c a tt le  were challenged at 
monthly intervals using G.m.central is infected with e ither  
the Galana or the Likoni T.vivax (5 c a tt le  per population, 
10 infected f l ie s  per animal) (see table 29). At each 
challenge one control animal for each group, to which 
isometamidium chloride had not been administered, was 
challenged in a sim ilar manner.
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RESULTS
1) DETERMINATION OF THE SENSITIVITY OF THE GALANA T . V I V A X  
AND THE LIKONI T . V I V A X  TO THE THERAPEUTIC ACTIVITY OF 
ISOMETAMIDIUM CHLORIDE AT A DOSAGE OF 0.5ma ka-i
Of 5 animals infected with the Galana T.vivax and 5 
infected with the Likoni T .v iv ax . parasitaemia was not 
detected in any animal on any occassion during the 200-day 
post-treatment observation period. Thus, in fections in a l l  
animals appeared to be cured with a dosage of 0.5mg kg-1 
isometamidium chloride.
2) DETERMINATION OF THE SENSITIVITY OF THE GALANA T . V I V A X  
AND THE LIKONI T . V I V A X  TO THE PROPHYLACTIC ACTIVITY OF 
ISOMETAMIDIUM
The time of appearance of trypanosomes in experimental 
animals, following each challenge, is shown in tab le  30.
All 5 drug-administered animals challenged with the Galana 
T.vivax became infected following the f i r s t  challenge; four 
with parasitaemia prepatent periods identica l to the 
control and one with a parasitaemia prepatent period 5 days 
longer than the control. The haemorrhagic syndrome, 
characterised by a rapid and progressive decrease in PCV 
and death (produced by the parental population of the 
Galana T.vivax ( IL  2982) (P.R. Gardiner, personal 
communication) was not observed in any group J animal. By 
approximately 30 days post-in fection  PCV values in a l l  
animals had declined to about 20%. However, a f te r  day 30, 
PCV values in a l l  6 animals began to gradually increase,
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Table 30
DEVELOPMENT OF INFECTION IN CATTLE CHALLENGED WITH T . V I V A X -INFECTED 
TSETSE AFTER ADMINISTRATION OF 0.5mqkq-i ISOMETAMIDIUM CHLORIDE
ANIMAL
TRYPANOSOMA
VIVAX
CHALLENGE:
MONTHS AFTER ISOMETAMIDIUM 
CHLORIDE ADMINISTRATION
1 2 3 4 5
J1 IL 2982y 9*
J2 It 9
J3 II 9
J4 It 14
J5 II 9
CONTROL II 9
K1 IL 2986z - 12
K2 ti - 12
K3 ii - 12
K4 it - 12
K5 ii - 14
CONTROL+ ii 11 12
* Numbers correspond to the day following challenge when parasites  
were f i r s t  detected.
- Refractory to challenge.
+ D if fe re n t  animals used fo r  each challenge, 
y Gal ana T .v iv a x . 
z Likoni T .v ivax.
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indicating that a ll  were self-curing.
Of the 5 animals administered isometamidium chloride 
and challenged with the Likoni T .vivax. a l l  were refractory  
to the f i r s t  challenge. However, a ll became infected 
following the second challenge; 4 with parasitaemia 
prepatent periods identical to the control and one 2 days 
longer than the control.
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DISCUSSION
With apparently "sensitive" trypanosome populations of 
both T.congolense and T .v ivax. 0.5mg kg-1 isometamidium 
chloride can be expected to confer complete protection for  
at least 12 weeks (Fairclough, 1963a; Chapter 1). The 
early occurrence of breakthrough infections following drug 
administration has generally been taken as evidence of 
resistance to isometamidium (Jones-Davis and Folkers,
1966a; Na'Isa, 1967; Bourn and Scott, 1978; Pinder and 
Authie, 1984).
Following treatment of infections with 0.5mg kg-1 
isometamidium chloride, no relapses occurred in 5 ca tt le  
infected with the K i l i f i  T.vivax (IL  2969) and in only one 
out of 5 infected with the Zaria T.vivax ( IL  2968). Thus, 
neither clone appeared to show evidence for the expression 
of marked resistance to isometamidi urn's therapeutic  
a c t iv i ty .  However, prophylactic administration of 0.5mg 
kg-1 isometamidium chloride afforded c a tt le  less than one
Ck
month's complete protection against challenge with the 
K i l i f i  T .v ivax . Hence, the K i l i f i  T.vivax appears to be 
resistant to the prophvlactic a c t iv ity  of the drug, 
although sensitive to the therapeutic a c t iv ity  of the drug. 
I t  would also appear that since the 5 c a t t le ,  susceptible 
to K i l i f i  T.vivax challenge, were s t i l l  refractory to 
challenge with T.congolense ILNat 3.1 three months a fte r  
administration of isometamidium chloride, the 
susceptib ility  was not due to absence of drug a c t iv ity  in 
the animals. Further evidence for this conclusion comes
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from studies in v itro  (see chapter 4 ).
These findings provide corroborative evidence for the 
expression of a low level of sens it iv ity  to the 
prophylactic a c t iv ity  of isometamidium by the K i l i f i  
T.vivax'. in contrast to the high level of sen s it iv ity  
expressed by both T.congolense populations investigated in 
the c a tt le  experiment described in chapter 1.
In a s im ilar manner to the K i l i f i  T .vivax. the Galana 
T.vivax (IL  2982) has also been shown to be sensitive to 
the therapeutic a c t iv ity  of isometamidium but resistant to 
the prophylactic a c t iv ity  of the drug.
The Likoni T.vivax (IL  2986) has also been shown to be 
sensitive to the therapeutic a c t iv ity  of isometamidium. 
However, the level of resistance expressed against the 
prophylactic a c t iv ity  of isometamidium was less than that 
expressed by the K i l i f i  T.vivax and the Galana T .v ivax . but 
greater than that expressed by T.congolense ILNat 3.1 and 
the Zaria T .v ivax .
In a s im ilar manner to studies conducted with 
T.congolense. antibody was not detected in any animal 
refractory to challenge with the Zaria T.vivax or the 
K i l i f i  T .v ivax. thereby indicating that prophylaxis was 
e n tire ly  mediated by the action of drug. Furthermore, 
rodent-infective breakthrough populations occurring in 
drug-administered ca tt le  did not appear to express a 
decreased level of sens it iv ity  to the therapeutic a c t iv ity  
of isometamidium in mice, when compared to trypanosome 
populations from controls.
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In a sim ilar manner to the Zaria T.vivax and the 
K i l i f i  T .v ivax . tsetse-transmission of a T.vivax stock from 
Likoni, Kenya, to a cow, fa iled  to produce a detectable 
skin reaction (Dwinger, Grootenhuis, Murray, Moloo and 
Gettinby, 1986a). The absence of skin reactions may be 
associated with rapid migration (within a few days) of 
parasites away from the skin (Emery et a l . .  1980b). In so 
doing, localised trypanosome m ultip lication to numbers 
required to e l i c i t  a skin reaction would not, presumably, 
occur.
Temperature measurements made during the T.congolense 
c a tt le  experiment showed that of measurements made when 
c a tt le  were parasitaemic, 13.9% were in excess of 39.4°C 
when parasitaemic with T.congolense ILNat 3 .1 , and 20.6% 
were in excess of 39.4°C when parasitaemic with 
T.congolense IL 2642. In contrast, of the temperature 
measurements made when animals were parasitaemic with 
T.vivax . 41% were in excess of 39.4°C when infected with 
the Zaria T.vivax and 31% in excess of 39.4°C when infected 
with the K i l i f i  T .v ivax . Losos and Ikede (1972) stated 
that both T.congolense and T.vivax reside only within the 
blood c ircu la tion . However, the presence of T.vivax within  
extravascular s ites , such as the myocardium of c a tt le  (Van 
den Ingh and De Neijs-Bakker, 1979), and within the eye 
(Hornby, 1952; Ilemobade and Schilhorn van Veen, 1974; D.D. 
White!aw, personal communication) suggests that the 
parasite may invade certain tissues. The release of 
inflammatory mediators in association with tissue invasion
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may account for the more frequent occurrence of pyrexia in 
animals infected with T.vivax.
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CHAPTER 4
I N  VITRO EXAMINATION OF SERA FROM T .V I V A X  EXPERIMENT 1 
CATTLE. AND STUDIES WITH T .V I V A X  I N  VITRO
- 217 -
INTRODUCTION
In chapter 3, the susceptib ility  of a ll  5 group H 
c a tt le  to challenge with the K i l i f i  T.vivax ( IL  2969) one 
and 2 months a fte r  administration of 0.5mg kg-1 
isometamidium chloride (T.vivax experiment 1, part A) 
suggested that the population was resistant to the 
prophylactic a c t iv ity  of the drug.
In an attempt to ascertain whether or not trypanocidal 
a c t iv i ty ,  associated with the administration of 
isometamidium chloride, could be demonstrated in v itro  in 
the sera of group H infected c a tt le ,  serum samples from a ll  
5 animals were incubated in v itro  with T.congolense ILNat
3.1 bloodstream forms to examine for (a) th e ir  growth 
inh ib itory  e ffec t a fte r  24, 48 and 72 hours incubation, and 
(b) th e ir  e ffec t on mouse in fe c t iv i ty  a fte r  24 hours 
incubation.
Maintenance of T.vivax in v itro  has proven more 
d i f f i c u l t  than T.congolense. Bloodstream forms cultured 
within tsetse tissues were shown to be in fective  for sheep 
a fte r  39 days culture (Trager, 1959) and transformation to 
epimastigote forms using sim ilar culture conditions has 
also been described (Trager, 1975). Brun and Moloo (1982) 
maintained animal in fective forms of T.vivax in culture for  
3 months using a Microtus montanus f ib ro b la s t - l ik e  (MEF) 
feeder-layer using MEM medium with Earle's sa lts ,  
supplemented with 20% heat-inactivated goat serum. ILRAD 
(1984) has developed a culture system using bovine
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fibroblasts in MEM, and Matrix Green Gel A beads, for  
complete cyclical development of T .vivax.
Using sim ilar culture conditions to that described by 
Brun and Moloo (1982), Waithaka et a l . (1985) described a 
technique for screening the a c t iv ity  of drugs on T.vivax  
second generation bloodstream forms (bloodstream forms 
produced a fte r  cyclical transformation in v i t r o ) . A 
sim ilar technique has been used in this chapter for  
screening for trypanocidal a c t iv ity  in serum from c a tt le  
administered isometamidium chloride, except that freshly  
isolated bovine and murine bloodstream forms were used.
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MATERIALS AND METHODS
SCREENING OF SERA FROM CALVES ADMINISTERED Q.25mq kq-i 
ISOMETAMIDIUM CHLORIDE WITH BOVINE AND RODENT-DERIVED 
ZARIA T . V I V A X  ( IL  2968) BLOODSTREAM FORMS
24 Hour Incubation
These experiments were set up in a s im ilar  manner to 
that described in section 3(a) of the in v i t ro  general 
materials and methods, except that MEF ce ll monolayers were 
used and the medium into which trypanosomes were added 
consisted of 20% (v /v ) serum, 1% (v /v )  L-Glutamine (29.2mg 
ml-1 MEM medium) and 79% (v /v ) MEM medium.
All other techniques u t i l is e d  in th is  chapter have 
been described in the general materials and methods 
section.
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RESULTS
1) PART A -
SCREENING OF SERA FROM CATTLE IN T .V I V A X  EXPERIMENT 1
Three group H animals (H3, H4 and H5) became 
parasitaemic following the f i r s t  challenge. Four serum 
samples from each animal were examined in v itro  for th e ir  
trypanocidal a c t iv ity ;  those collected 0, 32, 39 and 46 
days a fte r  treatment. Day 0 sera were used as controls for 
other sera from the same animal. Growth inh ib ition  
produced by each sample is shown in table 31. All 9 
post-drug-administration sera inhibited trypanosome growth 
a fte r  48 and 72 hours incubation and only one of the 9 sera 
(H4, day 39) fa ile d  to do so a fte r  24 hours incubation.
All 9 sera produced greater growth inhib ition  when the 
incubation period was increased from 24 to 48 hours. 
Incubation for 72 hours further accentuated growth 
inh ib ition  in a l l  but one serum sample; H3, day 39.
The number of trypanosomes remaining a fte r  each period 
of incubation is shown graphically for H4 in figure 2. In 
a s im ilar manner to sera from H3 and H5, trypanosome 
numbers remaining in a ll  sera a fte r  48 hours incubation 
were lower than the in i t ia l  well inoculum. In addition, 
numbers remaining a fte r  72 hours incubation were always 
lower than a fte r  48 hours. Since the described loss of 
trypanosome v ia b i l i t y  also occurred in day 0 sera i t  would 
indicate that a "die out" occurred in a ll  trypanosome 
populations. A s im ilar pattern in loss of trypanosome 
v ia b i l i t y  occurred in sera collected on days 0, 60, 67 and
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FIGURE 2
•  Day 0 
O 'O  Day 32 
□••••□ Day 39 
A —A  Day 46
160
120
80
40
24 48 72
Incubation period (hours)
Figure 2 : In vitro incubation of sera from bovine H4 with
T .congolense ILNat 3.1 bloodstream forms; trypanosome 
numbers remaining after 24, 48 and 72 hours incubation.
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74 from HI and H2; group H animals f i r s t  detected 
parasitaemic following the second (day 60) challenge (see 
table 1, appendix IV ).
Although trypanosome numbers remaining in day 0 sera 
from a ll  5 group H animals decreased with time, in a ll  
cases the number of trypanosomes remaining in day 0 sera 
a fte r  72 hours incubation was always greater than numbers 
remaining in post-drug-administration sera. However, 
differences in the growth inhib ition  produced a fte r  72 
hours incubation in post-drug-administration sera as 
opposed to pre-drug-administration sera were not pronounced 
because of the inherent s ta t is t ic a l  inaccuracy of the 
neubauer chamber counting method at low trypanosome numbers 
(Dacie and Lewis, 1970). Even so, on a growth inh ib ition  
basis, there were indications for the presence of 
trypanocidal a c t iv ity  in a ll post-drug-administration sera 
collected from a ll  group H animals at a time when they were 
infected with the K i l i f i  T .v ivax.
Further evidence for the presence of trypanocide in 
the same post-drug-administration sera was derived from 
mouse in fe c t iv i ty  studies conducted with trypanosome 
populations (T.congolense ILNat 3.1) a fte r  24 hours 
incubation in the sera (see table 32). All mice inoculated 
with trypanosomes incubated in day 0 sera from a ll  group H 
animals became infected. In contrast, when inoculated with 
trypanosomes incubated in day 32, day 39 or day 46 sera 
from H3, H4 and H5, no mouse became parasitaemic. An 
exception to this generalisation was the day 32 serum
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sample from H5 which p a r t ia l ly  inhibited trypanosome 
in fe c t iv i ty  (5/10 mice became infected). H3, H4 and H5 
were a ll  susceptible to challenge with the K i l i f i  T.vivax  
on day 32.
In a sim ilar manner, sera collected from HI and H2 on 
days 60, 67 and 74, inhibited trypanosome in fe c t iv i ty .  HI
and H2 were f i r s t  observed parasitaemic 7 and 9 days,
respectively, following challenge with the K i l i f i  T.vivax  
on day 60.
Thus, a l l  sera collected from a ll  5 group H animals 
when infected with the K i l i f i  T.vivax (IL  2969) inhibited
in fe c t iv i ty  of T.congolense ILNat 3.1 for mice. The
presence of trypanocidal a c t iv ity  in a ll  these sera was 
therefore confirmed.
Only day 0 and day 91 sera from group G animals were 
analysed in v itro  for th e ir  e ffec t on T.congolense ILNat
3.1 in fe c t iv i ty  (table 32). Day 0 samples from a ll  4 
animals examined fa i le d  to in h ib it  trypanosome in fe c t iv i ty .  
Day 91 sera from G1 and G2 inhibited in fe c t iv i ty  whilst day 
91 sera from G3 and G5 had no apparent e ffec t on 
in fe c t iv i ty .  G1 and G2 were refractory to challenge on day 
91 with the Zaria T.vivax whilst G3 and G5 were susceptible 
to challenge on the same day with the same population.
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2) PART B -
I N  VITRO SCREENING OF SERA FROM CALVES XI. X2 AND X3 FOR 
TRYPANOCIDAL EFFECTS ON ZARIA T .V I V A X  ( IL  2968) BLOODSTREAM 
FORMS OF BOVINE AND MURINE ORIGIN
(See chapter 2 for T.congolense in v itro  experiments 
conducted with sera from calves XI, X2 and X3.)
(a) Bovine-derived T . v i v a x  IL 2968
Using bovine-derived T.vivax IL 2968 bloodstream 
forms, sera collected on day 0 through to day 49 from XI,
X2 and X3 were screened for th e ir  e ffec t on trypanosome 
in fe c t iv i ty  and growth a fte r  24 hours incubation. The 
results from these experiments are shown in table 33.
( i ) Growth Inhib ition
Nine post-drug-administration sera from each animal 
were examined. In many samples, trypanosomes grew better  
than in control sera; 8 from XI, 5 from X2 and 6 from X3.
In addition, growth inhib ition produced by sera from each 
animal varied widely from one sample to the next (see table  
33 and figure 3); to a much greater extent than did 
T.congolense ILNat 3.1 bloodstream forms a fte r  the same 
incubation period in the same sera (see table 21).
( i i )  Mouse in fe c t iv i ty
All mice inoculated with T.congolense ILNat 3.1 
bloodstream forms incubated for 24 hours in day 0 sera,
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FIGURE 3
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- 160 -
40 5010 3020
Day after Samorin administration
Figure 3 : 24 hour in vitro incubation of bovine-derived T.vivax IL 2968
in 20% serum from Boran cattle administered 0.25mgkg-  ^
isometamidium chloride; percentage growth inhibition.
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from each c a lf ,  became infected (see table 21). In 
contrast, day 0 sera from XI and X2 completely inhibited  
in fe c t iv i ty  of T.vivax IL 2968. Furthermore, the mouse 
in fe c t iv i ty  of trypanosomes incubated in a l l  3 animals' 
sets of sera appeared highly inconsistent, e .g . ,  day 35 and 
day 49 sera from X2 completely inhibited trypanosome 
in fe c t iv i ty  whilst that collected on day 42 from the same 
animal had no apparent e ffec t on in fe c t iv i ty .
(b) Murine-derived T . v i v a x  IL 2968
Since a ll  sets of data, in table 33, regarding growth 
inh ib ition  and mouse in fe c t iv i ty  appeared highly variable  
from one animals' sample to the next, sera from X3 was 
analysed again, in an identical manner, using 
murine-derived T.vivax IL 2968 bloodstream forms. 
(Murine-derived T.vivax IL 2968 appears to exhib it a higher 
level of in fe c t iv i ty  for rodents than the same trypanosome 
population derived from ca tt le  (personal observation)). 
Table 2, appendix IV, shows the resultant data.
Growth inh ib ition  followed an approximately sim ilar  
pattern to that previously described for bovine-derived 
bloodstream forms of T.vivax IL 2968.
Serum collected on days 0, 28, 35, 42 and 49 had no 
apparent e ffec t on trypanosome in fe c t iv i ty  whilst that 
collected on days 1, 3, 7 and 14 completely inhibited  
in fe c t iv i ty .  Rodent in fe c t iv i ty  data thus followed a more 
logical and consistent progression from week to week when 
murine-derived rather than bovine-derived trypanosomes were
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used. The in fe c t iv i ty  of murine-derived T.vivax IL 2968 
a fte r  exposure for 24 hours to sera from c a lf  X3 was almost 
identical to the in fe c t iv i ty  of T.congolense ILNat 3.1 
a fte r  24 hours incubation in the same sera (compare table  
21 with table 2, appendix IV ).
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DISCUSSION
Studies have been conducted in v itro  with sera from 
c a tt le  in the f i r s t  T.vivax experiment to ascertain whether 
or not trypanocidal a c t iv ity ,  associated with the 
administration of isometamidium chloride, could be 
detected.
All 5 animals in group H were susceptible to challenge 
with the K i l i f i  T.vivax e ither 32 or 60 days following 
administration of 0.5mg kg-1 isometamidium chloride, and 
a ll sera collected from these animals from day 32 to day 74 
(when infected with the K i l i f i  T .vivax) inhibited the 
in fe c t iv i ty  of T.congolense ILNat 3.1 a fte r  24 hours 
incubation in v i t r o . The same sera, when compared to 
pre-drug-administration sera, also exerted growth 
inh ib itory  effects on T.congolense ILNat 3.1 which, 
although not pronounced, became greater as the incubation 
period was extended from 48 to 72 hours.
Studies with sera from 4 group G c a tt le  showed a 
complete correlation between in v itro  inh ib ition  of 
T.congolense ILNat 3.1 in fe c t iv i ty  and susceptib ility  of 
the 4 animals to challenge with T.vivax IL 2968 on day 91; 
(a) day 91 sera from G1 and G2 completely inhibited  
trypanosome in fe c t iv i ty  and both were refractory to 
challenge on day 91, (b) day 91 sera from G3 and G5 did not 
in h ib it  trypanosome in fe c t iv i ty  and both were susceptible 
to challenge on day 91.
In contrast to T.congolense. T.vivax appears to be
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much more sensitive to the growth supportive properties of 
individual sera (R.T.Nelson, personal communication). This 
may account for the great range in growth inh ib ition  of 
both bovine and murine-derived Zaria T.vivax ( IL  2968) 
bloodstream forms when incubated in sets of weekly 
collected sera from 3 calves administered 0.25mg kg-i 
isometamidium chloride. Inhibitory effects on in fe c t iv i ty  
for mice appeared almost identical to murine-derived 
T.congolense ILNat 3.1 bloodstream forms when 
murine-derived Zaria T.vivax bloodstream forms were used. 
This therefore indicated that an approximately sim ilar  
level of s en s it iv ity  was expressed by the two trypanosome 
populations to the prophylactic a c t iv ity  of isometamidium. 
When bovine-derived Zaria T.vivax was incubated in the same 
sera the e ffec t on in fe c t iv i ty  was highly variable and 
inconsistent. This would appear to indicate that T.vivax 
populations freshly isolated from c a tt le  are unsuitable for 
d irect in v itro  drug-sensitiv ity  studies.
Borowy et a l . (1985b) suggested that the mammalian 
feeder-layer system they described for T.b.brucei might be 
suitable for the determination of the level of trypanocide 
s e n s it iv ity  expressed by f ie ld  isolates. However, in 
addition to the d i f f ic u l t ie s  encountered in adapting f ie ld  
isolates to continuous culture in v itro  (H i l l  and Hirumi, 
1983) there is a lack of information on the e ffec t adaption 
to culture has on the level of drug s e n s it iv ity  expressed 
by a trypanosome population. However, Brown, Ross, Holmes, 
Luckins and Taylor (in  press) have shown, in a small
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experiment, that adaption of three T.congolense populations 
to in v itro  culture did not appear to a lte r  th e ir  
s en s it iv ity  to isometamidium.
In v itro  drug sens it iv ity  screening on trypanosomes 
freshly isolated from a parasitaemic animal could 
circumvent the above described problems and prove 
considerably cheaper. However, of the 3 trypanosome 
species pathogenic for c a tt le  only T.vivax commonly attains  
levels of parasitaemia in c a tt le  s u ff ic ie n t ly  high so as to 
make trypanosome separation procedures reasonably 
manageable for trypanocide sensitivity-screening purposes. 
Using a bovine-derived rodent-infective T.vivax population 
from Zaria, Nigeria (IL 2968), inhib itory effects on growth 
and in fe c t iv i ty ,  associated with the presence of 
trypanocide in serum, have been shown to be masked by the 
growth supportive properties of the serum per se. Since 
the Zaria T.vivax used in these experiments appears to be 
much less sensitive to the growth supportive properties of 
individual sera than the 3 T.vivax populations from Kenya 
(IL  2969 ( K i l i f i ) ,  IL 2982 (Galana) and IL 2986 (Likoni) 
(R.T.Nelson, personal communication), i t  would appear that 
drug s en s it iv ity  screening on T.vivax populations freshly  
isolated from c a tt le  is not a useful s c ie n t i f ic  exercise.
An a lte rna tive , ind irec t, approach to determine the level 
of resistance expressed by a trypanosome population in an 
infected animal, would be to analyse the serum in which 
trypanosomes were growing. Examination of sera from c a tt le  
with regard to i ts  e ffec t on in fe c t iv i ty  of an
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isometamidium "sensitive" T.congolense population (ILNat 
3.1) has been shown to be a re lia b le  indicator for the 
presence or absence of trypanocidal a c t iv ity  in sera from 
c a tt le  administered isometamidium chloride.
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SECTION I I I  
DRUG SENSITIVITY STUDIES
- 236 -
CHAPTER 5
DETERMINATION OF THE I N  VIVO AND I N  VITRO ISOMETAMIDIUM- 
SENSITIVITY OF TRYPANOSOME POPULATIONS USED IN THE CATTLE
EXPERIMENTS
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INTRODUCTION
In the past, determination of the drug s e n s it iv ity  of 
rodent-infective trypanosome populations has been conducted 
by infecting groups of mice and then, at a la te r  date, 
treating d if fe re n t groups of mice with d if fe ren t dosages of 
drug (Browning and Gulbransen, 1935; Murgatroyd, Yorke and 
Corson, 1937; Goble, 1950; Hawking, 1963a; Mwambu et a l .,  
1969; G i l l ,  1971; Arowolo and Ikede, 1977; Pinder and 
Authie, 1984; Nyeko, Golder and Otieno, 1985b). The level 
of resistance expressed by a population can be expressed in 
a number of d if fe re n t ways: The minimum effec tive  dose
(MEDX) refers to the dosage of drug that clears 
trypanosomes from the blood of a certain percentage (x) of 
mice, and the curative dose (CDX) refers to the dosage of 
drug that cures a certain percentage (x) of infected mice; 
i . e . ,  the CD50 value denotes the dose which cures 50% of 
infected animals. S im ilarly , the IC50 (50% inhib itory  
concentration) refers to the concentration of drug required 
to in h ib it  in v itro  growth by 50% (Borowy et a l . ,  1985b).
In this chapter CD50 and IC50 values have been derived 
for rodent-infective trypanosome populations described in 
th is thesis. For comparative purposes an 
isometamidium-"resistant" T.conoolense from Burkina Faso, 
T.conoolense IL 2856 (derived from isolate Banankeladaga 
83/CRTA/67 described by Pinder and Authie, 1984 (see figure  
7, appendix V )) , has also been included.
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MATERIALS AND METHODS
1) ISOMETAMIDIUM CHLORIDE CD™ DETERMINATION 
Isometamidium chloride C D 50 values were determined at
both 6 hours post in fection and when parasitaemia attained  
107 trypanosomes per ml. For the 6 hour CD50 
determination, mice were inoculated in tra p e r ito n e a lly  with 
lx lO 6 rodent-derived bloodstream forms at time 0 and 
treated 6 hours la te r :  Doubling d ilu tions  of isometamidium
chloride in 0.2ml, down to a concentration equivalent to a 
dosage of 0.244ug kg-1, were administered in tra p e r ito n e a lly  
to groups of 6 mice each. Mice were monitored twice weekly 
fo r 30 days following treatment.
2) DETERMINATION OF THE ISOMETAMIDIUM CHLORIDE ICsn FOR 
T.C0NG0LENSE  ILNat 3.1
IC50 values were determined in flat-bottomed 24-well 
culture p lates, each tes t well containing a confluent 
bovine aorta endothelial ce ll monolayer. Maintenance 
medium was removed from each well and replaced with 1.000ml 
of medium containing 20% (v /v ) foetal bovine serum, 1%
(v /v ) L-Glutamine (2 9 .2mg ml-1 RPMI 1640) and 79% (v /v )
RPMI 1640.
In each experiment seven d if fe re n t  concentrations of 
isometamidium chloride were used, along with control medium 
where no drug was added. Drug was prepared in s te r i le  
d is t i l le d  water in a concentrated (100X) form (lOOug ml-1, 
30ug ml-1, lOug ml-1, 3ug ml-1, lug ml-1, 0.3ug ml-1 and 
O.lug ml-1) in order to maintain the osmolarity of the
- 239 -
medium. lOul aliquots of isometamidium chloride solutions 
were added to wells; two wells per concentration. (When 
the ra tio  of added drug volume to the tota l volume was 
1:100, the osmolarity did not a lte r  by more than 0.8% and 
had no influence on T.b.brucei cultures (Borowy et a l . .  
1985a,b).)
Trypanosomes were isolated as described in part 2 of 
the in v itro  general materials and methods and 5x105 
(suspended in the test medium) added to each w e l l . Before 
adding drug and trypanosomes to each well an identical 
volume to that to be added (lOul drug + volume of 
trypanosome suspension containing 5xl05 trypanosomes) was 
removed from each well so that a volume of 1.000ml was 
contained in each w ell, thereby resulting in test  
isometamidium chloride concentrations of lug ml-1, 0.3ug 
ml-1, lOOng ml-1, 30ng ml-1, lOng ml-1, 3ng ml-1 and lng 
ml-1. Immediately following addition of trypanosomes, a ll  
wells were checked for the presence of trypanosomes using 
an inverted microscope.
A fter 24 hours incubation the number of trypanosomes 
present was determined by counting the contents of 
individual wells.
The growth inhib ition  produced was calculated by 
comparing the mean number of trypanosomes in each drug 
concentration with the number of trypanosomes in the 
control sample.
Each experiment was repeated at least twice.
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3) DETERMINATION OF THE ISOMETAMIDIUM CHLORIDE IC™ FOR
T . V I V A X  IL 2968
The isometamidium chloride IC50 value fo r  T.vivax IL 
2968 was determined in an identica l manner to that  
described fo r T.conoolense ILNat 3.1 except that the medium 
into which drug and trypanosomes were added was composed of 
10% (v /v ) goat serum, 10% (v /v ) foetal bovine serum, 1% 
(v /v ) L-Glutamine (29.2mg ml-1 MEM), 1% (v /v ) non-essential 
amino acids (GIBCO, U.K.) and 79% (v /v ) MEM medium.
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RESULTS
1) MURINE CD™ VALUES
C D 50 values were determined for a l l  trypanosome 
populations using a minimum lo g it  chi-square analysis 
(Hewlett and P lackett, 1979) and are shown, along with 95% 
confidence in te rv a ls , in tab le  34.
Both T.conoolense ILNat 3.1 and T.conoolense IL 2642 
appeared to express approximately the same level of 
s e n s it iv ity  to the therapeutic a c t iv i ty  of isometamidium. 
In contrast, the Zaria T.vivax ( IL  2968) expressed a level 
of s e n s it iv i ty  a fac to r of 8 times lower than both 
T.conoolense ILNat 3.1 and T.conoolense IL 2642 when 
treated 6 hours post-in fection , and 16 times lower when 
treated at a parasitaemia of 107 trypanosomes per ml. 
However, a comparison of the CD50 value of T.conoolense IL 
2856 (pu ta t iv e ly  drug-resistant) with other trypanosome 
CD50 values indicated that T.conoolense ILNat 3 .1 ,  
T.conoolense IL 2642 and T.vivax IL 2968 a l l  express a 
r e la t iv e ly  high level of s e n s it iv i ty  to the therapeutic  
a c t iv i ty  of isometamidium.
2) I N  VITRO  ICsn VALUES
The s e n s it iv i ty  of T.conoolense ILNat 3.1 and the 
Zaria T.vivax ( IL  2968) to the therapeutic a c t iv i ty  of  
isometamidium in v i t ro  has been determined a f te r  24 hours 
incubation in medium containing 20% foeta l bovine serum.
The s e n s it iv i ty  has been expressed as the drug 
concentration required to  in h ib it  parasite growth by 50%
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Table 34
ISOMETAMIDIUM CHLORIDE Cfon VALUES. AS DETERMINED IN MICE
TRYPANOSOME
POPULATION
TIME OF 
TREATMENT CD50 (mgkg-i)
95% CONFIDENCE 
INTERVAL
T.conoolense ILNat 3.1 6 hours* 0.0066 0.0055 - 0.0079
T.conoolense IL 2642 6 hours 0.0072 0.0056 - 0.0093
T.vivax IL 2968 6 hours 0.0583 0.0522 - 0.0652
T.conoolense ILNat 3.1 107 ml-i+ 0.0177 0.0125 - 0.0251
T.conoolense IL 2642 107 mW 0.0210 0.0153 - 0.0287
T.vivax IL 2968 107 ml-i 0.3021 0.2033 - 0.4489
T.conoolense IL 2856 10? ml-i 6.537 3.864 . - 11.06
* Mice treated 6 hours after intraperitoneal inoculation of IxlO6 
trypanosomes.
+ Mice treated when parasitaemia attained approximately 107 ml-1.
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( I C 50) • Experiments were repeated at least twice. Before 
determination of the I C 50 value by the same minimum lo g it  
chi-square analysis as used for C D 50 values, consistency 
between experiments was determined using an analysis of 
variance technique with a 3-factor design (G. Gettinby, 
unpublished data). Any inconsistent data was not included 
in the chi-square analysis. I C 50 values are expressed as 
ug ml-1 and are shown in table 35.
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Table 35
ISOMETAMIDIUM CHLORIDE IC™ VALUES. AS DETERMINED IN  VITRO
TRYPANOSOME 95% CONFIDENCE
POPULATION IC50 (ug ml -1) INTERVAL
T.conaolense ILNat 3.1 0.1109 0.1037 - 0.1186
T.vivax IL 2968 0.0053 0.0041 - 0.0067
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DISCUSSION
Comparison of the 6 hour and 107 ml-1 CD50 values for  
each trypanosome population showed there to be consistently  
a higher CD50 value when treated at 107 ml-1 rather than 6 
hours post-infection. Davey (1957), with l i t t l e  
experimental evidence, suggested that another 
chemoprophylactic, antrycide prosalt, became bound to 
trypanosomes and was excreted along with the trypanosomes. 
He thereby suggested that drug would be more rapidly  
excreted in infected animals. However, G ilbert et a l . 
(1979) showed that the levels of rad ioactiv ity  in blood and 
tissue f lu id s , associated with the administration of 
[ 14C]-ethidium bromide, followed a sim ilar course in 
non-infected and T.congolense-infected calves. Although 
the pharmacokinetics of ethidium bromide were apparently 
unaltered in T.congolense-infected calves i t  may be that in 
mice the pharmacokinetics in non-infected animals do d i f fe r  
from infected animals since parasitaemia in murine 
T.congolense infections may atta in  anything up to 100 times 
the maximum level attained in c a t t le .  The occurrence of 
more rapid pharmacokinetics in infected mice would explain 
the occurrence of higher CD50 values when mice were treated 
at a parasitaemia of 107 ml-1 as compared to 6 hours 
post-infection.
Determination of in v itro  IC50 values has previously 
only been conducted with culture-adapted bloodstream forms 
of T.b.brucei (Borrowy et a l . ,  1985a, b) and second 
generation bloodstream forms of T.vivax (Waithaka et a l . ,
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1985). The only isometamidium chloride IC50 value 
described in the l i te ra tu re  is for T.vivax IL 1392, a 
derivative of the same isolate from which T.vivax IL 2968 
was derived; Zaria Y486 (Waithaka et a l . .  1985). The IC50 
value given by Waithaka et a l . (1985) for T.vivax IL 1392 
was 0.545ug ml-1. No confidence interval was indicated. 
Thus, there is a great difference in the level of 
s en s it iv ity  expressed by T.vivax IL 1392 and T.vivax 2968 
(IC50 = 0.0053ug ml-1) .  Both populations are d ire c t ly  
re lated. However, since both are clones, th is may account 
for the d if fe re n t levels of sens it iv ity  expressed by the 
two populations.
F ina lly , the isometamidium chloride IC50 value for 
T.conoolense ILNat 3.1 was shown to be much greater than 
that for T.vivax IL 2968. A comparison with the mouse 
isometamidium chloride CD50 values for the same trypanosome 
populations shows the reverse. This difference in the 
therapeutic a c t iv ity  of isometamidium in vivo and in v itro  
may be associated with d iffe ren t active forms of the drug: 
Hutchings (1979), without presenting any experimental 
evidence, stated that Samorin was a mixture of 3 
substances; isometamidium, a purple isomer and a 
b i s - compound, and was not 100% isometamidium. Since Wragg 
et a l . (1958) indicated that the p-amidino and m-amidino 
isomers of isometamidium differed in th e ir  in vivo 
therapeutic a c t iv ity  against a T.conoolense population, i t  
may be that some of Samorin's constituents exert the drug's 
in vivo a c t iv i ty ,  and others the in v itro  a c t iv i ty .
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GENERAL DTSCUSSTnN
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Isometamidium chloride has been marketed for 25 years. 
However, i t  is only very recently that an extensive survey 
has been carried out on the cost benefit to the farmer 
using a regular isometamidium-administration programme. 
Under an e f f ic ie n t  animal health programme, c a tt le  
maintained under isometamidium prophylaxis on the Mkwaja 
ranch, Tanzania (a region where ca ttle  cannot survive 
without the use of chemotherapy), were 80% as productive as 
Boran c a tt le  in a tsetse-free area of Kenya (ILCA, 1985).
At a dosage of lmg kg-1, isometamidium chloride has 
been shown to confer c a tt le  prophylaxis against 
trypanosomiasis from 2 to 22 weeks (Kirkby, 1964; 
Lwembandisa, 1970; Lewis and Thomson, 1974; Omwero-Wafula 
and Mayende, 1979; Pinder and Authie, 1984; Whitelaw et 
a l . , 1986). In a sim ilar manner, quinapyramine in its  
prophylactic formulation (pro-sa lt)  has been shown to 
confer c a tt le  1 to 4 months' protection (Davey, 1950; 
Unsworth and Chandler, 1952; Fiennes, 1953; Robson and 
Wilde, 1954). Recognising the wide variation in apparent 
prophylaxis that quinapyramine pro-salt conferred to 
c a tt le ,  workers suggested that the duration of protection  
afforded by quinapyramine pro-salt was d ire c t ly  related to 
the in tensity  of tsetse challenge (Fiennes, 1953; MacOwan, 
1955, 1956; Davey, 1957; Whiteside, 1958, 1962a).
Whiteside (1958) suggested that a combination of 
"trypanosome challenge" and "accessory factors" determined 
the apparent prophylactic period. The term "trypanosome 
challenge" encompassed both the in tensity  of infection and
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the trypanosome characteristics. Included in " intensity  of 
infection" were the f ly  species, the number of f l i e s ,  the 
f l y  feeding habits, the f ly  infection rate and mechanical 
transmission. Thus, " intensity of infection" was almost 
synonymous with the number of in fective testse bites per 
unit time.
"Characteristics of the trypanosome" included the 
trypanosome species, th e ir  pathogenicity, th e ir  drug 
susceptib ility  and th e ir  l i a b i l i t y  to become drug-fast.
F ina lly , "accessory factors" were divided into two 
groups: those concerned with the innate resistance of 
c a tt le  to trypanosomiasis (breed, sex, place of orig in ,  
previous history) and those modifying the innate resistance 
(c a tt le  condition, pregnancy, lac ta tion , intercurrent 
disease, condition of grazing and clim atic condition).
The demonstration from f ie ld  studies that the 
prophylactic period of quinapyramine pro-salt appeared to 
be inversely related to the tsetse density (MacOwan, 1955, 
1956; Davey, 1957; Whiteside, 1958, 1962a) indicated to 
these workers that the essential factors determining the 
period of prophylaxis may be the density of infected f l ie s  
and the transmission rate of those f l ie s  (Whiteside,
1962a). Relating the natural incidence of trypanosomiasis 
(expressed as the mean time in weeks between individual 
treatments with diminazene aceturate) to the period of 
prophylaxis conferred by prothidium, in 22 f ie ld  t r ia ls  in 
Kenya, Whiteside (1962a,b) showed that the higher the 
incidence of trypanosomiasis in an area the shorter the
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period of prophylaxis conferred by a chemoprophylactic in 
the same area.
The work described in this thesis has been directed 
towards determining the importance of a number of the 
factors discussed by Whiteside (1958) in determining the 
duration of prophylaxis conferred to c a tt le  by 
administration of isometamidium chloride; namely, dosage of 
drug, infection at the time of treatment, trypanosome 
species, trypanosome species serodeme and the level of 
metacyclic challenge.
Using an experimental protocol identical to that 
described in this thesis, Whitelaw et a l . (1986) showed 
that isometamidium chloride at a dosage of lmg kg-1 
completely protected c a tt le  against monthly tsetse 
challenge with T.congolense ILNat 3.1 for 5 months. Work 
described in th is  thesis using the same drug dosage has 
shown that in c a tt le  challenged in a s im ilar manner, 
complete prophylaxis was conferred for 4 months against 
T.congolense ILNat 3.1 and for 5 months against 
T.conoolense IL 2642. At a dosage of 0.5mg kg-1 the period 
of complete prophylaxis against T.congolense ILNat 3.1 was 
reduced to 3 months. Analyses of the prophylaxis results  
indicated a s ign ificant (P<0.06) dose-dependent 
re lationship, in that a higher dosage of drug afforded a 
longer period of prophylaxis. This finding is consistent 
with that of Boyt et a l . (1962) who showed that 
isometamidium conferred complete prophylaxis for 147 days 
at a dosage of lmg kg-1 and for 173 days at a dosage of 2mg
In Burkina Faso, the occurrence of T.congolense 
infections in ca tt le  as l i t t l e  as 2 weeks a fte r  
administration of lmg kg-1 isometamidium chloride suggested 
that the trypanosome populations were highly resistant to 
the prophylactic a c t iv ity  of isometamidium. The same 
populations expressed a high level of resistance to the 
therapeutic a c t iv ity  of isometamidium in mice (Pinder and 
Authie, 1984). Since lmg kg-1 isometamidium chloride 
conferred complete prophylaxis for 4 months against 
T.congolense ILNat 3.1 and for 5 months against 
T.congolense IL2642 i t  would suggest that both populations 
are highly sensitive to the prophylactic a c t iv ity  of 
isometamidium.
Both T.congolense ILNat 3.1 and T.congolense IL 2642 
also appeared to be highly sensitive to isometamidium's 
therapeutic a c t iv ity  in mice; whilst T.congolense ILNat 3.1 
and T.congolense IL 2642 had (107 parasites ml-i) CD50 
values of 0.0177mg kg-1 and 0.0210mg kg-1, respectively, 
that for T.congolense IL 2856 was 6.537mg kg-1, 340-fold  
greater. T.congolense IL 2856 is a derivative of isolate  
Banankeladaga/83/CRTA/67 (see figure 7, appendix V), an 
isometamidium-resistant isolate described by Pinder and 
Authie (1984).
As noted previously, Whiteside in a personal 
communication to D.G. Davey (1957) suggested that the level 
of trypanosome challenge determined the duration of 
prophylaxis conferred to ca tt le  by quinapyramine pro-salt
(Davey, 1957). Davey himself supported this theory (Davey, 
1957).
To ascertain whether this theory was true for  
isometamidium, 3 groups of 4 ca ttle  each were administered 
0.5mg kg-1 isometamidium chloride and subsequently 
challenged at monthly intervals with metacyclic forms of 
T.congolense ILNat 3.1; e ither 5 in fective tsetse 
(approximately 500 metacyclic trypanosomes (Whitelaw et 
a l . ,  1986)) or one of two d iffe ren t doses of in 
v i t r o -derived metacyclic trypanosomes, 5xl03 or 5xl05. 
Complete protection lasting 3 months was afforded to a ll  3 
groups. That the level of metacyclic challenge had no 
effec t on the duration of prophylaxis conflicts  with 
previous f ie ld  observations, although is consistent with 
previous experimental findings (Whitelaw et a l . ,  1986). 
Although e a r l ie r  workers had suggested (on the basis of 
f ie ld  observations) an inverse relationship between f ly  
density and the duration of quinapyramine prophylaxis, the 
findings presented in this thesis have shown that the level 
of metacyclic challenge appears not to influence the 
prophylactic period. There are several possible reasons 
for th is  difference: F irs t ly ,  both populations of
T.congolense used in the ca tt le  experiment have been well 
characterised in terms of th e ir  s e n s it iv ity  to 
isometamidium at normal therapeutic doses, whereas in the 
f ie ld  c a tt le  might encounter trypanosome populations less 
sensitive to the drug. Secondly, the challenge was 
administered on a single day each month, whereas in the
f ie ld ,  challenge probably occurs more frequently at a lower 
in tensity .
I f  there is an inverse relationship between the tsetse 
density and the duration of prophylaxis in the f ie ld ,  one 
might hypothesise that a fly-associated factor influences 
the prophylactic period. Following repeated bites of 
uninfected tsetse, both immediate and delayed 
hypersensitivity reactions have been observed in humans 
and animals in response to salivary components (Gordon and 
Crewe, 1948; E l l is  et a l . .  1986). Since metamidium and 
isometamidium act as depot prophylactics, being stored at 
the s ite  of in jection (Smith and Brown, 1960; H il l  and 
McFadzean, 1963), and isometamidium appears to reside as 
deposits within the cytoplasm of macrophages at the 
in jection s ite  (B e ll,  1987), one might propose that the 
release of systemically acting inflammatory mediators in 
response to such hypersensitivity reactions may cause a 
more rapid e ff lux  of drug-containing-macrophages from the 
in jection s ite ,  thereby shortening the prophylactic period.
In fection, associated with c lin ic a l signs of 
trypanosomiasis, at the time of drug administration has 
been suggested as a factor that may shorten the 
prophylactic period (Davey, 1957). To provide information 
on this factor, two groups of 4 ca tt le  were administered 
0.5mg kg-1 isometamidium chloride and then challenged at 
monthly intervals with T.congolense ILNat 3.1-infected  
tsetse. One group was fly - in fec ted  with T.congolense IL 
2642 four weeks before drug administration. Complete
protection was afforded the group previously infected with 
T.congolense IL 2642 for 4 months whilst 3 months complete 
protection was afforded the other group. Thus, i t  appears 
that heterologous infection at the time of drug 
administration had no shortening e ffect on the prophylactic 
period. Furthermore, since T.congolense ILNat 3.1 and 
T.congolense IL 2642 are cloned populations and belong to 
d iffe re n t serodemes (Dwinger, 1985b) i t  can be concluded 
that immunity did not contribute to the period of 
prophylaxis conferred to the group o r ig in a lly  infected with 
T.congolense IL 2642.
Jennings et a l . (1977a,b, 1979) demonstrated that the 
brain, inaccessible to most trypanocides, may act as a 
source of relapse infections following treatment. Thus, 
infections occurring in animals maintained on a 
chemoprophylactic regime, may in re a l i ty  be the result of a 
relapse from a drug-privileged s ite  rather than from a new 
in fection. This phenomenon cannot have occurred in any of 
the experiments described within this thesis since no 
animals, except the 4 group D animals, were infected with 
trypanosomiasis prior to administration of isometamidium 
chloride. The four animals in group D were infected with 
T.congolense IL 2642 at the time of drug administration and 
were then challenged with T.congolense ILNat 3 .1 .
Infections that subsequently developed in a ll  4 animals 
were shown serologically to be T.congolense ILNat 3 .1 .
Whiteside (1962a) suggested that antrycide p ro -sa lt 's  
prophylactic period consisted of two parts; one due to the
drug and independent of the trypanosome challenge, and the 
other, added to i t ,  due to an immune response by the host, 
which may be antigenically  primed during part or a ll  of the 
protective period. The experiments described here, both 
with T.conoolense and T .v ivax. have shown that antibody was 
not detected in any animal under isometamidium prophylaxis 
until i t  became parasitaemic. The only exception to this  
finding was one group of 4 c a tt le ,  (group F) administered 
0.5mg kg-1 isometamidium chloride and challenged at monthly 
in tervals with 5xl05 in v i t r o -derived T.conoolense ILNat 
3.1 metacyclic trypanosomes. Low anti-metacyclic antibody 
t i t r e s  were detected in a ll  4 animals one to 4 months 
before they became parasitaemic, when antibody t i t r e s  rose 
f iv e - fo ld .  Thus, acquisition of immunity whilst under 
chemoprophylactic cover appears highly unlikely in animals 
maintained by an isometamidium prophylactic regime, as the 
size of metacyclic inoculum required to stimulate a 
protective immune response was excessively large in 
re la tion  to what is l ik e ly  to be encountered in the f ie ld .
Although immunity appears not to be acquired whilst 
under chemoprophylactic cover i t  may be acquired under 
therapeutic regimes and contribute to the chemoprophylactic 
period. Wilson et a l . (1975b, 1976) described a f ie ld  
based experiment in which partia l immunity, as determined 
by a lengthening of the intertreatment period, appeared to 
develop a fte r  2 years in a group of c a tt le  treated on an 
individual basis with diminazene aceturate when animals 
developed c lin ica l disease or the PCV had gone below 20%.
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Immunity did not appear to develop in a group of c a tt le  
treated on a group basis with diminazene aceturate when one 
animal in the group was detected parasitaemic. Thus, 
development of immunity in c a tt le  was greatest in animals 
in which infections were well established before 
treatment. S im ilarly , ca tt le  treated with diminazene 
aceturate 5 days a fte r  cyclical infection with T.congolense 
were completely susceptible to homologous challenge, whilst 
c a tt le  treated 15 days following infection were completely 
immune to homologous challenge (Akol and Murray, 1985). 
Cattle treated on days 10-12 exhibited a range of 
susceptib ility  to homologous challenge.
In addition to the development of immunity following 
treatment being dependent on the timing of treatment 
following infection, the presence of concomitant 
heterologous serodemes may in terfere  with the development 
of immunity (Luckins, 1986). Induction of immunity to a 
particu lar T.congolense serodeme by a regime of infection  
and treatment with homidium chloride appeared to be 
adversely affected i f  animals were concurrently infected 
with a heterologous T.congolense serodeme. Immunity was 
impaired e ither when infection was conducted simultaneously 
with both serodemes (when establishment of both infections  
appeared to proceed normally) or when infection with the 
second serodeme was conducted at a la te r  date. In the 
l a t te r  case th is  may have been due to interference in 
establishment of the second infection (Morrison, Wells,
Moloo, Paris and Murray, 1982b; Luckins and Gray, 1983;
Dwinger, Luckins, Murray, Rae and Moloo, 1986b). All 
experiments on interference have been conducted with cloned 
populations belonging to two d if fe re n t serodemes. In the 
f ie ld  the situation is probably more complex since animals 
are constantly exposed to mixed infections with d iffe ren t  
serodemes and d iffe ren t trypanosome species (Luckins,
1986).
Chemoprophylaxis in neonatal animals may be enhanced 
by an immunoprophylactic contribution. Whitelaw and 
Urquhart (1985) showed that immunity to T.brucei could be 
conferred to mice when allowed to suckle, from b ir th , a 
mother e ither infected or whose infection was cured before 
parturit ion  with a trypanocide. Immunity lasted until 
approximately 25 days of age and was transmitted via the 
mother's colostrum. Administration of diminazene 
aceturate to normal newbown mice conferred protection  
against T.brucei challenge for approximately 25 days. In a 
sim ilar group of drug-administered mice, also receiving 
colostral antibody, combined immunochemoprophylaxis lasted 
40-50 days.
In contrast to mice, l i t t l e  protection appeared to be 
afforded neonatal goats by colostral transfer of antibody 
from th e ir  dams. Studies on East African goats showed that 
whilst 3 out of 5 kids fed colostrum from immunised dams 
resisted homologous T.brucei challenge at 12 days of age, 
none out of 3 were immune at 28 days of age (Whitelaw and 
Jordt, 1985).
In studies with T.vivax (described in this thesis)
isometamidium chloride at a dosage of 0.5mg kg-1 has been 
shown to confer complete prophylaxis for 2 months against 
T.vivax IL 2968, a derivative of an isolate made in Zaria, 
Nigeria, and for 1 month against T.vivax IL 2986, a 
derivative of an isolate made in Likoni, Kenya. The same 
dosage of isometamidium chloride conferred less than 1 
month's prophylaxis against T.vivax IL 2969 and T.vivax IL 
2982, derivatives of isolates made in K i l i f i  and Galana, 
Kenya, respectively. Likoni, K i l i f i  and Galana are 
situated within 100km of each other in the Kenyan coastal 
province.
Thus, experiments have been conducted with two East 
African T.congolense populations (ILNat 3.1 and IL 2642) 
and three East African T.vivax populations ( K i l i f i  (IL  
2969), Galana (IL  2982) and Likoni (IL  2986)). In a 
sim ilar manner to the two T.congolense populations, 
parental populations of the K i l i f i  T.vivax and the Galana 
T.vivax have been shown to belong to d if fe re n t serodemes 
(Dwinger, 1985b; Nantulya et_al_., 1986). In contrast, 
parental populations of the K i l i f i  T.vivax and the Likoni 
T.vivax may belong to the same serodeme (Nantulya et a l . .
1986). All 3 T.vivax populations expressed a much greater 
level of resistance to the prophylactic a c t iv ity  of 
isometamidium, as compared to both T.congolense 
populations. I f  the 3 T.vivax populations and the two 
T.congolense populations are representative of the 
respective trypanosome species in East Africa as a whole 
then one would hypothesise that T.vivax populations in East
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Africa express a greater level of resistance to 
isometamidiurn's prophylactic a c t iv ity  than East African 
T.congolense populations. This being so, i t  would be 
expected that T.vivax infections in East Africa would occur 
more frequently in c a tt le  maintained by an isometamidium 
prophylaxis regime than in ca ttle  maintained in the same 
area without the use of isometamidium. Some evidence to 
support this hypothesis was provided from the findings of 
Njogu, Dolan, Sayer, Wilson and Alushula (1985): They
described a series of experiments conducted on the Galana 
ranch, Kenya, and compared the percentage T.vivax  
infections occurring in two groups of c a tt le  from 1982 to 
1984; one group was maintained on a regular isometamidium 
prophylaxis regime and the other (a sentinel group) was 
maintained in the same area on an individual basis with 
diminazene aceturate, i . e . ,  a sentinel animal was only 
treated with diminazene aceturate when detected 
parasitaemic. In each of the three years a greater 
percentage of T.vivax infections occurred in the group 
maintained with isometamidium as compared to the sentinel 
group. In 1985 and 1986 almost 100% of infections  
occurring in the isometamidium prophylaxis group were 
associated with T.vivax (R.B. Dolan, personal 
communication).
Reports of resistance to isometamidium by trypanosomes 
in East Africa are lacking. Rottcher and Schillinger
(1985) reported the occurrence of multiple drug resistance 
associated with a haemorrhagic type T.vivax from the Tana
r iv e r  d is t r ic t  of Kenya. Experiments were conducted with 
blood from a donor cow that had been infected with 11 
isolates. The resultant trypanosome "cocktail" was shown 
to be resistant to the therapeutic a c t iv ity  of 
isometamidium chloride, quinapyramine sulphate, diminazene 
aceturate and homidium chloride at dosages of 2mg kg-1, 5mg 
kg-1, 3.5mg kg-1 and 2mg kg-1, respectively. Commenting on 
th is work, Njogu and Heath (1986) stated that the 
association of a drug-resistant strain of T.vivax with a 
haemorrhagic syndrome could not be confirmed. Furthermore, 
although the Kenyan Trypanosomiasis Research In s t itu te  had 
confirmed the resistance of the cocktail to isometamidium, 
they had fa iled  to establish from which c a tt le  group the 
resistant strain originated. Only 7 of the original 
isolates were available and a ll  were sensitive to 
isometamidium chloride at.lmg kg-1. Thus the report of 
Rottcher and Schillinger (1985) was not confirmed. Herds 
of c a tt le  are s t i l l  being maintained on the Galana ranch 
using an 8-weekly isometamidium prophylaxis regime with no 
apparent evidence of resistance (R.B. Dolan, personal 
communication).
Following on from the work described by Rottcher and 
Schillinger (1985), Schonefeld and Rottcher (1987) reported 
on drug resistance studies conducted with 7 T.vivax  
isolates from Kenya and Somalia. All 7 isolates were 
resistant to the recommended therapeutic dosages of 
isometamidium chloride, homidium chloride and quinapyramine 
sulphate. Sensitiv ity  to isometamidium's prophylactic
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a c t iv ity  was investigated with only one iso late; that from 
Bamburi, Kenya (situated on the coast, approximately 50 km 
south of K i l i f i ) .  Cattle administered lmg kg-i 
isometamidium chloride were fly-challenged with the Bamburi 
T.vivax e ither 10 or 20 days following drug 
administration. All c a tt le  were detected parasitaemic 
within 7-10 days following each challenge.
Drug-resistant trypanosomes are a potential major 
threat to c a tt le  productivity in Africa. However, this  
threat may be reduced, f i r s t l y  by the finding that some 
c a tt le  infected with populations of T .vivax. T.congolense 
or T .brucei, a ll  of East African orig in , may self-cure  
(Wellde, Hockmeyer, Kovatch, Bhogal and Diggs, 1981; 
Nantulva et a l . ,  1984,1986), and secondly, trypanosome 
populations arising in c a tt le  maintained by a 
chemoprophylactic regime in the f ie ld  may express decreased 
pathogenicity (Stephen, 1962a). In the T.congolense 
experiment described in chapter 1, greater than 50% of 
T.congolense infections arising in c a tt le  administered 
isometamidium chloride expressed decreased pathogenicity as 
compared to the same populations in controls.
The a b i l i ty  of a trypanosome population to acquire an 
increased level of drug resistance has been suggested as a 
reason for shortening of antrycide p ro -sa lt 's  prophylactic 
period (Fiennes, 1953; Whiteside, 1958). However, this did 
not appear to occur in any of the experiments described in 
th is thesis. Extensive isometamidium s e n s it iv ity  screening 
was conducted in mice on a ll T.congolense ILNat 3 .1 ,
T.congolense IL 2642 and Zaria T.vivax (IL  2968) 
populations arising in ca tt le  administered isometamidium 
chloride. In no case (22 infections) did breakthrough 
populations appear to express a greater level of resistance 
to isometamidium as compared to those in controls.
In addition to isometamidium exerting trypanocidal 
a c t iv ity  within the host, i t  may also exert trypanocidal 
a c t iv ity  within the tsetse f ly .  Using wild caught Glossina 
pallid ipes Hawking (1963b) showed that infections with 
T.congolense. T.vivax or T.brucei were eliminated when the 
f l ie s  were allowed to feed through membranes on blood 
containing O.lmg ml-1 isometamidium chloride. Using a 
sim ilar feeding technique and the same drug concentration, 
both immature and mature T.vivax infections were eliminated 
from G.p.palpal is (Agu, 1985). Furthermore, when used at a 
lower concentration of O.lug ml-1, isometamidium chloride 
has also been shown to decrease the number of mature 
T.b.brucei infections in G.m.centralis when fed to f l ie s  
throughout the whole period of trypanosome development 
(Jefferies  and Jenni, 1987). Since trypanocidal a c t iv ity  
was evident at the level of the salivary glands and not in 
the midgut, the authors suggested that isometamidium 
interacted with kinetoplast DNA preventing expression of 
genes important for trypanosome transformation.
All the above described studies have examined the 
effec t of feeding infected f l ie s  on blood spiked with 
native drug. Since in vivo a c t iv ity  of Samorin may be 
associated with constituents that do not e ffec t the drug's
in v itro  a c t iv ity  (see chapter 5 discussion) there is a 
danger in extrapolating in v itro  findings to the in vivo 
situation. In an attempt to examine the situation in vivo. 
Agu (1984) fed TYvivax-infected G.p.pal pal is on sheep, 24 
hours a fte r  intramuscular administration of lmg kg-1 
isometamidium chloride. Both immature and mature T.vivax  
infections were eliminated from the f l ie s .  In contrast, 
when T.congolense-infected G.m.morsitans were fed on 
drug-administered rabbits, no a lteration  was observed in 
midgut or proboscis infections, or transm iss ib ility  of 
parasites (Nyeko, Golder and Otieno, 1985a). These authors 
also showed that infections in mice, resulting from feeding 
of the above described tsetse, expressed a decreased level 
of se n s it iv ity  to isometamidium.
There is thus l i t t l e  experimental evidence to indicate  
that trypanosome transm iss ib ility  of tsetse in the f ie ld  is 
influenced by the feeding of tsetse on drug-administered 
animals.
Techniques for the determination of isometamidium 
levels in body flu ids  and tissues are lacking. Ali and 
Hassan (1984), using an insensitive spectrophotometric 
technique described by Philips et a l . (1967), were unable 
to detect isometamidium in camel plasma 48 hours a fter  
intravenous inoculation of e ither 0.5mg kg-1 or l.Omg kg-1 
isometamidium chloride. Using the same technique to 
examine slaughterhouse material, Shetty (1986) showed that 
highest levels of drug were detected in l iv e r ,  then kidney, 
skeletal muscle, heart ventric le  and spleen; decreasing in
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that order (the time interval between drug administration 
and slaughter was unknown). A similar tissue d istr ibution  
has been reported in dogs, monkeys and goats (Philips et 
al_., 1967; Braide and Eghianruwa, 1980). The level of 
s en s it iv ity  of the technique described by Braide and 
Eghianruwa (1980) was down to approximately l.Oug ml-1 of 
serum and 2.3ug g-1 of tissue. That described by Shetty
(1986) was 2 . lug g_1 of wet tissue. Because of the 
in se n s it iv ity  of these techniques the actual duration of 
pharmacologically active drug within body flu ids  and 
tissues may in fact be much longer than that currently  
reported.
Perschke and Vollner (1985) described a high 
performance liqu id  chromatography technique for the 
measurement of isometamidium in bovine plasma or serum. 
Using spiked samples th e ir  lower l im it  of detection was 
20ng ml-1. This technique was not, however, applied to the 
examination of sera from drug-administered animals.
Other workers have fa ile d  to reproduce the results of 
Perschke and Vollner (1985) (D.D. Whitelaw, personal 
communication).
Using a T.congolense in v itro  culture system described 
by Hirumi and Hirumi (1984), a qu a lita tive  technique for  
the detection of trypanocidal a c t iv ity  in plasma or sera 
from drug-administered c a tt le  has been developed. 
Trypanocidal a c t iv ity  was detected in c a tt le  plasma 
collected as long as 6 months a fte r  administration of lmg 
kg-i isometamidium chloride; levels that correlated with
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susceptib i l i ty  of ca t t le  to challenge. The same technique 
was used to confirm the high level of resistance expressed 
by the K i l i f i  T.vivax (IL 2969) to the prophylactic 
a c t iv i ty  of isometamidium: Trypanocidal a c t iv i ty  was
detected in serum taken from catt le  1 and 2 months a fter  
administration of 0.5mg kg-1 isometamidium chloride, at a 
time when they were susceptible to challenge with the 
K i l i f i  T .vivax.
There are, however, problems with the in v i t ro  
technique. In part icular ,  the detection of trypanocidal 
a c t iv i ty  in serum from some animals prior  to 
drug-administration and, therefore, the absence of a true 
serum control for any animal.
In the past, putative isometamidium-resistant 
trypanosome populations have been investigated by a 
strategy of infection and treatment (Jones-Davies and 
Folkers, 1966a; Na'Isa, 1967; Gray and Roberts, 1971;
Lewis and Thomson, 1974; Gitatha, 1979; Kupper and Wolters, 
1983; Rottcher and Schi l l inger, 1985). Studies described 
in this thesis on T.vivax populations originating from 
K i l i f i  ( IL  2969), Galana (IL 2982) and Likoni ( IL  2986), in 
Kenya, have indicated them to be sensitive to the 
therapeutic a c t iv i ty  of isometamidium but resistant  to the 
prophylactic a c t iv i ty  of the drug, as defined in the f ie ld  
situation.  Differences between prophylactic and 
therapeutic a c t iv i ty  have also been reported for the 
2,7-di-m-amidinophenyldiazoamino derivative of homidium 
(Berg, Brown, H i l l  and Wragg, 1961). Although the compound
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was much less active therapeutically than metamidium 
against a T.congolense population, i t  was no less active 
prophylactical ly . These findings might suggest that the 
form(s) of isometamidium chloride (Samorin) exerting the 
drug's therapeutic ac t iv i ty  may be di f ferent  from the 
form(s) exerting the prophylactic a c t iv i ty .  Possibly, the 
therapeutic ac t iv i ty  is associated with native drug whilst  
drug metabolite(s) exert(s) the drug's prophylactic 
a c t iv i ty .  Alternatively , d i f ferent  constituents of Samorin 
may be responsible for the d i f ferent  ac t iv i t ie s  (Wragg et 
al_., 1958; Hutchings, 1979).
Since isometamidium is pr incipally  used for conferring 
prophylaxis against bovine trypanosomiasis, i t  is suggested 
that future in vivo studies on putative isometamidium- 
resistant trypanosomes should ideal ly  be conducted using a 
prophylactic rather than a therapeutic protocol. In v i tro  
studies on putative drug-resistant isolates should be 
conducted in a similar manner; instead of adding native 
isometamidium chloride to cultures (Waithaka et a l . ,  1985), 
i t  is suggested that sensit iv i ty  screening of trypanosome 
isolates should be conducted by incubating trypanosomes in 
sera collected from catt le  a f ter  administration of  
isometamidium chloride. Incubation of trypanosome isolates 
with native drug should only be conducted with isolates 
collected from areas where isometamidium chloride is used 
as a therapeutic.
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Table 1, appendix I 
T.CONGOLENSE EXPERIMENT - CATTLE CODES
ANIMAL CODE GROUP NUMBER ANIMAL CODE GROUP NUMBER
A1 A C862 D1 D C890
A2 A C882 D2 D C892
A3 A C933 D3 D C893
A4 A C954 D4 D C894
B1 B C879 El E C871
B2 B C888 E2 E C885
B3 B C936 E3 E C891
B4 B C953 E4 E C952
Cl C C870 FI F C860
C2 C C875 F2 F C861
C3 C C886 F3 F C872
C4 C C932 F4 F C889
CONTROLS
CHALLENGE
MONTH GROUPS A.C.D GROUP B GROUPS E.F
2 C868 C934 C874
3 C887 C730 C869
4 C935 C731 C938
5 C597 C535 C420
6 C865 C734 C937
7 C730 C887
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Table 2, appendix I
INFECTIVITY TITRATIONS OF T.CONGOLENSE IL 2642 
METACYCLIC TRYPANOSOMES FOR MICE
INOCULUM DEAE-COLUMN SEPARATION PLASMA SEPARATION
No. Parasitaemic 
/No. inoculated
Parasitaemia 
onset (days)
No. Parasitaemic 
/No. inoculated
Parasitaemia 
onset (days)
5x104 4/4 4,5 4/4 3
5x103 4/4 3-5 4/4 3
5x102 4/4 5-7 4/4 4-6
5x101 4/4 5-9 4/4 5,6
5x100 3*/4 6-9 4/4 7,8
‘Negative mouse monitored for 40 days.
- 320 -
Table 3. appendix I 
DETECTION OF TRYPANOSOMES IN GROUP D ANIMALS PRIOR TO THE 2 MONTH CHALLENGE
DATE: 17 .1.85 18.1 .85 25.1 .85 15.2,.85
DAY: 0* 1 8 29
ANIMAL NO. B.C. M .I . B.C. M .I . B.C. M .I . B.C. M .I .
D1 3+ 5/5 _ 0/5 - 0/5 _ 0/5
D2 2+ 5/5 - 0/5 - . 0/5 - 0/5
D3 - 5/5 3+ 0/5 - 0/5 - 0/5
D4 3+ 5/5 2+ 0/5 " 0/5 0/5
DATE: 22.2.85 1.3.85 15.3.85
DAY: 36 43 57
ANIMAL NO. B.C. M .I . B.C. M .I . B.C. M .I .
D1 0/5 0/5 0/5
D2 0/5 0/5 0/5
D3 0/5 0/5 0/5
D4 0/5 0/5 0/5
B.C. = Buffy-coat phase-contrast technique
M .I .  = Mouse inoculation: Data = No. parasitaemic/No. inoculated
* =  All four animals observed consistently  parasitaemic fo r  at leas t  
17 days p r io r  to day 0.
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Table 4 . appendix I 
DETECTION OF TRYPANOSOMES BY THE BUFFY-COAT PHASE-CONTRAST
(BC) TECHNIQUE AND MOUSE INOCULATION (M.I .) FOLLOWING
CHALLENGE AT 2 AND 3 MONTHS
2 MONTH CHALLENGE 3 MONTH CHALLENGE
M.I • M. I .
ANIMAL NO. BC/DFOP DAY 12 DAY 24 BC/DFOP DAY 12 DAY 24
A1 _ 0* 0 — 0 0
A2 - 0 0 - 0 0
A3 - 0 0 - 0 0
A4 - 0 0 - 0 0
B1 - 0 0 - 0 0
B2 - 0 0 - 0 0
B3 - 0 0 - 0 0
B4 - 0 0 - 0 0
Cl - 0 0 - 0 0
C2 - 0 0 - 0 0
C3 - 0 0 - 0 0
C4 - 0 0 - 0 0
D1 - 0 0 - 0 0
D2 - 0 0 - 0 0
D3 - 0 0 - 0 0
D4 - 0 0 - 0 0
El - 0 0 - 0 0
E2 - 0 0 - 0 0
E3 - 0 0 - 0 0
E4 - 0 0 - 0 0
FI - 0 0 - 0 0
F2 - 0 0 - 0 0
F3 - 0 0 - 0 0
F4 - 0 0 - 0 0
A,C,D CONTROL 12 2 2 12 1 2
B CONTROL 11 2 2 12 2 2
E,F CONTROL 13 1 2 16 0 2
BC/DFOP = Day f i r s t  observed parasitaemic using BC technique. 
* =  Number of mice parasitaemic (2 inoculated).
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Table 5 , appendix I 
DETECTION OF TRYPANOSOMES BY THE BUFFY-COAT PHASE-CONTRAST
(BC) TECHNIQUE AND MOUSE INOCULATION (M .I, .) FOLLOWING
CHALLENGE AT 4 AND 5 MONTHS
4 MONTH CHALLENGE 5 MONTH CHALLENGE
M.I • M. I .
ANIMAL NO. BC/DFOP DAY 12 DAY 24 BC/DFOP DAY 12 DAY 24
A1 0* 0 . 0 0
A2 0 0 24 0 2
A3 0 0 - 0 0
A4 0 0 - 0+ 0
B1 0 0 - 0 0
B2 0 0 - 0 0
B3 0 0 - 0+ 0
B4 0 0 - 0+ 0
Cl 0 0 14 0 2
C2 0 0 - 0 0
C3 0 0 14 1 2
C4 21 0 2
D1 0 0 14 0 2
D2 0 0 - 0 0
D3 0 0 - 0 0
D4 0 0 30 0 0
El 0 0 - 0 0
E2 0 0 7 2 1
E3 0 0 - 0 0
E4 16 0 2
FI 0 0 - 0 0
F2 0 0 14 0 2
F3 21 0 2
F4 0 0 14 0 2
A.C.D CONTROL 14 0 2 12 1 2
B CONTROL 12 2 2 12 1 2
E,F CONTROL 14 0 2 14 2 2
BC/DFOP = Day f i r s t  observed parasitaemic using BC technique.
+ = Inoculation on day 15.
* =  Number of mice parasitaemic (2 inoculated).
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Table 6 , appendix I
DETECTION OF TRYPANOSOMES BY THE BUFFY-COAT PHASE-CONTRAST 
(BC) TECHNIQUE AND MOUSE INOCULATION (M . I . )  FOLLOWING
CHALLENGE AT 6 AND 7 MONTHS
6 MONTH CHALLENGE 7 MONTH CHALLENGE
M .I. M . I .
ANIMAL NO. BC/DFOP DAY 12 DAY 24 BC/DFOP DAY 12 DAY 24
A1 - 0* 0 _ 0 0
A3 - 0 0 - 0 0
A4 24 0 0
B1 14 0 2
B2 - 0 0 - 0 0
B3 - 0 0 - 0 0
B4 29 0 0
C2 - 0 0 - 0 0
D2 28 0 0
D3 12 0 2
El 21 0 2
E3 19 0 2
FI - 0 0 24 0 2
A.C.D CONTROL 14 1 1 12 1 2
B CONTROL 12 2 2 14 2 2
E,F CONTROL 14 0 2
BC/DFOP = Day f i r s t  observed parasitaemic using BC technique.
* =  Number of mice parasitaemic (2 inoculated).
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T a b l e  7 .  a p p e n d i x  I
TEMPERATURE MEASUREMENTS OVER 39.4°C
2 MONTH CHALLENGE (27*1 
NPM
3 MONTH CHALLENGE ( 2 6 * )  
NPM
ANIMAL NO. DFOP NTMP NPM NTMP % DFOP NTMP NPM NTMP
A1 _ 0 _ _ _ 0 _
A2 - - 0 - - - 0 -
A3 - - 0 - - - 0 -
A4 - - 0 - - - 0 -
B1 - - 0 - - - 0 -
B2 - - 0 - - - 0 -
B3 - - 0 - - - 0 -
B4 - - 0 - - - 0 -
Cl - - 0 - - - 0 -
C2 - - (1) - - - 0 -
C3 - - (1) - - - 0 -
C4 - - (1) - - - 0 -
D1 - - 0 - - - 0 -
D2 - - 0 - - - 0 -
D3 - - 0 - - - 0 -
D4 - - 0 - - - 0 -
El - - 0 - - - 0 -
E2 - - 0 - - - 0 -
E3 - - 0 - - - 0 -
E4 • - - 0 - - - 0 -
FI - - 0 - - - 0 -
F2 - - 0 - - - 0 -
F3 - - 0 - - - 0 -
F4 - - (1) - - - 0 -
CONTROLS
A,C,D 12 16 4 25 12 15 5 33
B 11 17 0 0 12 15 3 20
. e , f 13 15 1 7 16 11 0 0
DFOP = Day f i r s t  observed parasitaemic.
NTMP = Number of temperature measurements when parasitaemic. 
NPM = Number of pyrexic temperature measurements.
( ) = Not parasitaemic.
* = Number of measurements.
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T a b l e  8 .  a p p e n d i x  I
TEMPERATURE MEASUREMENTS OVER 39.4°C
4 MONTH CHALLENGE (28*) 
NPM
ANIMAL NO. DFOP NTMP NPM NTMP %
A1
A2
A3
A4
B1
B2
B3
B4
Cl
C2
C3
C4
D1
D2
D3
D4
El
E2
E3
E4
FI
F2
F3
F4
CONTROLS
21
16
21
14
0
0
( 1)
0
0
0
0
0
0
0
0
1
0
0
0
( 1)
0
0
0
2
0
0
0
0
13
14
5 MONTH CHALLENGE (28*) 
NPM
DFOP
24
14
14
14
30
7
14
14
NTMP NPM
0
1
0
(1)
0
0
0
0
0
0
1
14
14
14
0
21
14
14
(1)3
0
0
0
0
0
0
0
3
NTMP % 
20
7
21
0
0
21
14
A,C,D 14 15 4 27 12 16 2 13
B 12 17 4 24 12 16 9 56
E,F 14 16 (1)2 13 14 14 4 29
DFOP = Day f i r s t  observed parasitaemic.
NTMP = Number of temperature measurements when parasitaemic. 
NPM = Number of pyrexic temperature measurements.
( ) = Not parasitaemic.
* = Number of measurements.
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T a b l e  9 .  a p p e n d i x  I
TEMPERATURE MEASUREMENTS OVER 39.4oC
6 MONTH CHALLENGE ( 2 7 * )  
NPM
7 MONTH CHALLENGE (28*) 
NPM
ANIMAL NO. DFOP NTMP NPM NTMP % DFOP NTMP NPM NTMP %
A1
A3
A4
B1
B2
B3
B4
24
14
29
6
14
0
( 2 )
0
1
0
0
0
C2
D2
D3
28
12
3
16
0
25
El
E3
21
19
9
10
0
30
FI - - 0 - 24 6 0 -
CONTROLS
A,C,D 14 14 1 7 12 17 5 29
B 12 16 3 19 14 15 (1)7 47
E,F 14 14 1 7
DFOP = Day f i r s t  observed parasitaemic.
NTMP = Number of temperature measurements when parasitaemic. 
NPM = Number of pyrexic temperature measurements.
( ) = Not parasitaemic.
* = Number o f measurements.
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Table 10. appendix I
STUDIES IN MICE ON THE THERAPEUTIC ACTIVITY OF ISOMETAMIDIUM ON 
TRYPANOSOME POPULATIONS ISOLATED FROM CATTLE SUSCEPTIBLE TO THE 4 MONTH
CHALLENGE
Data = No. mice parasitaemic/No. mice treated
TREATMENT ANIMAL: 
6 hours
*fA.C.D) *( E,F) C4 E2 E4 F3
O.Bmgkg-1 0 /6 0 /6 0 /6 0 /6 0 /6 1 /6
1. Omgkg-1 0 /5 0 /6 0 /6 0 /6 0 /6 0 /6
2. Omgkg-1 0 /5 0 /6 0 /5 0 /6 0 /6 0 /6
4. Omgkg-1 0 /6 0 /6 0 /6 0 /6 0 /6 0 /6
107 t r v D s .m l - 1
O.Smgkg-1 0 /6 0 /4 0 /6 1 /6 1 /6 0 /6
1 .Omgkg'1 0 /5 0 /6 0 /6 0 /6 0 /6 0 /6
2. Omgkg*1 0 /6 0 /6 1 /6 0 /6 0 /6 0 /5
4. Omgkg-1 0 /6 0 /6 0 /6 0 /6 0 /6 0 /6
None
Control 6 /6 6 /6 6 /6 6 /6 6 /6 6 /6
* C o n t r o l
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STUDIES IN MICE
TABLE 13. aDDendix I 
ON THE THERAPEUTIC ACTIVITY OF ISOMETAMIDIUM
ON TRYPANOSOME POPULATIONS ISOLATED FROM CATTLE SUSCEPTIBLE
TO THE 7 MONTH CHALLENGE 
Data = No. mice parasitaemic/No. mice trea ted
TREATMENT ANIMAL: *IA,C) FI
6 hours
0.5mgkg-1 0 /6 0 /6
1. Omgkg-1 0 /6 0 /6
2. Omgkg-1 0 /6 0 /6
4. Omgkg-1 0 /6 0 /6
IO7 trvps .m l-1
0.5mgkg-1 0 /6 1 /6
1 .Omgkg-1 0 /5 0 /6
2. Omgkg-1 0 /6 0 /5
4. Omgkg-1 0 /5 1 /4
None
Control 6 /6 6 /6
* C o n t r o l
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Table 14. appendix I
MOUSE INFECTIVITY OF I N  V I T R O -DERIVED T.CONGOLENSE ILNat 
3.1 METACYCLIC TRYPANOSOMES SUBSEQUENT TO 
GAMMA-IRRADIATION 
(Mouse inoculum = lxlO5 trypanosomes)
Data = No. mice parasitaemic/No. mice inoculated
GAMMA- MOUSE GROUPS
RADIATION __________________________________
(KILORADS) IRRADIATED CONTROL
0 -  6 /6
5 3/6 6/6
10 0 /6  6 /6
15 0/6 6/6
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Table 15, appendix I
INFECTIVITY NEUTRALISATION TEST USING T .C ON GOL E NS E  ILNat 3.1  
METACYCLIC TRYPANOSOMES
Figures = No . mice parasitaemic/No. mice inoculated.
All !sera tested at a d i lu t io n  of 1:2.
ANIMAL: D127 D128 D129 D133 D134 D135
DAY
0* 6/6 6/6 6/6 5/6 6/6 6/6
2 6/6 6/6 6/6 6/6 5/6 5/6
4 5/6 6/6 6/6 6/6 6/6 6/6
6 6/6 6/6 6/6 5/6 6/6 5/6
8 5/5 6/6 5/6 6/6 5/6 3/6
10 6/6 6/6 4/6 5/6 5/6 6/6
12 6/6 5/6 5/6 6/6 6/6 5/6
14 6/6 6/6 2/6 6/6 6/6 5/6
16 6/6 6/6 4/6 4/4 2/6 4/6
*Dav 0 - c a t t le  administered 1x106 aamma-irradiated T.conaolense 
ILNat 3.1 metacyclic trypanosomes,intradermally.
Positive controls included (data not shown).
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Table 16. appendix I
I FA TEST USING FORMALDEHYDE FIXED T . CONGOLENSE ILNat 3,.1
METACYCLIC TRYPANOSOMES
Figures = % populationi strongly fluorescent.
A ll sera tested at a d i lu t io n  of 1:10 •
ANIMAL: D127 D128 D129 D133 1D13 4 D135
DAY
0* 0 0 0 0 0 0
2 0 0 0 0 0 0
4 0 0 0 0 0 0
6 0 0 0 0 0 0
8 5 30 48 26 36 44
10 0 0 0 0 0 0
12 0 0 0 0 0 0
14 0 0 0 0 0 0
16 0 0 0 0 0 0
*Day 0 - cattle administered lxlO6 gamma-irradiated T.conaolense 
ILNat 3.1 metacyclic trypanosomes,intradermally.
Positive sera included (data not shown).
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FIGURE 1
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Figure 1 : 2 month T.congolense IL 2642 tsetse challenge control.
Change in skin thickness at tsetse bite sites and width of 
draining lymph node; change in temperature and development 
of parasitaemia.
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Appendix I,
FIGURE 2
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Figure 2 : 2 month T.congolense ILNat 3.1 metacyclic (5x10 ) challenge
control. Change in skin thickness at inoculation sites and 
width of draining lymph node; change in temperature and 
development of parasitaemia.
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Appendix I,
FIGURE 3
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Figure 3 : 3 month T.congolense ILNat 3.1 metacyclic (5x10 ) challenge
control. Change in skin thickness at inoculation sites and 
width of draining lymph node; change in packed red cell 
volume (PCV) and development of parasitaemia.
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Appendix I,
FIGURE 4a
Control
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Figure 4a : 4 month challenge. Change in width of the draining lymph 
node; and development of parasitaemia in E4, F3 and the 
T.congolense ILNat 3.1 metacyclic (5x10^) challenge control.
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Appendix I,
FIGURE 4b
Control
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Figure 4b: 4 month challenge. Change in skin thickness at inoculation 
sites in E4, F3 and the T.congolense ILNat 3.1 metacyclic 
(5x103) challenge control.
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Appendix I,
FIGURE 5
24
.XT'
12
40
30 ■a
10
0 10 20
DAYS AFTER INFECTION
Figure 5 : 3 month T .congolense ILNat 3.1 tsetse challenge control.
Change in skin thickness at tsetse bite sites and width 
of draining lymph node; change in packed red cell volume 
(PCV) and development of parasitaemia.
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Appendix I,
FIGURE 6
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Figure 6 : 3 month T.congolense IL 2642 tsetse challenge control.
Change in skin thickness at tsetse bite sites and width 
of draining lymph node; change in packed red cell volume 
(PCV) and development of parasitaemia.
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APPENDIX I I
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BORAN W5
Table 1, aDDendix I I  
- 24 HOUR I N  V I T R O  INCUBATION OF PLASMA
WITH T . c o n a o l e n s e  ILNat 3. 1 BLOODSTREAM FORMS
(susceptible to challenge on day 181)
% GROWTH MOUSE INFECTIVITY
SAMPLE DAY INHIBITION INOCULUM FOR MICE*
la 0 0 1.0x105 5/5
lb 0 0 1.0x105 5/5
2a 34 57.1 7.8x104 0/5
2b 34 -3 .5 1.0x105 0/5
3a 58 100 ND
3b 58 95.8 3.5x103 0/5
4a 83 100 ND
4b 83 100 ND
5a 118R 100 ND
5b 118R 100 ND
6a 153 100 ND
6b 153 100 ND
7b 174 -17 .2 1.0x105 4/5
8a 188 100 NTC 0 /5
8b 188 100 NTC
* Data = No. mice parasitaemic / N o .  mice inoculated, 
a = Experiment 1. 
b = Experiment 2.
ND = Not done.
NTC = No trypanosomes counted.
R = Refractory to challenge.
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Table 2. appendix I I
BORAN W6 - 24 HOUR I N  V I T R O  INCUBATION OF PLASMA 
WITH T . c o n a o l e n s e  ILNat 3.1 BLOODSTREAM FORMS
SAMPLE DAY
% GROWTH 
INHIBITION
MOUSE
INOCULUM
INFECTIVITY 
FOR MICE*
la 0 0 1.0x105 5/5
lb 0 0 1.0x105 5/5
2a 27 100 - ND
2b 27 100 ND
3a 58 67.1 5.8x104 4/5
3b 58 25.5 1.0x105 1/5
4a 83 99.3 1.3x103 0/5
4b 83 94.7 1.9x104 0/5
5a 118R 100 ND
5b 118R 100 ND
6b 148 100 NTC 0/5
7a 181s 6.7 l.OxlO5 5/5
7b 181s -0.8 l.OxlO5 5/5
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment 1. 
b = Experiment 2.
ND = Not done.
NTC = No trypanosomes counted.
R = Refractory to challenge. 
s = Susceptible to challenge.
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Table 3. appendix I I
BORAN W7 - 24 HOUR IN  VITRO INCUBATION OF PLASMA 
WITH T . conpolense  ILNat 3.1 BLOODSTREAM FORMS
SAMPLE DAY
% GROWTH 
INHIBITION
MOUSE
INOCULUM
INFECTIVITY 
FOR MICE*
la 0 0 1.0x105 5/5
2a 27 100 ND
3a 58 100 ND
4a 83 100 ND
5a 118R - 7 . 5 l.OxlO5 0 /5
6a 148 9.3 1.0x105 0/5
7a 181R 8 .6 l.OxlO5 3 /5
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment 1.
ND = Not done.
NTC = No trypanosomes counted.
R= Refractory to challenge.
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BORAN
Table 4, aDDendix I I  
W1 - 24 HOUR I N  V I T R O  INCUBATION OF PLASMA
WITH T . c o n a o l e n s e  ILNat 3.,1 BLOODSTREAM FORMS
(day 181 plasma sample = control)
% GROWTH MOUSE INFECTIVITY
SAMPLE DAY INHIBITION INOCULUM FOR MICE*
la 0 100 ND
2a 27R 100 ND
3a 58R 93.6 ND
4a 83R 100 ND
5a 118R 100 ND
6a 148R 12.5 l.OxlO5 5/5
7a 181s 0 l.OxlO5 5/5
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment 1 (only one experiment conducted).
ND = Not done.
R = Refractory to challenge. 
s = Susceptible to challenge.
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Table 5, appendix I I
BORAN W2 - 24 HOUR I N  V I T R O  INCUBATION OF PLASMA 
WITH T . c o n v o l e n s e  ILNat 3.1 BLOODSTREAM FORMS
SAMPLE DAY
% GROWTH 
INHIBITION
MOUSE
INOCULUM
INFECTIVITY 
FOR MICE*
la 0 100 ND
2a 27 100 ND
3a 58R 100 ND
4a 83 100 ND
5a 118 100 ND
6a 148 100 ND
7a 181s 0 6.7xl04 5/5
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment I  (only one experiment conducted).
ND = Not done.
R = Refractory to challenge. 
s = Susceptible to challenge.
- 347 -
BORAN W3
Table 6, aDDendix I I  
- 24 HOUR I N  V I T R O  INCUBATION OF PLASMA
WITH T . c o n a o l e n s e  ILNat 3..1 BLOODSTREAM FORMS
(day 181 plasma sample «* control)
% GROWTH MOUSE INFECTIVITY
SAMPLE DAY INHIBITION INOCULUM FOR MICE*
la 0 100 ND
2a 27 100 ND
3a 58R 93.6 ND
4a 83 100 ND
5a 118 100 ND
6a 148 100 ND
7a 181s 0 l.OxlO5 4 / 4
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment 1 (only one experiment conducted).
ND = Not done.
R = Refractory to challenge. 
s = Susceptible to challenge.
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BORAN W4
Table 7a. aDDendix I I  
- 24 HOUR I N  V I T R O  INCUBATION OF PLASMA
WITH T . c o n a o l e n s e  ILNat 3. 1 BLOODSTREAM FORMS
(day 174 sample = control)
SAMPLE DAY
% GROWTH 
INHIBITION
MOUSE
INOCULUM
INFECTIVITY 
FOR MICE*
la 0 100 NTC 0/5
lb 0 100 NTC 0/5
2a 34 100 ND
2b 34 100 ND
3a 58 96.9 6.9x103 0 /5
3b 58 99.2 3.1x103 0 /5
4a 83R 100 ND
4b 83R 100 ND
5a 118 100 ND
5b 118 100 ND
6a 153 100 ND
7b 157 100 ND
8a 174 0 1.0x105 5 /5
8b 174 0 1.0x105 5 /5
9a 188 100 ND 0 /5
9b 188 100 ND
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment 1. 
b = Experiment 2.
ND = Not done.
NTC = No trypanosomes counted.
R = Refractory to challenge.
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Table 7b. appendix I I
BORAN W4 - 24 HOUR I N  V I T R O  INCUBATION OF PLASMA 
WITH T . c o n a o l e n s e  ILNat 3.1 BLOODSTREAM FORMS
(foeta l bovine serum (FBS) » control)
% GROWTH MOUSE INFECTIVITY
SAMPLE DAY INHIBITION INOCULUM FOR MICE*
la FBS 0 1.0x105 5/5
lb FBS 0 1.0x105 5/5
2a 41 100 ND
3a 48 100 ND
4a 55 3.4 1.0x105 0/5
5a 58 66.5 1.0x105 0/5
6a 62 100 ND
7a 70 100 ND
8a 76 100 ND
9b 153 100 ND
10b 160 ■100 ND
l ib 167 100 ND
12b 181s 23.0 l.OxlO5 5/5
13b 196 100 ND
14b 202 100 ND
15b 209 73.3 1.0x105 4/5
* Data = No. mice parasitaemic /  No. mice inoculated, 
a = Experiment 1. 
b = Experiment 2.
ND = Not done.
s = Susceptible to challenge.
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Table 1. appendix I I I  
T . V I V A X  EXPERIMENTS - CATTLE CODES
________ EXPERIMENT_1________   EXPERIMENT 2________
ANIMAL CODE GROUP NUMBER ANIMAL CODE GROUP NUMBER
G1 G D335 01 0 D316
G2 G D339 J2 0 D317
G3 G D343 J3 0 D318
G4 G D359 J4 0 D319
G5 G D363 05 0 D374
HI H D338 K1 K D321
H2 H D340 K2 K D329
H3 H D347 K3 K D365
H4 H D350 K4 K D366
H5 H D355 K5 K D370
CONTROLS
MONTH CODE GROUP G GROUP H GROUP 0 GROUP K
1 la D330 D332 D536 D561
1 lb D331 D334 -
2 2a D336 D348 - D562
2 2b D341 D349 - -
3 3a D354 - - -
3 3b D356 - - -
4 4a D337 - - -
4 4b D357 - - -
5 5a D21 - - -
5 5b D51 - - -
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T a b l e  2 .  a p p e n d i x  I I I
1 MONTH CHALLENGE - TSETSE DATA
T.V IVA X ANIMAL DAY
N o.+ve
BITES DAY
N o.+ve
BITES
TOTAL
+ve
BITES
IL  2968 G1 32 6 35 5 11
II G2 II 7 II 3 10
11 G3 II 4 II 7 11
II G4 II 4 II 7 11
II G5 II 5 II 8 13
IL  2969 HI 32 10 35 - 10
11 H2 II 7 ii 3 10
II H3 II 8 ii 2 10
II H4 It 11 ii - 11
If H5 II 13 ii - 13
C 0 N T R O L S
IL  2968 a 32 10 - - 10
II b ii 10 - - 10
IL  2969 a 32 10 - - 10
II b II 10 - - 10
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T a b l e  3 ,  a p p e n d i x  I I I
DETECTION OF TRYPANOSOMES BY THE BUFFY-COAT PHASE-CONTRAST (BC) 
TECHNIQUE AND MOUSE INOCULATION (MI) FOLLOWING CHALLENGE 
1 AND 2 MONTHS AFTER ADMINISTRATION OF ISOMETAMIDIUM CHLORIDE
1 MONTH CHALLENGE 2 MONTH CHALLENGE
MI MI
Group Animal BC/DFOP d 12 d24 BC/DFOP dl2 d24
G G1 - 0* 0 - 0 0
G G2 - 0 0 - 0 0
G G3 - 0 0 - 0 0
G G4 - 0 0 - 0 0
G G5 - .0 0 - 0 0
H HI - ND ND 7 ND ND
H H2 - ND ND 9 ND ND
H H3 12 ND ND
H H4 23 ND ND
H H5 24 ND ND
G CONTROL a 10 2 3 11 3 3
G CONTROL b 10 3 3 11 3 3
H CONTROL a 10 ND ND 11 ND ND
H CONTROL b 9 ND ND 11 ND ND
BC/DFOP = Day f i r s t  observed parasitaemic using BC technique.
*  = Number of mice parasitaemic (3 mice inoculated).
ND = Not done; non-infective fo r mice.
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T a b l e  4 ,  a p p e n d i x  I I I
DETECTION OF TRYPANOSOMES BY THE BUFFY-COAT PHASE-CONTRAST (BC) 
TECHNIQUE AND MOUSE INOCULATION (MI) FOLLOWING CHALLENGE 
3. 4 AND 5 MONTHS AFTER ADMINISTRATION OF ISOMETAMIDIUM CHLORIDE
3 MONTH CHALLENGE 4 MONTH CHALLENGE
MI MI
Group Animal BC/DFOP d 12 d24 BC/DFOP d 12 d24
G G1 . - 0* 0 - 0 0
G G2 - 0 0 - 0 0
G G3 11 2 3
G G4 - 0 0 11 3 3
G G5 11 3 3
G CONTROL a 11 3 3 11 3 3
G CONTROL b 9 3 3 11 3 3
5 MONTH CHALLENGE
MI
Group Animal BC/DFOP dl 2 d24
G G1 - 0 0
G G2 - 0 0
G CONTROL a 11 3 3
G CONTROL, b 9 3 3
BC/DFOP = Day f i r s t  observed parasitaemic using BC technique. 
*  = Number of mice parasitaemic (3 mice inoculated).
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Table 6 ,appendix I I I
DRAINAGE PREFEMORAL LYMPH NODE BREADTH CHANGE IN ANIMALS 
SUSCEPTIBLE TO CHALLENGE
GROUP ANIMAL
% INCREASE IN PREFEMORAL 
LYMPH NODE BREADTH
H
H
G control 
G control 
H control 
H control
2 MONTH CHALLENGE (DAY 60)
HI 40
H2 50
a 240
b 180
a 60
b 130
G
G
G control 
G control
3 MONTH CHALLENGE (DAY 91)
G3
G5
a
b
150
270
210
220
4 MONTH CHALLENGE (DAY 119)
G G4 0
G control a 180
G control b 200
5 MONTH CHALLENGE (DAY 151)
G control 
G control
180
210
G control mean = 203% + 22% (S .D .). 
H control mean = 110% + 34% (S .D .).
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Table *7, appendix III
TEMPERATURE MEASUREMENTS OVER 39.4 C FOLLOWING THE FIRST AND SECOND CHALLENGE
1 MONTH CHALLENGE (25 ) 2 MONTH CHALLENGE (27 )
NPM NPM
GROUP ANIMAL DFOP NTMP NPM NTMP % DFOP NTMP NPM NTMP %
G G1 - ND ND — _ _ 0 _
G G2 - ND ND - - - 0 -
G G3 - ND ND - - - 0 -
G G4 - ND ' ND - - - 0 -
G G5 - ND ND - - - 0 -
H HI - ND ND - 7 21 3 14
H H2 - ND ND - 9 19 i 2 11
H H3 12 ND ND -
H H4 23 ND ND -
H H5 24 ND ND -
CONTROLS
G a 10 16 9 56 11 17 5 29
G b 10 16 (1)9 56 11 17 5 29
H a 10 16 4 25 11 17 8 47
H b 9 17 (1)2 12 11 17 (1)14 82
G = T.vivax IL 2968 challenge challenge; H = T..vivax IL 2969 challenge.
DFOP = Day first observed parasitaemic.
NTMP = Number of temperature measurements made when parasitaemic. 
NPM = Number of pyrexic temperature measurements.
( ) = Non parasitaemic.
* = Number of measurements.
ND = Not done.
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Table 9a, aDDendix I I I
TRYPANOLYSIS TEST USING T . V I V A X  IL 2968 ANTIGEN AND SERA FROM GROUP G
CATTLE (CHALLENGED WITH T . V I V A X  IL 2968)
Figures = Percentage trypanosomes lysed (100 counted)
1 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1 1 1 0 4 3
G2 1 1 0 8 12
G3 0 3 1 2 2
G4 3 3 1 3 1
G5 0 3 3 4 9
CONTROLS
a 2 0 4 73 100
b 0 1 4 59 93
Serum controls = 7, 12
2 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1 3 1 3 6 2
G2 12 1 2 3 9
G3 2 0 1 0 2
G4 1 2 0 1 9
G5 9 1 0 7 17
CONTROLS
a 6 0 4 85 100
b 13 0 3 82 95
Serum controls = 7, 12
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Table 9b. appendix I I I  
TRYPANOLYSIS TEST USING T . V I V A X  IL 2968 ANTIGEN AND SERA FROM GROUP G
CATTLE (CHALLENGED WITH T . V I V A X  IL 2968)
Figures = Percentage trypanosomes lysed (100 counted)
3 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1 0 4 0 0 0
G2 0 0 2 0 2
G3 0 0 2 68 82
G4 0 0 3 0 1
G5 0 2 5 83 92
CONTROLS
a 3 2 6 84 85
b 2 0 3 87 93
Serum controls = 5, 3
4 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1 3 3 3 2 3
G2 1 1 6 3 4
G4 2 4 3 68 84
CONTROLS
a 1 0 3 76 81
b 1 1 5 74 98
Serum controls = 7, 1
5 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
G1 0 0 1 0 3
G2 0 0 0 1 0
CONTROLS
a 1 1 3 72 84
b 2 1 1 56 75
Serum controls = 1, 2
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Table 10, appendix I I I  
TRYPANOLYSIS TEST USING T . V I V A X  IL 2969 ANTIGEN AND SERA FROM GROUP H
\ CATTLE (CHALLENGED WITH T . V I V A X  IL 29691
Figures = Number trypanosomes lysed/50 counted
1 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
HI 1 0 0 1 0
H2 0 0 0 6 0
H3 1 0 0 46 8
H4 1 2 1 4 1
H5 1 1 2 1 2
CONTROLS
a 0 0 1 50 50
b 0 0 1 50 50
Serum controls = 2, 1
2 MONTH CHALLENGE
ANIMAL DAY 0 DAY 7 DAY 14 DAY 21 DAY 28
HI 0 0 25 48 46
H2 0 0 2 41 38
H3 8 37 ND ND ND
H4 1 34 ND ND ND
H5 2 32 ND ND ND
CONTROLS
a 0 6 0 46 40
b 1 0 2 45 48
Serum controls = 2, 1
ND = Not done.
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Table 11, appendix I I I
1S0METAMIDIUM SENSITIVITY STUDIES ON BREAKTHROUGH TRYPANOSOME 
POPULATIONS OCCURRING IN GROUP G CATTLE
3 MONTH CHALLENGE 4 MONTH CHALLENGE
ANIMAL:
TREATMENT
G3 G5 (a) G4 (a)
6 hours
0.5nigkg-1 0/6*> 0 /6 3 /6 0 /6 0 /6
1 .Omgkg-1 0 /5 0 /6 0 /6 0 /6 0 /6
2.0niqkq-1 1 /6 0 /6 0 /6 0 /6 0 /6
4. Omgkg-1 0 /6 0 /6 0 /3 0 /6 0 /3
107 t r v D s .m l -1
0.5mgkg-1 4 /6 5 /6 2 /6 2 /6 2 /6
1 .Omgkg-1 0 /4 2 /6 3 /6 1 /5 1 /6
2. Omgkg-1 0 /5 0 /6 0 /6 0 /6 0 /6
4. Omgkg-1 0 /6 0 /6 0 /6 1 /6 0 /6
None 6 /6 6 /6 6 /6 6 /6 6 /6
( ) = Control animal.
*=  Number of mice parasitaemic /  Number of mice inoculated.
«■
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Table 12. appendix I I I
DETECTION OF PARASITAEMIA IN GROUP H ANIMALS FOLLOWING 3 MONTH 
CHALLENGE WITH T . CONGOLENSE ILNat 3.1
1st Day
detected parasitaemic Mouse inoculation 
by BC technique Day 12 Day 24Animal/Status
HI*
H2*
H3*
H4*
H5*
Controls
1 - Group H 1 month control*
2 - Group H 1 month control*
3 - Berenil only*
4 - Berenil only*
5 - Berenil only*
6 - Non-infected + no Berenil
12
12
12
12
17
12
0/3+
0/3
0/3
0/3
0/3
3/3
3/3
3/3
3/3
0 / 2
2/3
0/3
0/3
0/3
0/3
0/3
3/3
3/3
3/3
2/3
3/3
3/3
* = 3.5mg kg-1 diminazene aceturate administered 18 days prior to 3 
month (day 93) challenge.
+ Figures = Number mice parasitaemic /  Number mice inoculated.
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Table 13. appendix I I I
SKIN THICKNESS AND DRAINAGE LYMPH NODE BREADTH CHANGES IN GROUP H 
ANIMALS FOLLOWING 3 MONTH CHALLENGE WITH T .C ON GO L E N S E  ILNat 3.1
Change in skin thickness 
at ( f iv e )  challenae s ites
% Increase in 
prefemoral
Animal/Status Large
65+%
Moderate S lig h t 
41-64%  20-40%
lymph node 
breadth
H I* - - -
H2* - 2 -
H3* - 3 -
H4* - - -
H5* - - -
Controls
1 - Group H 1 month contro l* 5 —  _ 210
2 - Group H 1 month control* 2 3 210
3 - Berenil only* 1 4 340
4 - Berenil only* 5 - 220
5 - Berenil only* 5 - 320
6 - Non-infected + no Berenil 5 - 240
* =  3.5mg kg-1 diminazene aceturate administered 18 days p r io r  to 3 
month (day 93) challenge.
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FIGURE 1
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Figure 1: Group G (T .vivax IL 2968) 1 month challenge control (la).
Change in temperature; change in skin thickness at tsetse 
bite sites and width of draining lymph node; change in 
packed red cell volume (PCV) and development of 
parasitaemia.
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Appendix III,
FIGURE 2
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Figure 2 : Group H (T .vivax IL 2969) 1 month challenge control (la).
Change in temperature; change in skin thickness at tsetse 
bite sites and width of draining lymph node; change in 
packed red cell volume (PCV) and development of 
parasitaemia.
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Appendix III,
FIGURE 3
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Figure 3: 1 month T .vivax IL 2969 tsetse challenge. Change in
packed red cell volume (PCV) and development of 
parasitaemia in H3, H4 and H5.
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Appendix V,
FIGURE 1
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Figure 1: T.congolense ILNat 3.1
- 373 -
Figure 2:
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FIGURE 3
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Figure 3: T.vivax IL 2968
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Appendix V,
FIGURE 4
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Figure 4: T.vivax IL 2969
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Appendix V,
FIGURE 5
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Figure 5: T.vivax IL 2982
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Appendix V,
FIGURE 6
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Figure 6: T.vivax IL 2986
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FIGURE 7
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